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Abstract
In biochemistry, sulfur-containing biomolecules enrich the chemical diversity in cells.
This occurs via their participation in several reactions including disulfide formation,
metal-binding and redox catalysis. Since sulfur occurs in various oxidation states, it
exhibits interesting chemistry and reactivity. In this Dissertation computational modeling
techniques have been used to investigate several aspects of sulfur's unique chemistry.
Chapter 1 provides a brief introduction summarizing the importance of sulfur in
biochemistry. In particular it discuss the chemical diversity and redox chemistry of sulfur
in biology. Chapter 2 provides an overview of the computational methods commonly
used in studying enzymatic reactions.
Chapter 3 discusses the reduction mechanism of S-methionine sulfoxide (Met-O) to
methionine via a ubiquitous antioxidant enzyme known as methionine sulfoxide reductase
A (MsrA). We used a wide range of computational methods including docking, molecular
dynamics simulations and QM/MM calculations. Our results have proposed new roles for
active site residues such as Asp87. In addition, the activation mechanism of the catalytic
cysteine was revealed. Furthermore, the effect of active site tyrosyl residues after
mutation were also considered and found in agreement with experimental results. The
formation and reduction mechanism of sulfenic acid intermediate was computationally
elucidated. It showed that sulfenic acid is formed via the activation of a water molecule in
accordance with a new experimental study. Notably, our results support that sulfenic acid
is readily reduced upon proper positioning of the second cysteinyl residue solving the
controversy in experimental studies regarding this step.
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In Chapter 4, we discuss our computational investigation on the last step in the
reductase step of the catalytic mechanism of methionine sulfoxide reductase B (MsrB),
the formation of disulfide directly or via sulfenic acid intermediate. Our previous work on
MsrB showed that, unlike MsrA, sulfenic acid is not formed in the catalytic mechanism.
Due to a disagreement with experimentalists, we considered investigating the effect of
level of theory, the effect of model choice QM-cluster vs. QM/MM and the effect of
choosing a starting structure from X-ray vs. MD. Our QM/MM results based on MD
show that sulfenic acid occurs in the mechanism. We also considered running MD
simulations throughout the reaction coordinates to test the effect of substrate binding on
the distance between the two catalytic cysteinyl residues.
In Chapter 5, we discuss our synergistic use of docking, MD simulations and virtual
screening to investigate the mechanism of MsrA activation via small ligands. The
possibility of their direct molecular interaction with MsrA was tested using docking
techniques identifying a novel allosteric site. Furthermore, the effect of ligand-MsrA
binding was elucidated using MD simulations. Our MD results suggest that their binding
facilitates the unfolding of two-stranded antiparallel β–sheet revealing the active site for
subsequent reduction by thioredoxin (Trx). Finally, virtual screening was employed to
identify other potential ligands to act as MsrA activators.
Chapter 6 discusses our computational investigation on the second step (formation
sulfenyl-amide intermediate from sulfenic acid) in protein tyrosine phosphatase 1B
(PTP1B). We propose an alternative pathway to the previously suggested high-energy
barrier mechanism proposing new roles for active site residues. Furthermore, the role of
non-covalent interactions was highlighted and supported using QTAIM and NBO
analysis.
In Chapter 7 the reduction mechanism of peroxide via the archaeal peroxiredoxin
(ApTPx) antioxidant enzyme was discussed. In addition, the formation of the previously
proposed hypervalent intermediate from sulfenic acid was tested.
!
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interactions in this highly coordinated species was elucidated using QTAIM and NBO
analysis. Furthermore, the transferability of this unique sulfenic acid protection
mechanism to other enzymes was also considered. Moreover, the overoxidation
mechanism of sulfenic acid to sulfinic acid was examined for the first time.
Chapter 8 describes our MD and ONIOM investigation on the unique reduction
mechanism of the 2-Cys perxoiredoxins (Prxs) sulfinic acid via sulfiredoxin (Srx). The
previously suggested sulfinic acid phosphoryl ester and thiosulfinate intermediate were
characterized in the active site. Understanding the generally irreversible sulfinic acid
intermediate reduction mechanism can potentially enable the development of new
antioxidant drugs.
In Chapter 9 we discuss our investigation of the cis-trans isomerization mechanism of
maleate to fumarate via maleate isomerase (MI) enzyme. Small DFT models, QM-cluster
approach, QM/MM and MD were employed to investigate previously proposed
mechanisms. Previous X-ray and mass spectrometry studies have suggested a novel
mechanism in the racemase family in which an active site cysteinyl residue covalently
bonds to the substrate forming either a succinyl-cysteinyl or enediolate intermediate. Our
calculations show that the enediolate intermediate is unstable and succinyl cysteine
intermediate occurs in the mechanism. Also, proton affinities calculations of active site
cysteinyl residues and substrate in protein environment indicated different roles for active
site cysteinyl residues from the proposed ones. Notably, our QM/MM calculations of both
pathways (experimental and proton affinities-based) have confirmed our conclusion.
These results highlights that the mutation of active site residue might mislead the
conclusion of the enzymatic mechanism.
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Figure A8. QM layer of the QM/MM model used to investigate the overoxidation
mechanism of ApTPx.
Figure A9. QM layer of the QM/MM model used to investigate the pseudo-sulfurane
intermediate formation in hORF6.
Table B1.

XYZ-coordinates of the optimized structures of all species considered in

this study.
Table B2.

A full list of the top 292 potential MsrA activator ligands and their

docking score.
Appendix C. Copyright permission
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List of Abbreviated
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AMBER

Assisted Model Building and Energy Refinement

AMD

Arylmalonate decarboxylase

ApTPx

Thioredoxin peroxidase of A. pernix.

ATP

Adenosine triphosphate

CASSCF

Complete active space SCF

CC

Coupled cluster

CG

Coarse grain

CI

Configuration interaction

CTI

Cis-trans isomerization

Cys

Cysteine

DFT

Density functional theory

DFTB

Self-consistent charge density functional tight-binding method

DMSO

Dimethyl sulfoxide

DTT

Dithiothreitol

EE

Electrostatic embedding

EVB

Empirical valence bond

FAD

Flavin adenine dinucleotide

GHO

Generalized hybrid orbital

GluR

Glutamate racemase

GR

Glutathione reductase
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GSH

Glutathione

HF

Hartree Fock

LDA

Local density approximation

MD

Molecular dynamics

ME

Mechanical embedding

Met

Methionine

Met-O

Methionine sulfoxide

MI

Maleate isomerase

MNDO

Modified neglect of diatomic differential overlap approximation

MM

Molecular mechanics

MOE

Molecular Operating Environment program

MP2

Second-order Møller-Plesset perturbation theory

Msr

Methionine sulfoxide reductase

NAD

Nicotinamide adenine dinucleotide

NBO

Natural bond orbitals

Nox

NADH oxidase

Npx

NADH peroxidase

PA

Proton affinity

PC

Product complex

PCM

Polarized continuum model

Perg

Pergolide

PerSO

Pergolide sulfoxide

PRC

Pre-reactive complex

ProR

Proline racemase

Prx

Peroxiredoxin

PTP

Protein tyrosine phosphatase

QCISD

Quadratic configuration interaction
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QM

Quantum mechanics

QM/MM

Quantum mechanics/molecular mechanics

QTAIM

Quantum theory of atoms in molecule

RC

Reactive complex

RMSD

Root mean square deviation

RNS

Reactive nitrogen species

ROS

Reactive oxygen species

SAM

S-adenosyl-L-methionine

Srx

Sulfiredoxin

Trx

Thioredoxin

TS

Transition state
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Chapter 1
Introduction

!

1!

1.1 Introduction:
The importance of sulfur in biochemistry has been recognized as early as the first half
of the 20th-century with the discovery of insulin.1 Subsequently it has been found to play
a key role in all major classes of biomolecules such as proteins, nucleic acids, and
carbohydrates, as well as cofactors and many metabolites.2 In fact, sulfur is the only
element other than N, C, and H that occurs in the 20 genetically encoded amino acids,
being found in both cysteine (Cys) and methionine (Met).3 Sulfur-containing
biomolecules greatly enrich the chemical diversity in cells in part as they can undergo a
diverse variety of chemical reactions including nucleophilic substitution (e.g.
thioredoxin), electron transfer (e.g. glutathione reductase (GR)), proton, hydrogen or
hydride transfer (e.g. NADH peroxidase (Npx)), and oxygen atom transfer (e.g. NADH
oxidase (Nox)).4,5
This versatile chemistry of sulfur containing-biomolecules partially originates from
being in the chalcogens group of the periodic table wherein sulfur and oxygen share
similar chemical reactivity.6,7 However, being in lower position in the periodic table,
sulfur has a lower electronegativity.6 As a result, sulfur-containing biomolecules are often
better nucleophiles than oxygen-containing biomolecules. Additionally, disulfide bonds
(RS–SR) are generally more stable than the peroxide bonds (RO–OR).6,7
Another important contributing reason for sulfur's distinct reactivity is its electronic
configuration of [Ne]3s23p43d0, which contains an energetically accessible d-orbital that
can be involved in bonding.8 Indeed, this electronic configuration enables sulfur to exhibit
a range of oxidation states.8 Notably, in biochemistry, the oxidation states of sulfur have
been found to vary from -2 to +6.5,8,9 Interestingly, it has been noted that there appears to
be a correlation between the complexity of a cell and its sulfur content. For instance, in
archaea the average occurrence of Cys in proteins is 0.4%-0.5% while in mammalian
cells it is 2.26%.6
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Thiol (–SH) is a common sulfur containing functional group within biochemical
systems. Indeed, the unique R-group of Cys contains a thiol. At physiological pH it
predominantly exists in its neutral form (i.e., RSH). For example, as the pKa of the Rgroup thiol of Cys is around 9.8 However, the reactivity of a thiol can be increased by its
deprotonation to form a thiolate anion (RS–). The latter is a much better nucleophile, and
can react with soft or hard electrophiles such as carbonyl and phosphoryl groups.8
Notably, the high reactivity of RS– plays key roles in a range of cellular functions such as
catalysis, post-translational modifications, protein structure, metal binding, and
detoxification of xenobiotics.4,5,10
The R-group of Met contains a divalent sulfur atom (RSCH3). Notably, Met has been
found to play a number of crucial cellular roles, especially in redox signaling.11,12 This is
due in part to the fact that it is one of the most readily oxidized amino acids.13 Indeed, due
to its ability to undergo reversible oxidation under some conditions it has been suggested
to play a role as a protein 'oxidation sink' or antioxidant.12,14 It is also noted that Met is the
initiating amino acid in eukaryotic protein synthesis.15 In addition, upon its metabolism,
Met can act as a methyl group donor, and form other sulfur containing amino acids such
as homocysteine and cysteine.16
Unlike other redox reactions in biochemistry, Cys mediated redox systems are unique
as they do not require metal ions or cofactors (e.g. NAD+ or FAD).4,17 In Cys the sulfur is
in its fully reduced oxidation state of -2 and can readily undergo several redox
reactions.4,18 This is due to the low oxidation/reduction potential of the Cys side chain;
E°! -0.27 to -0.125 V.8 In general, higher oxidation states of Cys, specifically from -1 to
+4, are less stable and a larger amount of energy is required for their further oxidation.6
Regardless, a diverse array of thiol-derived species' can be obtained via redox reactions in
biochemical systems including sulfenic, sulfinic and sulfonic acids, thiosulfinate,
thiosulfonate, disulfide trioxide, disulfone and disulfide (Figure 1.1).4,6,19 It is noted that
the formation of a disulfide is the most common thiol redox modification.5,17
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R–SOH

R–SO2H
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Thiol
(-2)
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(+3/+3)

O
Disulfide Trioxide
(+1/+3)

R–S–S–R
O
Thiosulfonate
(-1/+3)

Figure 1.1. Schematic illustration of some thiol-derived species obtained via redox in
biochemical systems.

With a sulfur oxidation state of 0, sulfenic acid (RSOH) has both nucleophilic and
electrophilic character. As such, it is a chief intermediate in thiol redox chemistry with
broad biological roles in signal transduction, non-enzymatic protein folding, protection
against reactive oxygen species' (ROS) and modulating gene transcription.6,20,21 It is also
now proposed to be an essential precursor intermediate for disulfide bond formation.22
RSOH can be formed via the direct oxidation of Cys by reactive oxygen or nitrogen
species' (ROS/RNS), peroxynitirite, or hypochlorous acid. Alternatively, it can be formed
indirectly either during some enzymatic mechanisms, or xenobiotic metabolism.21,23
Sulfenic acid is highly reactive and unstable,6,19 and can be irreversibly oxidized to form
sulfinic or sulfonic acid.20 Hence, it generally occurs as an intermediate along a reaction
pathway.
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Figure 1.2. Schematic illustration of sulfenic acid proposed reactions in biochemistry.

The protection of sulfenic acid against overoxidation is crucial to maintaining cellular
health.20,21 In fact, the presence of high oxidation state intermediates are hallmarks for
many diseases.6 Consequently, many reactions in biochemical systems have been
identified as protective mechanisms for sulfenic acid. The most common mechanism is its
reduction to disulfide. However, some mechanisms involve the formation of unusual and
unique species'.6,19,24 For instance, using X-ray crystallography a sulfenyl-amide
intermediate was identified in the enzyme protein tyrosine phosphatase 1B.25 In archaeal
peroxiredoxin (ApTPx) a unique electron density was identified in the crystal structure
that was suggested to be a hypervalent sulfurane intermediate.26 The oxidation of sulfenic
acid to a sulfinic intermediate in some Prx's was found to be reversible via interactions
with sulfiredoxin and an ATP cofactor.27-29
Despite its importance to biochemical systems, much of sulfur's redox chemistry, for
example that of sulfenic acid, remains unknown or unclear. Notably, some of the above
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proposed intermediates have not been experimentally or computationally characterized. In
this thesis several computational modeling approaches have been applied, at times
synergistically, to investigate sulfur-related biochemistry, in particular the redox
chemistry of Cys and Met including the formation and chemistry of sulfenic acid.
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Chapter 2
Overview of Computational
Methods

2.1 Introduction
In 1888 J. L. Gay-Lussac wrote, “We are perhaps not far removed from the time when
we shall be able to submit the bulk of chemical phenomena to calculation”.1 Almost 40
years after Gay-Lussac's prophecy, Schrodinger and Dirac independently established the
foundation of quantum chemistry conveying his dream to reality. However, the
application of quantum chemical calculations remained limited; for decades only the
investigation of simple systems involving one or a few atoms were practical. Later, the
advent of computers together with the work of many scientists such as John Pople and
Walter Kohn (Nobel Prize winners in chemistry 1998)2 have pushed the limits of
chemical calculations to deal with more complex systems. More recently, Karplus, Levitt
and Warshel were awarded the Nobel Prize in chemistry 20133 “for the development of
multi-scale models for complex chemical systems”. As a result, the application of
quantum chemical calculations has been extended to deal with complex systems not only
in chemistry but also biology, enzymology, genetics, and engineering.

2.2 Computational Enzymology
Enzymes are remarkable natural biological catalysts that speed up chemical reactions
dramatically to maintain cellular life. Elucidating the origin of enzymes' catalytic power
as well as their mechanism of action is central to gaining a more complete understanding
of biochemistry, as well as fundamental chemical principles. Indeed, such information
could be used for several applications such as designing new catalysts as well as new
therapeutic drugs (e.g. enzyme inhibitors).4 Enzymes are very versatile and utilize
numerous mechanisms of action, making their characterization challenging.5,6 In addition,
due to the nature of transition states and the fact that many reaction intermediates are
highly reactive and transient,6 traditional experimental methods are generally unable to
determine all atomistic-level details involved in their chemical reactions.7,8
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In the last two decades, computational modeling techniques have been established as a
powerful tool to dissect in detail enzymatic chemical reactions describing the nature of
intermediates and transition states.7,9,10 More importantly, several fundamental questions
could be answered such as the origin of the enzyme catalytic power, the important
catalytic residues and their mutations, the mode of ligand binding in the protein as well as
the dynamics of its structure and energetics of the reaction.7,8 Thus, currently, the
synergistic use of chemical modeling and laboratory experimentation is essential to study
these powerful catalysts.6,8
Computational enzymology (Figure 2.1) is a growing field of study with potential
contributions in pharmaceutical, chemical and biotechnology industries.11,12 Several
computational chemistry methods have been developed to help answer questions in
enzymology. These methods include quantum mechanics (QM)-cluster, hybrid quantum
mechanical/molecular mechanical (QM/MM), empirical valence bond (EVB), molecular
dynamics simulations (MD) and Car-Parrinello molecular dynamics (CPMD).9,13-15
Notably, the aforementioned methods can achieve high accuracy when studying chemical
systems. For example high-level QM-based methods can accomplish chemical accuracy
near 1 kcal mol-1,16 while parameterized-empirical based methods have also been shown
to be able to provide good agreement with experiment.17

2.3 Protein Dynamics and MD Simulations
MD simulations are one of the fundamental tools in molecular modeling.18 They
enable one to simulate the time dependent behavior of a molecular system by integrating
Newton's laws of motion, providing insights into for example protein dynamics, proteinligand and protein-protein interactions as well as conformational fluctuation. In
computational enzymology, MD simulations can also be used to generate a number of
plausible conformers of the initial reactive complex (RC).19 Subsequently the generated
conformers can be analyzed to select either a single average structure to represent the
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reactive complex or in some cases, several starting structures could be used to examine
the effect of conformer variation on the mechanism.19,20 Notably, choosing an accurate
RC is important to obtaining meaningful results in subsequent mechanistic
calculations.10,21

Figure 2.1. Graph indicating the results of a search on ISI Web of Science using the
criteria: Topic = computational and Topic = enzyme sorted by publication year.

A large number of conformers are needed to calculate the free energy of an enzymatic
system.22 This can be achieved by calculating molecular trajectories using several
simulation methods, such as potential of mean force (PMF).23 In general, understanding
protein dynamics is important as many enzymes undergo large conformational changes
during their catalytic cycle.19 Protein dynamics is involved in both substrate binding and
product release, which could be the rate-limiting step of the mechanism.7
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In biological systems, the size of the required chemical model is often quite large and
complex. Similarly, the time scale required for their simulation is prolonged. Therefore, a
cheaper level of theory is usually used to run the simulation. Typically, a molecular
mechanical (MM) force field is used in simulating the trajectories of these systems. There
are several computational programs to preform MD simulations such as AMBER,
CHARMM, GROMOS and NAMD.24-27 The simulation starts by calculating the forces at
particular time for a finite time period via solving the Newton equation of motion
numerically.

2.4 Molecular Mechanics (MM) Force Fields
These methods use classical mechanics to predict the total energy of molecules as a
function of their conformation. As a consequence, in MM force fields electrons are
ignored and the system is expressed using empirical parameters derived from experiment
or at times high-level conventional ab initio results. Hence, they are most applicable to
ground state and covalent structures. Thus, processes that includes bond breaking or
formation can not be described using MM.28 However, MM force field is very useful in
investigating energy changes upon structural rearrangements as in MD simulations.
Additionally, the total energy is calculated using simple functions,28 an example of
which is shown in equation 2.1.
! !! =

!!"# +

!!"#$ +

!!"#$ +

!!"# +

!!"

(2.1)

In the above example the total MM energy of the system (EMM) is written as the sum of
simple harmonic terms of bond stretching (Estr) and valence angle bending (Ebend), a
periodic term to represent the torsional angles (Etors), while Van der Waals (Evdw) and
electrostatic (Eel) interaction contributions are calculated using Lennard-Jones potentials
and Coulomb's law, respectively (equation 2.2).
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The terms !!" and !! are the repulsion and attraction parameters respectively, !! is the
atomic partial charge, !!" is the interatomic distance, and ! ! and !! !are the unit charge
and dielectric constant, respectively.
Many force fields have been developed for biomolecules (e.g. protein and DNA). This
includes all atom force fields that represent all atoms in the system such as AMBER,
CHARMM22-27 and OPLS/AA.24,26,29 Other force fields only deal with heavy atoms and
polar hydrogen. In this case nonpolar hydrogens are represented as part of the carbon
atom to which they are bonded. It is important to mention that atomic partial charges in
most force fields are kept constant and do not change in response to environmental and/or
conformational changes. Thus, electronic polarization is only included in an average way.
Recently, there has been great interest and research into generating new polarizable force
fields which would include electron polarization.30,31
Although MD simulations based on MM methods are a well-established tool to
simulate protein motion and dynamics, the size and the complexity of the biological
systems generally allows for only relatively short simulations in the nanosecond (ns) time
scale to be performed.32 Many biological problems would need much longer MD
simulations (in micro to millisecond time scale) to be executed allowing for better
sampling of the system.33 In atomistic classical MD simulations the high barriers between
minima often cannot be crossed. Several approaches have been developed to overcome
these limitations. For instance, steered molecular dynamics allows the system to cross
barriers by applying a force to the system forcing it to deviate from its initial
conformational state.34 This approach is very useful especially in studying the (un)folding
of proteins and transportation of molecules through membrane proteins.35,36 Another
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approach that has been fast growing is the generation of coarse-grained (CG) force
fields.32 These force fields reduce computational cost by representing a small group of
atoms as a single particle and thus allow for much longer simulation times. CG-MD has
been successfully applied to study lipids and membrane proteins.37,38 Several CG force
fields have been developed such as the all atom MRTINI force field.39 Finally, other
approaches are also been used such as targeted MD simulations and Monte Carlo MD
simulations.40,41

2.5 Quantum Mechanical (QM) Methods
Unlike MM methods, QM methods allow one to describe bond(s) formation/breaking
processes in chemical systems.13,16 Thus in order to study the catalytic reactions in
enzymes, generally, QM is the method of choice to obtain all detail including the
geometries and energies of the unstable transition states and intermediates. To date,
several different QM methods have been developed which can be categorized into three
main types: 1) wavefunction-based (ab initio), 2) density functional theory (DFT) and 3)
semiempirical methods. Each of these aim to find an approximate solution to the timeindependent Schrödinger equation as it cannot be solved exactly for system containing
more than one electron. The Hamiltonian of the non-relativistic time-independent
Schrödinger equation of a molecular system is represented in equation 2.3.
Ĥ=−
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The first two terms represent the kinetic energies of the electrons and nuclei,
respectively. The following three terms describe the potential energy of electron-nuclei
attraction, electron-electron repulsion and nuclei-nuclei repulsion, respectively. In
addition, α and β represent the nuclei, i and j represent the electrons, and N and n
represent the total number of electrons and nuclei in the system, respectively.
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In order to address the complexity of the time-independent Schrödinger equation,
several approximations must be made. Two of the most widely applied and common
approximations are the (i) Born-Oppenheimer approximation in which the nuclei are
assumed from the perspective of the electrons to be stationary, and (ii) orbital
approximation in which the motions of the electrons are assumed to be independent of
each other and hence each electron can be assigned its own spin orbital. In fact, QM
methods differ based on the approximations applied. For example, the simplest ab initio
method is based on Hartree Fock (HF) theory, which assumes that each electron can be
considered as moving through an average field generated by the other electrons. As a
result, the HF method is said to be an uncorrelated method. Unfortunately, the error in HF
energies due the neglect of electron correlation can lead to significant errors in describing
molecular and electronic properties of the system. Therefore, several post-HF methods
have been developed to account for electron correlation. These methods include MøllerPlesset perturbation theory (e.g. MP2), coupled cluster theory (CC), complete active
space SCF (CASSCF) and Configuration interaction techniques (CI). Although all
previous mentioned methods significantly improve the accuracy of the calculation, they
cannot be applied to large systems due to their high computational cost.
DFT provides an alternative method that retains chemical accuracy at lower
computational cost. It can calculate electronic and molecular properties using the
molecules electron density. This reduces the computational cost dramatically as the
electron density is a function of three variables instead of the wavefunctions dependence
on 3N variables. The main basis of DFT theory is that the energy of the system is a
functional of the electron density.42 Unfortunately, the exact functional correlating the
two is not known. Thus, numerous approximate functionals have been proposed and
parameterized based on experimental results or high level ab initio calculations. These
functionals can be categorized into: pure DFT (e.g. Local Density Approximate (LDA)
methods),43 generalized gradient approximation (GGA) (e.g. PBE),44 hybrid-GGA
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functionals (e.g. B3LYP)45,46 in which part of the exchange energy is calculated using HF,
meta-GGA functionals (e.g. M06L) and hybrid-meta-GGA (e.g. M06-2X).47 B3LYP was
the most commonly employed functional in enzymology.6 However in the recent years
other functionals have started to gain increasing use such as the M06 series.47
Semiempirical methods are the least computationally demanding as they involve a
number of approximations that aim to simplify the calculation, for instance, entire types
of integrals. Therefore, they are also on average the least accurate among QM methods.
Despite such drawbacks, they allow for the study of larger systems and are widely used in
studying protein dynamics (e.g. QM/MM MD).48 Therefore, several semiempirical
methods have been developed based on different approximations. For instance, the
modified neglect of diatomic differential overlap (MNDO) approximation includes some
of the most widely used semi-empirical methods, AM1 and PM3.49 Furthermore, a
semiempirical DFT based method, self-consistent charge density functional tight-binding
(DFTB) has been recently developed and has been successfully applied to enzymatic
systems.50

2.6 Choosing a Starting Structure
For most computational studies the choice of the starting chemical structure is very
important. Typically, the primary model of the enzyme is obtained from a high-resolution
X-ray structure of the protein in complex with the substrate, substrate analogue or
inhibitors.6,9 Alternatively, docking techniques can be used to model the binding of the
substrate in the active site. Although abovementioned approach is very useful, it suffers
from limitations such as lacking protein dynamics and conformational variability.
Therefore, another alternative is to use NMR structures as they provide information on
protein dynamics. However, in general, NMR structures suffer from low resolution on
atomic positions especially with respect to the flexible parts of the protein.10 In addition,
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in some cases if there is no X-ray or NMR structure, homology modeling could be used to
generate the starting structure.
Notably, in order to address the limitations of the generated structures, preparation
steps need to be used to generate a more reliable representation of the in vivo structure of
the enzyme-substrate complex via MD simulations. Once a representative structure is
chosen, the mechanistic details of the reaction can be elucidated using several approaches.
In enzymology, two main approaches are usually used to study chemical reactions: QMcluster and quantum mechanical/molecular mechanical (QM/MM). It is noted that other
methods can also be used such as empirical valence bond (EVB).9,13,15,28

2.7 Quantum Mechanical (QM)-Cluster Approach
QM-cluster is one of the main approaches to study chemical reactions. It has been
successfully used for many years to study enzymatic reactions with good accuracy,
especially for metalloenzymes.51,52,53 In part, this is due to the fact that most enzymatic
reactions occur within a small region (e.g. enzymes active site). In fact, using small
models of the active site allows one to apply highly accurate QM methods, which cannot
be used with larger models due to prohibitive computational cost. Furthermore, it
provides an efficient tool to test the accuracy of several levels of theories against highly
accurate methods and subsequently to select a suitable method for further calculations
using larger models.
The initial model is usually derived from a high-resolution X-ray structure of an
enzyme complex with substrate/substrate analogue or from the generated conformers of
an enzyme-substrate complex using MD simulation. The enzyme-substrate complex is
truncated to include a minimal number of atoms in the QM model that adequately
describe or mimic the active site chemistry. In the case of using DFT, which is commonly
used to study enzymes, a chemical model consisting of between 150-200 atoms is
chosen.9,10 The selection of the active site atoms is quite crucial and might affect the
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obtained results. Therefore it is important to include certain residues and interactions in
the active site including:9,10 1) the catalytic amino acids involved in the reactions, 2)
residues that are responsible for substrate binding and conformation in the active site, 3)
residues that can alter catalysis via their interactions (e.g. hydrogen bond, charge
stabilization) with the catalytic residues or the substrate and 4) minimal part of the
substrate without affecting its binding or properties. Generally, only models of the
selected residues are included and only those parts of them that are necessary (e.g., Rgroups). For instance, histidine and aspartate are often modeled by imidazole and acetate,
respectively. Furthermore, a minimal number of peripheral atoms are usually fixed during
the optimization to keep the active site conformation similar to the native enzyme
structure.
If all important interactions and residues are maintained in the model, the QM-cluster
can offer very useful and accurate insights in the reaction including stationary points on
the potential energy surface (PES) (intermediates and transition states) and energetics. In
general, a PES describes the relation between the system coordinates and its energy,
which is important for a complete understanding of their chemical reactions. In fact, QMcluster can be used as an efficient tool to compare between alternative catalytic pathways
by obtaining their PESs ruling out those pathways whose activation energies are too high.
Furthermore, free energies can be also estimated using frequency calculations, which are
commonly done on the optimized structure. Moreover, since the QM-cluster model does
not include the surrounding residues, the effect of enzymatic environment is modeled
using a solvation model method and an appropriately chosen dielectric constant. Several
implicit solvation approaches are usually used including IEF-PCM, COSMO and
CPCM.54 The values of the dielectric constant to mimic protein environments vary
between 2-20 with a value of 4 being commonly used.9
Although a QM-cluster approach is very useful in revealing reaction chemical
insights, in some cases this approach might fail.9 For instance, if the long-range
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interactions are important for the reaction, truncating the surrounding residues can affect
the calculated results dramatically. Furthermore, the dynamics of the enzyme are
neglected and the investigated reaction is elucidated using a single model, which might
not represent the reaction effectively.55

2.8 Quantum Mechanical/Molecular Mechanical (QM/MM) Approach
QM/MM is a hybrid approach that allows for high accuracy calculations using QM
methods, combined with the simplicity of cheap MM calculations.13,28 This combination
enables the study of large enzymatic systems in which the core region (active site) where
the bond(s) breaking/formation occur is described using QM calculations. The remainder
is described using MM force field allowing for environmental effects and interactions to
be accounted for in the calculations (see Figure 2.2). As in the QM-cluster approach, the
QM layer should include catalytic residues, reactive region of the substrate and important
interactions that can directly affect the catalytic mechanism. The MM layer can either
include the rest of the enzyme/solvent atoms or part of the enzyme, e.g., all those residues
within15 Å from the center of the QM layer.
The beginning of the QM/MM era started with the pioneering work of Warshel and
Levitt (Nobel prize winners in chemistry 2013) in 1976.56 However, this method started
to become widespread only in 1990 after the work of Field, Bash and Karplus who
described in detail the coupling between the QM (using semiempirical method) and the
MM layers (CHARMM forcefield) and compared the accuracy of the method against ab
initio calculations and experimental data.57 Since then QM/MM approaches have become
established as an important tool for the study of bimolecular systems.58 In general,
transition states, intermediate, activation energies, zero point corrections and tunneling all
can be elucidated using this approach.28 There are several QM/MM implementations
available in various computational chemistry programs.
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Figure 2.2. Schematic representation of QM/MM partitioning model.

The use of QM/MM has expanded and has been applied to study of
inorganic/organometallic and solid-state systems.28,59 In addition it is currently also being
used in free energies simulations allowing for better determination of ligand-protein
binding.60 A more recently developed extension of QM/MM is QM/MM-MD. It can, for
example, be performed using a cheap QM method (e.g. DFTB) allowing for simultaneous
modeling of the effects of protein dynamics.48

2.8.1 QM/MM Additive Scheme
One of the main differences in QM/MM schemes is how the total energy of the system
is calculated. In the additive scheme, the total energy is calculated by adding the
individual energies of the QM layer, the MM layer and their coupling energy.58 The full
effective Hamiltonian (Ĥ!"" )!of the QM/MM system is:
Ĥ!"" = Ĥ!",!""#$!!"#$% + Ĥ!!,!"#$%!!"#$% + Ĥ!"/!!/!"#$%&'(
!

(2.4)
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In which the first term is the quantum Hamiltonian of the inner layer (see equation 2.3)
and the second term is the molecular mechanical Hamiltonian representing the MM layer
(see equation 2.1). Finally, the third term in the equation represents the coupling between
the two regions including electrostatic and van der Waals interaction. In this term, the
MM atoms are described using point charges and van der Waals parameters (see equation
2.5).

Ĥ!"/!!/!"#$%&'( = −

!!
!" !

!"

+

!! !!
!" !
!"

+

!!"
!" ! !"
!"

!

− !!"
!
!"

(2.5)

In equation 2.5, !, ! and !!represent the MM atoms, the QM layer electrons and the
QM layer nuclei, respectively. Furthermore, the first term represents the electrostatic
interactions between the MM atoms and the QM layer electrons while the second term
accounts for MM and QM layer nuclei electrostatic interactions. The last term represents
the van der Waals interactions between the two layers. In general, the calculation of the
QM/MM coupling term is problematic especially upon using link atoms and/or upon
electrostatic embedding as will be discussed later in this chapter. The total energy of the
system can be written as:
E!"/!! = E!",!""#$!!"#$% + E!!,!"#$%!!"#$% + E!"/!!/!"#$%&'(

(2.6)

The additive scheme is a widely used approach in QM/MM and has been implemented in
many software packages.

2.8.2 QM/MM subtractive scheme
Unlike the additive scheme, in QM/MM subtractive schemes the total energy of the
system is obtained via addition and subtraction of component energy terms. More
specifically, the total energy is calculated through three individual calculations: 1) the
QM energy of the inner layer, 2) The MM energy of the entire system and 3) the MM
!
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energy of the isolated inner layer. By subtracting the MM energy of the inner layer form
the entire system, the coupling between the two layers is mainly calculated at the MM
level of theory. The total energy of the system is the result of the subtraction of the MM
inner system energy from the MM energy of the whole system, which is subsequently
added to the QM energy of the inner layer as follow:
E!"/!! = E!",!""#$!!

!"#

+ E!!,!"#$%!!!"!#$% − E!!,!""#$!!"#$%

(2.7)

In principle, this scheme can be used to extrapolate the energy of a system composed
of n layers. Three different methods based on this scheme have been developed by
Maseras and Morokuma including:61,62 1) IMOMM, 2) IMOMO and 3) ONIOM. The
latter allows for several layers to be used as well as numerous combinations of level of
theories. It is important to mention that ONIOM is the method of choice in our studies. In
addition, the following sections mainly discuss the interactions in ONIOM.
Although the subtractive QM/MM scheme does not require any parameterization of
the coupling region, it still needs parameterization of the inner layer, which might be
problematic to obtain accurately in certain cases (e.g. metal ions). However, all
systematic errors are cancelled in the calculations. In addition, its implementation is
straightforward as no coupling term to represent the interaction between the MM and the
QM calculations is required.

2.8.3 QM/MM Electrostatic Interactions
One of the main challenges in QM/MM is to accurately describe the coupling between
the two layers, including bonded and non-bonded interactions. More specifically
electrostatic interactions are one of the effects that one may need to describe accurately.
There are four different formalisms to evaluate QM/MM: A) mechanical embedding in
which there is no polarization between the two layers, B) electrostatic embedding where
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QM is polarized by MM, C) polarized embedding wherein MM is polarized by QM and
D) Iterative polarization between QM and MM layers.
Mechanical embedding is the most computationally efficient as the QM layer is
isolated during the calculations, that is, it is in a sense in the gas-phase. The coupling
between the QM and MM layers is calculated at the MM level of theory that could be
included in the force field. Since the QM inner system is evaluated in the absence of the
MM layer, the MM layer only provides a mechanical/steric effect in the optimization of
the QM layer. Furthermore, the interaction between the two regions is calculated based on
fixed charges, which might change during the reaction during bond(s) formation/breaking
in the inner layer. Thus in certain cases the partial charges of the QM inner layer should
be calculated at each step along the reaction pathway. Similarly, Lennard-Jones
parameters are usually kept constant in the calculations. All these limitations in the
mechanical embedding formalism might affect the accuracy of some calculations.
Another alternative to improve the way electrostatic interactions are calculated is to
use electrostatic embedding.63 The affects of the electrostatic environment of the protein,
surrounding the QM-region, can be modeled via the use of electrostatic embedding (EE).
In this formalism, the charged MM atoms polarize the electron density of the QM layer.
This is introduced into the calculation by adding a one electron operator to the QM
Hamiltonian (equation 2.8).

Ĥ!",!"#$%&'() = Ĥ!" −

! ! !!
!
! !!!

(2.8)

! !! !!!

The MM point charges are represented as !! . !! and !! !represent the MM atom (!)! and
the electron (!)! position, respectively.
Since the electronic Hamiltonian has an extra term, electrostatic embedding
calculations are more computationally demanding.13,58 Therefore, it is commonly
implemented via single point calculations on the structures optimized within the
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mechanical embedding formalism. Indeed, the use of electrostatic embedding can provide
more experimentally reliable results as the QM/MM coupling is now evaluated at the QM
level of theory. Subsequently, no parameterization of the inner system is required.
Despite all these advantages, electrostatic embedding might not be the best method to be
used in all cases as the presence of the MM point charges can lead to the overpolarization
of the QM inner layer, especially near the boundary region, in some cases. This mainly
occurs upon using large basis set to describe the system leading to electrons spilling into
the MM region.
In model C, the QM density polarizes the MM atoms but the polarized MM does not
then polarize the QM layer.31 This requires the development of new force fields with
flexible charges. Several approaches have been developed to model the polarization of
MM atoms including the induced dipole model and the fluctuating charge models. Finally
in model D both layers polarize each other via an iterative process. This requires the
calculation of the MM polarization at every step of the self-consistent field iteration. Such
calculations are very demanding and impractical to use with large QM/MM models.
Unfortunately, such polarizable forcefield for bimolecular system is not available yet.

2.8.4 QM/MM Boundary
Since the QM and the MM layer are connected by covalent bonds, the partitioning of
the two layers creates unpaired electrons in the QM subsystem, which is an artifact of the
method. Several approaches have been developed to remedy this problem and saturate the
valence of the frontier atoms.
The most straightforward approach and one that is commonly used, especially in
ONIOM calculations, is the addition of monovalent link atoms to the QM subsystem.
Hydrogen is the most commonly used link atom, however, in principle other atoms or
even a group of atoms (e.g. methyl group) could be employed.58 These atoms are only
added during the calculation of the inner QM layer. Despite the simplicity of this
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approach, it has several disadvantages:58 1) it complicates the energy expression, 2) it
generates three extra degree of freedom for each link atom, 3) the generated bond is
artificial and different from the original bond, and 4) it might lead to the overpolarization
of the QM layer. Some of these problems are already addressed in chemical software
packages. For instance, the extra degree of freedom is canceled by fixing the link atom
along the partitioned bond between the QM and the MM atoms. Furthermore, in order to
avoid overpolarization of the subsystem, many schemes have been developed
including:31,58 1) deleting MM charges atoms (e.g. Z1 scheme), 2) redistribution of the
point charges around the link atom, and 3) deletion of one electron integrals of the link
atom.
An alternative approach is the use of localized orbitals in which a doubly-occupied
molecular orbital is used. Two commonly used such approaches are the: 1) hybrid orbital
method, which introduces a molecular orbital at the boundary QM atom, and 2)
generalized hybrid orbital approach (GHO)64 which instead places a molecular orbital on
the MM atom. In the hybrid orbital method (e.g. LSCF)65 a hybrid occupied orbital is
added at the QM atom and pointed towards the MM atom of the broken bond and kept
frozen during the optimization. To apply this method the coefficient of the frozen orbital
has to be calculated, which is usually done using small models assuming its
transferability. Although this method does not cause overpolarization, it is more
complicated than using link atoms. In GHO,64 Gao and co-workers suggested the addition
of the hybrid orbitals to the MM atom. This allows for the hybrid orbital linking the
broken bond to be optimized while other auxiliary orbitals on the MM atom are fixed.
Nevertheless, extensive parameterization is still needed. In general localized orbital
approaches are more complicated. Comparative studies have shown that they can give
slightly better results compared to the use of link atoms.
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2.8.5 Setting-up QM/MM Model
In order to set-up a QM/MM model, special care is always required in choosing the
boundary between the two layers. For instance, all atoms involved in bond breaking and
formation must be included in the inner layer. Aromatic or conjugated systems cannot be
divided between the two layers. Atoms that change hybridization during the reaction
should also be included in the high layer. A general practice is to start the calculations
with a minimum QM layer, and then to systematically increase it in order to examine the
selection of model on the obtained energies.66
As mentioned earlier the accurate description of the boundary and coupling between
the two layers is important for obtaining reliable and accurate results. Therefore, it is
always important to partition the layer by cutting non-polar bonds. Replacing C-C bonds
by C-H when using link atoms also helps minimize any errors due to the need to partition.
Each MM atom of the broken bonds has to be replaced by only one single link atom. It is
also important to always cut single bonds to minimize the error. Furthermore, in the
subtractive approach, the broken bonds have to be at least three bonds away from bond
formation/breaking in the QM subsystem. This maintains the same MM parameters at the
boundary region to be used during the reactions.
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Chapter 3
An MD and QM/MM study on the Catalytic
Reductase Mechanism of Methionine Sulfoxide
Reductase A (MsrA): Formation and Reduction of
a Sulfenic Acid

3.1 Introduction
Of the standard 20 genetically encoded amino acids methionine (Met) is one of the
most easily oxidized.1 In particular, oxidation at its R-group sulfur can lead to formation
of methionine sulfoxide (Met-O).1 Remarkably, Met-O can be reduced to give Met.2 This
uncommon amino acid redox chemistry has increasingly been shown to be critical for
many biological processes including protein regulation, the calcium-induced signal
transduction pathway and immune responses.1,3-6 However, such post-translational
modifications induced by oxidative stress are also known to be involved in aging and age
related diseases including cancer and Alzheimer’s disease.7-9
Methionine sulfoxide reductases (Msr’s) are a family of ubiquitous enzymes that
reduce Met-O to Met.10,11 These enzymes have been shown to be important, for example,
in cellular responses to oxidative stress,12-14 bacterial virulence,15,16 and against amyloid
b-protein toxicity.17 There are two main classes of Msr’s, A and B, which are
stereospecific for the S- and R-Met-O epimers respectively.18,19 Both classes are thought
to utilize the same overall reaction despite having quite distinct active site compositions
and being structurally unrelated.20 The few shared similarities include an active site
cysteinyl and tryptophanyl that are thought to act as a nucleophile and help orient the
substrate, respectively. In addition, both have several hydrogen bond donors that interact
with the Met-O sulfoxide oxygen. However, the nature of these donors differs: MsrB has
multiple ionizable and polar residues21 while MsrA contains two tyrosyl and a glutamyl
residue.22 In vitro studies2 of recombinant MsrA have shown it to be 10-fold more active
than MsrB. Furthermore, for several species it has been found that knocking it out
enhances their susceptibility to oxidative stress23-25 while its overexpression results in
longer lifespans.26,27 Meanwhile, its down regulation in human breast cancer cells
increased the disease's aggressiveness both in vivo and in vitro.28
Several experimental kinetic studies on MsrA have examined the possible roles of
various active site amino acid residues. For instance, substitution of the Cys51 in
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Escherichia coli MsrA by serine deactivated the enzyme, thus confirming its essential
catalytic role.29 Similarly, substitution of the active site glutamyl (Glu94 in Neisseria
meningitidis), thought to be important both in activation of Cys51 and as a proton donor
to the substrate, by alanine drastically reduced the rate of catalysis 36500-fold.22 In
contrast, mutation of either active site tyrosyl (Tyr82 or Tyr134 in Neisseria meningitidis)
by Phe appeared to have little effect on the rate of reaction.22 However, simultaneous
substitution of both by Phe decreased the catalytic rate significantly by ~10000-fold.22 In
addition, using chemical probes and mass spectrometry a catalytic cysteine-derived
sulfenic acid was detected in a wild type MsrA from Escherichia coli.29 The ionization
states of Cys51 (the catalytic cysteine) and a second active site cysteine Cys198, known
as the recycling cysteine, have also been experimentally measured. In particular, it was
observed that upon substrate binding the pKa of Cys51 was reduced significantly from 9.5
to 5.7 in Neisseria meningitidis.22 However, it was only decreased to 8.0 if Glu94 was
replaced by Gln or if both Tyr82 and Tyr134 were replaced by Phe. This was suggested to
indicate that these three residues are important for polarizing the sulfoxide S=O bond
which also leads to a decrease in the pKa of Cys51.22
Based on these and related experimental studies, several possible catalytic
mechanisms for MsrA and by extension Msr's in general were proposed and are
summarized in Scheme 3.1.18,30,31 Specifically, upon activation of Cys51 by some as yet
unclear process to give the Cys51S– thiolate, the proposed mechanisms A and B in
Scheme 3.1 commonly begin with formation of a sulfurane via nucleophilic attack of
Cys51S– at the Met-O sulfur.32 However, two alternate mechanisms were suggested for
the subsequent reactions of the sulfurane: (A) it undergoes a 1,2-shift of the sulfurane's –
OH group from the substrate sulfur to the adjacent Cys51 sulfur to give the sulfenic acid
Cys51SOH and the desired Met product or, (B) it is protonated at its oxygen to give a
sulfonium. In the former the resulting catalytic cysteine-derived sulfenic acid
intermediate readily reacts with the recycling cysteine, which itself has been activated and
33

is in its thiolate form, to give an intra-molecular disulfide bond. In contrast, in the latter
proposed mechanism B the recycling cysteine thiolate directly attacks the Cys51S center
of the sulfonium to give an intra-molecular disulfide bond and the reduced Met product,
i.e., without formation of the sulfenic acid.14 In both cases, the active site is then
ultimately regenerated via reduction of the disulfide bond by Thioredoxin (Trx).33

Scheme 3.1. Proposed30,31 reductase mechanisms for MsrA via (A) a sulfenic acid
intermediate, or (B) via direct attack.

However, more recently Lim et al.18 using mass spectrometry and isotope labeling
identified peptide modifications formed during the catalytic mechanism of mouse MsrA.
To prevent other modifications such as disulfide bond formation they mutated Cys107,
Cys218 and Cys227 to serine. They observed that the catalytic cysteine was converted to
a sulfenic acid (CysSOH) during the course of the mechanism. Importantly, and in
contrast to that previously proposed, the CysSOH oxygen was not derived from the initial
Met-O substrate but instead from the aqueous solvent. Consequently, they proposed a
modified mechanism for MsrA involving sulfonium and sulfenic acid intermediates
highlighted in Scheme 3.2.
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Computationally, there have been very few studies on the catalytic mechanism of
Msr's. Recently, Thiriot et al.34 used a DFT-cluster approach to gain insights into the
reductase mechanism of MsrA. Specifically, the substrate was modeled by dimethyl
sulfoxide (DMSO) and the R-groups of the active site residues Tyr134 and Tyr82, Glu94
and Cys51S– by phenol and water, CH3S– and acetic acid respectively. In addition,
general environment effects were included via use of a PCM solvation method with a
dielectric constant (e) of 2. Importantly, they showed that formation of a sulfonium
intermediate may occur via nucleophilic attack of Cys51S– at the substrate's sulfur with
stepwise protonation of its sulfoxide oxygen by Glu94 and Tyr134. Furthermore, a
sulfenic acid intermediate was calculated to lie quite low in energy. Unfortunately, a
reaction pathway between the sulfonium ion and sulfenic acid was not elucidated.
However, they suggested it may involve dissociation of the sulfonium with the H2O
moiety released then attacking the catalytic cysteinyl's sulfur to give a sulfenic acid.

Scheme 3.2. Proposed18 catalytic reductase mechanism for MsrA involving formation of
a sulfenic acid intermediate via attack of a solvent water at the catalytic cysteine's sulfur
centre.

Previously, we performed a computational investigation on the complete catalytic
reductase mechanism of MsrB using a large DFT-cluster model and with the general
protein environment modeled by a PCM solvation method with e = 4 as common in such
approaches.35 In particular, we showed that the mechanism may be initiated by
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nucleophilic attack of the catalytic Cys at the substrate's sulfur with concomitant proton
transfer from a nearby histidyl residue to form a sulfurane. A sulfonium cation was then
formed via transfer of a proton from a second histidyl residue onto the sulfurane's oxygen.
However, within the computational model used, two possible enzymatically feasible
mechanisms were then obtained by which the Met product could be formed: (i) direct
attack of the recycling cysteine thiolate at the sulfonium's catalytic cysteinyl sulfur, or (ii)
via a sulfenic acid intermediate. The latter was found to not be feasible via intramolecular
rearrangement of the sulfurane as previously suggested. Instead, it required a solvent
water to attack the sulfonium's catalytic cysteinyl sulfur as experimentally observed in
MsrA.18
A clearer elucidation of the catalytic mechanism of Msr's is central to a greater
understanding of their role in aging, oxidative stress and other important physiological
processes. In addition, due to their use of a diverse variety of sulfur compounds and
chemistry, they represent a tremendous opportunity to obtain greater insights into the
important area of sulfur biochemistry, in particular that of highly reactive species such as
sulfenic acids. We have thus performed a detailed systematic computational investigation
into the catalytic mechanism of MsrA. More specifically, we have complementarily
applied Docking, Molecular dynamics (MD) simulations and an extensive ONIOM
QM/MM approach to investigate activation of the catalytic cysteinyl and the subsequent
reductase mechanism that leads to formation of Met and the intra-molecular disulfide
bond.

3.2 Computational Methods
Docking and MD Studies. These calculations were performed using the Molecular
Operating Environment (MOE) program.36 The X-ray crystal structure (PDB ID: 1NWA)
of MsrA from Mycobacterium tuberculosis (MsrAMtb) complexed with protein-bound
methionine was used as a template for docking.37 The substrate and all crystal structure
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waters were removed then the substrate methionine sulfoxide (Met-O) docked into its
active site where all residues within the first interaction shell of the catalytic cysteine
(Cys13) were considered as in the active site. The London dG scoring function was used
in conjunction with a force field refinement method in order to obtain the top 30 scoring
structures. These were visually examined to choose the most suitable starting structure for
further calculations. A molecular dynamics (MD) simulation was then performed on the
chosen structure to allow for thermal relaxation. More specifically, the enzyme-substrate
complex was spherically solvated up to 15 Å from the substrate. Then MD simulations
were performed for 1 ns using a time step of 2 fs in a same manner as has been
previously38 described. The structures generated during the simulation were analysed and
clustered according to the distance between the sulfur's of the catalytic cysteine and
substrate into 10 clusters. The overlay of the 10 average structures of the generated
clusters show similar interactions (See Appendix Figure A1); furthermore, the RMSD of
the QM-region moieties (QM-RMSD) of the 10 structures was 0.12 Å, indicating a very
consistent structure. The average structure of the most populated cluster was then
optimized using the AMBER99 force field,39 and the resulting structure (structure A')
being used to construct a QM/MM chemical model to examine the catalytic mechanism
of MsrA up to and including formation of a sulfenic acid intermediate.
A second MD simulation was performed to model possible rearrangements in the
active site upon sulfenic acid formation. Similar to the protocol detailed above the X-ray
crystal structure PDB ID: 1NWA was modified to remove the substrate and all
crystallographic waters. The catalytic cysteine was then modified to form a sulfenic acid
(CysSOH) and the resulting intermediate spherically solvated up to 15Å from the sulfur
of the CysSOH moiety. The complex was equilibrated for 0.5 ns followed by a 1 ns
production run as previously described.40 The S-O bond of the CysSOH moiety was
constrained to its optimized length as obtained at the B3LYP/6-31G(d) level of theory.
Partial charges for the sulfenic acid were also obtained via a Mulliken population analysis
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of IC3 performed at the below QM/MM level of theory. The resulting structures obtained
were cluster-analyzed based on the sulfenic acid hydrogen-bonding network into 10
clusters (see above). Similarly, the 10 average structures were overlaid ((See Appendix
Figure A2) and analyzed and found to have a QM-RMSD of 0.24 Å. Again, the average
structure of the most populated cluster was chosen and optimized using the AMBER99
force field.39 The resulting complex, structure B', was used to construct a QM/MM
chemical model to examine the catalytic mechanism of MsrA for formation of the final
product from the sulfenic acid intermediate.
QM/MM models and calculations. All QM/MM calculations were performed within
the ONIOM formalism41 using the Gaussian 0942 suite of programs. The density
functional theory method B3LYP; a combination of Becke’s three parameter exchange
functional43 and Lee, Yang and Parr’s correlation functional44 was used for the high-layer
(QM) while the AMBER9645 force field was used for the low-layer (MM)
parameterization. Optimized geometries (the default convergence criteria of Gaussian
0942 was used throughout) were obtained using the 6-31G(d) basis set for the high-layer
and within the mechanical embedding (ME) formalism, i.e., at the ONIOM(B3LYP/631G(d):AMBER96)-ME level of theory. Frequency calculations were also obtained at
this same level of theory in order to characterize the nature of the stationary points
obtained (i.e., minima or transition structures) and to calculate Gibbs energy corrections
(ΔGcorr). The single imaginary and first real frequencies for the optimized TSs are
reported (See Appendix Table B1). Relative energies were then obtained via single point
energy calculations at the ONIOM(B3LYP/6-311+G(2df,p):AMBER96) level of theory
within the electrostatic embedding (EE) formalism on the above optimized structures, and
with inclusion of the appropriate ΔGcorr. All atoms in the QM layer were unfixed while
for the MM layer only the Cα centres were kept fixed at their final MD positions. This and
similar QM/MM approaches have been successfully used to explore a range of enzymatic
systems.46-52
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The chemical models used were obtained by truncating structures A' and B' to only
include those residues in the first- and second-shell centered on the sulfur of the catalytic
cysteine and where appropriate the substrate. The resulting two active sites models, A and
B, enabled us to more effectively consider the different stages in the overall mechanism
and are shown in Figure 3.1. More specifically, models A and B were used to investigate
possible catalytic mechanisms of MsrA resulting in (i) formation of a enzyme-derived
sulfenic acid intermediate and (ii) conversion of a sulfenic acid intermediate to the final
products, respectively. In model A the Met-O substrate was modeled by ethylmethylsulfoxide. It should be noted that in model A (Figure 3.1A) the catalytic and recycling
cysteinyls (Cys13 and 154), three tyrosyl (Tyr 92, 44 and 152), three charged residues
(Glu52, Asp87, His155), three H2O and the backbone of Trp15, Phe14 and Cys154 were
included in the QM layer. The R-groups of Phe14 and Trp15 were kept in the low (MM)
layer as DFT does not take into account Van der Waals interactions which are important
for their interactions with the Met-O substrate.53 It is worth noting that several QM/MM
models were also tested that contained a smaller QM-region, e.g., lacking residues near
the catalytic and recycling cysteinyl residues. However, these were found to not
adequately describe the chemistry of the reactions that would likely occur as part of the
mechanism. For model B (Figure 3.1B) the QM-layer included the catalytic and recycling
cysteinyls (Cys13 and 154), two charged residues (Asp87 and His155), three H2O and the
backbone of Trp15 and Phe14.
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Figure 3.1. The QM/MM models used to examine the catalytic mechanism of MsrA for
(A) formation of an enzyme-derived sulfenic acid intermediate from the initial enzymesubstrate complex and (B) reaction of the enzyme-derived sulfenic acid intermediate to
give the final products. The inner circles represent the QM layer while the outer represent
the MM layer. Color key for MM residues: included in their entirety (black); R-group
replaced by hydrogen (red); R-group included in the MM layer while backbone is in the
QM layer (blue).

3.3 Results and Discussion
3.3.1 Substrate binding and activation of the catalytic cysteine.
As noted in the introduction, all previously proposed mechanisms involve
nucleophilic attack of the sulfur of the thiolate form of the catalytic cysteine (Cys13 in
MsrAMtb) at the sulfur center (Ssub) of the Met-O substrate.18,31,33 In order for this to occur,
however, Cys13 must be activated by deprotonation of its thiol. Indeed, as noted
previously it has been shown experimentally22 that in the absence of the substrate the pKa
of the thiol of the catalytic cysteine is 9.5, but decreases to 5.7 upon substrate binding. Xray crystal structures of MsrA's from different species have revealed that there is no basic
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residue in close proximity to the catalytic cysteine,22 the closest being a glutamyl (Glu52
in MsrAMtb) ~5 Å away.37 Nevertheless, Glu52 has been suggested to play a role in
activating Cys13 and lowering the pKa of its thiol.22
In the optimized structure of the pre-reactive complex (PRC) in which the substrate is
bound within the active site and Cys13 is neutral a water molecule forms a hydrogen
bond bridge between the Cys13 thiol and the R-group carboxyl of Glu52 with distances of
2.55 and 1.67 Å, respectively (Figure 3.2). In the MD simulations on the PRC complex, a
water is also observed to consistently be similarly positioned and hydrogen bonded (See
Appendix Figure A3). Meanwhile, the backbone amide -NH- moiety of W15 forms a
weak hydrogen bond with the Cys13SH sulfur with a length of 3.07 Å.54 Meanwhile, the
substrates sulfoxide oxygen (Osub) is observed to form shorter, stronger hydrogen bonds
with the phenol hydroxyls of Tyr92 and Tyr44 with lengths of 1.76 and 1.78 Å,
respectively. As a result, the substrates Ssub=Osub bond lengthens markedly upon binding
by 0.08 Å to 1.55 Å (See Appendix Table B1). It is noted that the distance between the
sulfurs of Cys13 and the substrate, r(Cys13S…Ssub), is quite long in PRC at 3.79 Å.
The structure and in particular hydrogen bond network within PRC suggests that
Cys13SH may be able to transfer a proton via a bridging H2O onto the R-group
carboxylate of Glu52. At the B3LYP/6-31G(d) level of theory the proton affinities (PAs)
of methylthiolate and acetate, models of the ionized R-groups of cysteine and glutamate,
are calculated to lie just 34.3 kJ mol–1 apart, with the former being the more basic (See
Appendix table B1). Indeed, Cys13SH is able to formally transfer a proton through a H2O
onto the carboxylate of the Glu residue. This step proceeds via TSAct at a cost of just 38.5
kJ mol–1 (Figure 3.3). The slightly lower relative energy of TSAct (10.8 kJ mol-1) with
respect to RC is an artifact of the use of free energy corrections and indicates that at 298
K RC can effectively convert back to PRC without a barrier. It indicates that the reverse
reaction, i.e., proton transfer from Glu51COOH via a water to Cys13S–, effectively
occurs without a barrier. As can be seen in the structure of TSAct (Figure 3.2) the thiol's
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proton lies approximately midway between the sulfur of Cys13 and the water's oxygen.
Meanwhile, the water has almost wholly transferred its proton onto the glutamyl's
carboxylate, r(Glu52COO–…H-OH) = 1.08 Å. This process may be facilitated by the
moderately strong hydrogen bond between the H2O and the backbone -NH- of Phe14 in
PRC and TSAct which would help stabilize negative charge build-up on the water's
oxygen and thus enhance the water's acidity. It should be noted that possible alternate
mechanisms were also examined involving proton transfer from Cys13SH via a H2O (i)
directly onto the sulfoxide oxygen of the Met-O substrate and, (ii) to the glutamyl with
concomitant nucleophilic attack of Cys13S– at the substrate's sulfur centre. However,
both mechanisms were found to be enzymatically unfeasible.

Figure 3.2. Schematic illustration of the optimized structures of the pre-reactive complex
(PRC), activated reactive complex (RC) and the transition structure (TSAct) for their
interconversion. For simplicity, only selected residues, functional groups and bond
lengths (Angstroms) are shown.
Two mechanistically relevant conformers of the reactive complex (RC) were
optimized that differed only in the nature of the hydrogen bond formed by Glu52COOH.
In one (RC', not shown), it is hydrogen bonded via the H2O with the now deprotonated
thiol of Cys13. However, a low barrier rotation of the glutamyl's R-group about its Cβ—
Cγ bond, i.e., a change in its ∠CαCβCγO angle, from -86.6° to -62.4° gives rise to the
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alternate conformer RC shown in Figure 3.3 lying slightly higher in energy than RC' by
3.7 kJ mol-1 and just 49.3 kJ mol-1 higher in energy than PRC. In RC, the Glu52COOH
group is now directly hydrogen bonded to the substrate's sulfoxide oxygen with
r(Glu52COOH…OsubS) = 1.82 Å (Figure 3.2). The two phenol hydroxyl's (Tyr92OH and
Tyr44OH) also remain strongly hydrogen bonded to the substrate's sulfoxide oxygen with
distances of 1.80 and 1.75 Å, respectively. As a result, the sulfoxide's Ssub=Osub bond has
now elongated further to 1.60 Å, increasing the negative charge on Osub and enhancing
the susceptibility of Ssub to nucleophilic attack. In addition, in RC the distance between
the sulfur's of Cys13 and Met-O has decreased significantly by 0.53 to 3.26 Å, such that
they are now more suitably positioned for reaction.

Figure 3.3. Free energy surface (kJ mol-1) obtained (see Computational Methods) for
activation of the catalytic cysteine (Cys13) by proton transfer via a bridging H2O to the
active site glutamate (Glu52).
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3.3.2 Reduction of the substrate with formation of a sulfenic acid intermediate.
Following activation of the catalytic cysteine (Cys13) via proton transfer to the
carboxylate of the glutamate (Glu52) residue, the latter is then able to transfer the proton
onto the substrate's sulfoxide oxygen. Concomitantly, the now anionic sulfur of Cys13
nucleophilically attacks the substrate's sulfoxide sulfur center thus generating a sulfurane.
This step proceeds via the transition structure TS1 with a quite low activation energy of
only 11.8 kJ mol–1 while the sulfurane intermediate formed, IC1, lies decidedly lower in
energy than RC by 47.0 kJ mol–1 (Figure 3.4).

Figure 3.4. Free energy surface (kJ mol-1) obtained (see Computational Methods) for
formation of a sulfenic acid intermediate (Cys13SOH) involving the proton donors (A)
Glu52COOH and Tyr92OH and (B) Glu52COOH and Tyr44OH.
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The optimized structures of the reactant and product complex, intermediates and
transition structures obtained, with selected bond and interaction distances in angstroms
(Å), are schematically illustrated in Figure 3.5. As can be seen, in TS1 the proton
transferring from the Glu52COOH group is roughly equidistant to the substrates sulfoxide
oxygen (Osub) with r(Glu52COO…H+) and r(Osub…H+) = 1.23 and 1.22 Å respectively.
More importantly, however, the substrates S—O bond has lengthened markedly to 1.74 Å
while the key Cys13S…Ssub distance has shortened significantly by 0.51 Å to 2.75 Å. In
the sulfurane intermediate IC1 the S—O bond has lengthened even further to 2.31 Å
while the Cys13S—Ssub disulfide bond has now formed as indicated by its length of 2.23
Å. It is noted that these bond lengths are in reasonable agreement with a sulfurane
intermediate we obtained previously35a as part of a computational study on the
mechanism of an MsrB using a DFT-large active site chemical model approach. In
contrast, the S–OH and S–S lengths are considerably longer and shorter respectively than
obtained by Thiriot et al.34 in a computational study using more modest active site
models. This suggests that the structure of the active site and its environment in MsrA and
Msr's in general may act to help to stabilize a more polarized sulfurane intermediate.
In IC1 the sulfurane's oxygen now forms even shorter and stronger hydrogen bonds
with the phenol hydroxyls of both Tyr44 and Tyr92 compared to that observed in RC
with distances of 1.60 and 1.56 Å, respectively (Figure 3.5). As noted previously,
experimental22 mutation studies involving the two active site tyrosyl's suggest that
substitution of either alone reduces the rate of the reaction only slightly while mutation of
both has a severe negative effect on the rate. Previous computational studies34,35a have
suggested that the sulfurane hydroxyl (Ssub-OsubH) can accept a proton from an acidic
residue. This is likely facilitated in part by the sulfurane's oxygen Osub greater basicity35a
than that of the sulfoxide oxygen in Met-O, which is likely further enhanced by the
sulfurane's polarized nature within the active site. Thiriot et al.34 suggested that one of the
active site tyrosyl's may be able to act as such an acid and protonate the sulfurane's –
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OsubH oxygen. Given the similar distances for the hydrogen bond interactions between
Osub and Tyr44OH and Tyr92OH (Figure 3.5), we considered the feasibility of either
tyrosyl acting as the second mechanistic acid.

Figure 3.5. Schematic illustration of the optimized structures with selected bond lengths
(in Angstroms) of the minima and transition structures obtained for MsrA catalysed
reduction of Met-O to Met with concomitant formation of an enzyme-derived sulfenic
acid intermediate.
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The phenol hydroxyl of Tyr92 is able to transfer its proton essentially without a
barrier onto the sulfurane's oxygen Osub via TS2a to give the sulfonium cation
intermediate IC2a (Figure 3.4). The latter lies slightly lower in energy than IC1 by 7.0 kJ
mol-1 (i.e., –54.0 kJ mol-1 with respect to RC). The fact that TS2a (upon adding free
energy corrections) is lower in energy than IC1 and IC2a suggests that these
intermediates should be able to readily interconvert. In TS2a the proton is almost
equidistant between the sulfurane and tyrosyl oxygen's as indicated by the fact that the
r(Tyr92O…H) and r(Tyr92OH…Osub) distances are 1.23 and 1.20 Å, respectively (Figure
3.5). In the sulfonium complex IC2a the Ssub…OH2 interaction has been effectively
cleaved as indicated by its distance of 2.74 Å, while the Cys13S—Ssub disulfide bond has
shortened to 2.13 Å (Figure 3.5).
Alternatively, Tyr44 can act as the second mechanistic acid. More specifically, it is
able to transfer its phenolic proton onto the sulfurane's oxygen Osub via TS2b without a
barrier (Figure 3.4). In contrast to that observed when Tyr92 acts as an acid, the resulting
sulfonium complex formed, IC2b, is calculated to lie decidedly lower in energy than IC1
by 40.4 kJ mol-1 (i.e., –87.4 kJ mol-1 with respect to RC). This greater stabilization of the
sulfonium may reflect in part enhanced stabilization of the positive charge on the
Cys13S—Ssub disulfide by the now anionic phenol oxygen of Tyr44 at a distance of 2.80
Å. In contrast, the Ssub…OH2 distance in IC2b is markedly longer than observed in IC2a
with a length of 3.30 Å (Figure 3.5).
Based in part on a previous computational study by Balta et al.,55 Thiriot et al.34
suggested that the sulfurane, upon protonation, may dissociate to a sulfonium cation and
water molecule. The water moiety may then attack at the Cys13 sulfur center of the
cationic disulfide to generate methionine (Met) and an enzyme-derived sulfenic acid
(Cys13SOH). Indeed, for MsrA a catalytic cysteine-derived sulfenic acid has been
detected in mutant and wild-type enzymes using chemical probes and mass
spectrometry.29 Unfortunately, they were unable to locate a pathway and barrier for this
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process. Also, it has previously been suggested that the sulfurane intermediate could
undergo an analogous 1,2-sigmatropic shift of its –OsubH group to generate Met and the
sulfenic acid derivative.14 However, we previously showed that the barrier for such a
process was enzymatically unfeasible.35a Recently, experimental labeling studies have
suggested that the oxygen of the sulfenic acid is in fact derived from the aqueous solvent
and not the Met-O substrate.18 Notably, in the optimized structures of both IC2a and IC2b
(see Figure 3.5) and in an X-ray crystal structure of the wild-type enzyme, a H2O is
positioned within the active site and oriented such that its oxygen is directed towards the
Cys13S center of the sulfonium disulfide moiety. Specifically, in IC2a and IC2b the
distance between the water oxygen (Ow) and sulfonium's Cys13 sulfur center is 3.42 and
3.25 Å respectively. Simultaneously, the water acts as a hydrogen bond donor to the
sulfur of the recycling cysteine Cys154 with r(OH2…SCys154) = 2.34 and 2.35 Å in
IC2a and IC2b, respectively (Figure 3.5).
However, for nucleophilic attack of the water at Cys13S to occur, the H2O needs to be
either be first deprotonated or be able to donate a proton to a suitable base. In our present
model Cys154 has been modeled as neutral based on its experimentally measure pKa
value of 9.5.22 Thus, in order to be able to act as a suitable base its thiol must itself be
able to transfer its proton to a suitable base. Importantly, during the initial MD
simulations on the initial active site-bound substrate complex (see Computational
Methods) the thiol of Cys154 was observed to consistently be directly hydrogen bonded
to the R-group carboxylate of a spatially adjacent aspartyl (Asp87). In the QM/MM
optimized structures of both IC2a and IC2b the Cys154SH group forms a short and strong
hydrogen bond to Asp87; r(Cys154SH…–OOC-Asp87) = 1.95 Å. Consequently, the
Cys154S—H bond itself is elongated now having a length of 1.37 Å in both complexes
compared to 1.33 Å (at the B3LYP/6-31G(d) level of theory) in an isolated methylthiol.
Thus, it appears that Cys154 may indeed be able to act as a suitable base to facilitate
sulfenic acid formation. It is noted that within the active site region the only other residue
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that may be able to act as base is His155. However, the distance between the nearest
nitrogen of its R-group imidazole and H2O is quite large (~4.85 Å). Hence, it would seem
less likely to be a suitable a base to facilitate sulfenic acid formation.
In the present study, for both situations in which Tyr92 or Tyr44 acts as the second
mechanistic acid, the H2O is able directly attack at the Cys13 sulfur center of the
sulfonium's disulfide bond. Importantly, this occurs with concomitant proton transfer
from the attacking H2O onto the thiol of Cys154 which itself has transferred its proton to
the adjacent R-group carboxylate of Asp87. For the case in which Tyr92 acted as an acid,
this step proceeds via TS3a at a cost of 32.6 kJ mol-1 with respect to IC2a. In the resulting
intermediate

complex

obtained,

IC3a,

the

desired

methionine

(modeled

by

ethylmethylsulfide) product is bound within the active site. In particular, it is positioned
such that its methyl is directed towards the R-group of the active site tryptophanyl residue
(Trp15). Furthermore, however, the catalytic cysteine (Cys13) has now been oxidized to a
sulfenic acid (Cys13SOH). Thermodynamically, the complex IC3a lies significantly
lower in energy than IC2a by 168.4 kJ mol-1 which is -222.4 kJ mol-1 with respect to RC.
Structurally, in TS3a it can be seen that the Cys154SH proton is essentially wholly
transferred onto the carboxylate of Asp87, r(Cys154S…H+) = 2.08 Å (Figure 3.5). In
contrast, the proton being abstracted from the attacking H2O lies between the Cys154S
and Ow centers with distances of 1.76 and 1.16 Å respectively (Figure 3.5). In contrast,
for the pathway in which Tyr44 acted as an acid this process occurs via TS3b with a
markedly higher cost of 85.6 kJ mol-1 with respect to IC2b (Figure 3.4). In fact, the
relative energy of TS3b is higher than that of TS3a by 19.6 kJ mol-1. As obtained for
IC3a, in the resulting sulfenic acid-containing active site complex IC3b, the desired
ethylmethylsulfide product is again positioned within the active site such that its methyl is
oriented towards the R-group of Trp15. In addition, IC3b also lies considerably lower in
energy than IC2b and RC, though now by 120.9 and 208.3 kJ mol-1, respectively.
Notably, while IC3b lies slightly higher in energy than IC3a by 14.1 kJ mol-1 (see Figure
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3.5), they can interconvert with each other. This could occur by a proton transfer via the
H2O that is simultaneously hydrogen bonded to the carboxylate of Glu52 and the phenolic
oxygen's of both Tyr92 and Tyr44 (see Figure 3.5). Structurally, TS3b is very similar to
TS3a and hence is not discussed in detail herein.
We have also considered the catalytic pathway from RC to IC2 in which either Tyr92
or 44 is substituted by a pheylalanyl (i.e., for the mutated enzymes Y92F or Y44F).
Structurally, mutating either tyrosyl leads to a strengthening of the Met-O S—O bond
(i.e., decreased polarization of the S–O bond via hydrogen bonds with the Tyr-OH
groups) and concomitantly longer –S—S– bond in the sulfurane (IC1). Furthermore, a
slight reduction is observed in the barrier for formation of IC1; specifically, it decreases
from 14.6 kJ mol-1 in the wild-type to 12.8 and 4.6 kJ mol-1 in the Y44F and Y92F
mutated enzymes, respectively (See Appendix Figure A4). It is noted that the magnitude
of these energy changes are within the expected error margins of our calculations.
Furthermore, these mutations lead to similar destabilizations of the resulting sulfurane
(IC1) from -52.1 kJ mol-1 (with respect to RC) to -21.0 and 22.4 kJ mol-1, respectively.
The subsequent sulfonium intermediates (IC2) are also destabilized, although now with a
marked difference in magnitude between the two mutations, as indicated by the increase
in its relative energy from -53.7 kJ mol–1 (wild-type) to -51.8 (Y92F) and -28.7 (Y44F) kJ
mol–1. It is noted that this change in the relative energies of the subsequent sulfonium
intermediates has little effect on the barrier for proton transfer from the remaining tyrosyl
to the sulfurane's oxygen. For instance in the wild-type system the barrier for reaction via
TS2a is 0.9 kJ mol–1 while in Y92F and Y44F it is 0.8 and 3.0 kJ mol–1, respectively.
Importantly, however, assuming that the tyrosyl's have no effect on the activation of
Cys13 (proton transfer from Cys13-SH via a H2O to Glu52COO–), the rate-limiting step
in the reductase stage remains formation of the sulfurane from RC (See Appendix Figure
A5).
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The above results may also give insights into observations from experimental22
mutagenesis studies in which the substitution of Tyr92 or Tyr44 (Tyr134 or Tyr82 in
Neisseria meningitidis) by Phe was shown to have little effect on the catalytic rate. In
particular, the experimentally measured difference in rates between the two mutations
corresponded to a difference in rate-limiting barrier heights of ~6 kJ mol–1. The results of
the present study emphasize the ability of either active site tyrosyl to act as a mechanistic
acid. Furthermore, they also suggest only minor changes within the error margins of the
present calculations in the thermodynamics of formation of the enzyme-sulfenic acid
intermediate upon mutation of either tyrosyl.
It should be noted that alternative mechanistic pathways were also considered. In
particular, the direct nucleophilic attack of the sulfur of the recycling cysteine (Cys154) at
the catalytic cysteine's (Cys13) sulfur center was investigated. That is, the direct reaction
of the sulfonium intermediate to give the final product complex (PC), bound Met with
formation of an intramolecular Cys13S–SCys154 disulfide bond (see Scheme 3.1B),
without formation of a sulfenic acid intermediate (see below). Previous computational
studies have shown that if a thiolate is suitably positioned it can readily react with a
sulfonium to give a disulfide, e.g., CysS—CysS, and a alkylated sulfide, e.g., Met.56
However, in the sulfonium complexes IC2a and IC2b the sulfurs of the two active site
cysteinyl residues are at least 5.1 Å apart and with a Cys13Cα—CαCys154 distance of
7.14 Å. Thus, direct nucleophilic attack of the thiol of Cys154 at the Cys13S center in
either sulfonium complex appears unlikely to occur. It is noted that larger distances
between the catalytic and recycling cysteines has been observed in the X-ray crystal
structures of MsrA's from several species. For example, for an MsrA from E. coli the
distance between the Cα carbons of the catalytic and recycling cysteinyl residues is
approximately 11.0 Å!37 However, if the Cys13S—Ssub bond was first cleaved, Cys13
would then be free to undergo a conformational change that reorients its sulfur closer to
that of the recycling cysteine.
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3.3.3 Reduction of the sulfenic acid with formation of an intramolecular disulfide bond
As noted for both of the above IC3 complexes (IC3a and IC3b), the initial Met-O
substrate has now been reduced to Met. Importantly, however, with cleavage of the
sulfonium's Cys13S—Ssub bond and formation of the sulfenic acid Cys13SOH, the Met
moiety is now free to leave the active site. This would likely enable water(s) to enter the
active site, the anionic tyrosyl residue (Tyr44 or Tyr92) to regain a proton and may result
in some changes in the hydrogen bonding network and possibly some repositioning of the
active site residues. Hence, as detailed in the Computational Methods, in order to better
model such changes an MD simulation was performed on a "resolvated Met-free"
Cys13SOH-containing active site complex. The QM/MM optimized structure obtained at
the same level of theory as above and hereafter referred to as IC3', is shown in Figure
3.7.
In IC3', both Tyr92 and Tyr44 are modeled as neutral while the R-group carboxylate
of Asp87 is modeled as anionic. That is, the two former residues have regained or kept
their proton while the latter has been deprotonated. It is noted that in both the average
structure obtained from MD simulations and in the QM/MM optimized structure, a chain
of waters was observed to interconnect the R-groups of Asp87 and the two tyrosyl
residues. It thus appears possible that regeneration of the neutral tyrosyl residues could
occur via proton transfer along a water chain from the Asp87COOH moiety generated
during or possibly after sulfenic acid formation (See Appendix Figure A6).
Structurally, in IC3' the hydroxyl of the Cys13SOH sulfenic acid acts as a hydrogen
bond donor to an active site H2O that is itself simultaneously hydrogen bonded to the
backbone carbonyl oxygen of Cys13, the R-group imidazole of His155 and the sulfur of
Cys154. The thiol of Cys154 is also hydrogen bonded via another water molecule to the
R-group carboxylate of Asp87. Due in part to this hydrogen bond network arrangement
the hydroxyl of the Cys13SOH moiety sits approximately between the sulfur's of Cys13
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and Cys154. Consequently, these two mechanistically important sulfur centers are not
suitably positioned for the required nucleophilic attack of the Cys154S center at the
sulfenic's acid sulfur to form an intramolecular Cys154S—SCys13 disulfide bond.
Therefore, a rotation about the C—SOH bond of Cys13SOH (i.e., a change in its dihedral
angle ∠CαCβSO) with a slight alteration to the active site hydrogen bonding network is
required in order to suitably position the sulfurs of Cys13S and Cys154 for further
reaction. More specifically, a change in ∠CαCβSO from 243.9° to 110.0° leads to
formation of the alternate conformer IC3" lying just slightly higher in energy than IC3'
by 14.0 kJ mol-1 (Figure 3.6). As can be seen in Figure 3.7, in IC3" the Cys13SOH
hydroxyl now acts as a hydrogen bond donor with a water that is itself hydrogen bonded
to the R-group carboxylate of Asp87. That is, the sulfenic acid is no longer hydrogen
bonded via a water molecule with the thiol of Cys154. Importantly, as a result of this
rotation, the sulfurs of the catalytic and recycling cysteine are now better positioned with
respect to each other for reaction and are closer than in IC3' by 0.39 Å with a
Cys154S…SCys13 distance of 4.54 Å. Furthermore, the sulfenic acids S—OH bond has
lengthened slightly from 1.69 (IC3') to 1.72 Å. Unfortunately, within the present
computational model we were unable to optimize a transition structure (TS4) for
interconversion of IC3' and IC3". However, for isolated ethanesulfenic acid
(CH3CH2SOH) at the B3LYP/6-31G(d) level of theory the analogous rotational barrier is
very low at around 4.0 kJ mol-1. Thus, while the active site sterics and the hydrogen bond
network may increase the barrier for this step, it is still unlikely to be significant or ratelimiting. It is also important to note that sulfenic acid orientation in IC3" is in agreement
with a sulfenic acid-containing X-ray crystal structure of MsrA from N. meningitides
(PDB ID: 3BQG).33 Furthermore, two water molecules were also found to be positioned
in the crystal structure such that they may be able to form a hydrogen bond bridge
between the sulfenic acid's –SOH oxygen and a carboxylate oxygen of Asp87. In
addition, a third water molecule was positioned such that it may form a hydrogen bond
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bridge between the sulfenic acid's sulfur and the R-group of His155. However, the X-ray
crystal structure as well as our MD structure also shows a chain of waters connecting the
sulfenic acid oxygen to Glu52, Tyr44 and Tyr92, suggesting the possibility that one or
more of these residues might also be able to play a role as proton donor's in the disulfide
formation step.
The nucleophilicity of the Cys154S sulfur center, and hence its ability to attack at the
sulfur of Cys13, would be facilitated by deprotonation of the Cys154 thiol. In the present
computational model this can be achieved by proton transfer from Cys154SH via a water
molecule onto the R-group carboxylate of Asp87. This step proceeds via TS5 to give the
Cys154S– thiolate-containing complex IC4 just 37.8 kJ mol-1 higher in energy than IC3".
In IC4 the Asp87COOH group remains hydrogen bonded via a water with the Cys154S–
thiolate while the Cys154S…SCys13 distance has decreased further by 0.13 Å to 4.41 Å
(Figure 3.6). The slightly lower relative energy of TS5 (17.8 kJ mol-1) with respect to IC4
is an artifact of the use of single-point energy calculations and free energy corrections. It
indicates that the reverse reaction, i.e., proton transfer from Asp87COOH via a water to
Cys154S–, occurs without a barrier.
In order for the hydroxyl of the sulfenic acid to be a better leaving group for disulfide
bond formation, it needs to gain a proton at some point and become H2O. The now
neutralized Asp87 residue could act as a suitable proton donor. In particular, it needs to
act as a hydrogen bond donor either directly or indirectly (e.g., via water) with the
Cys13SOH oxygen center. This can be achieved by rotation of its carboxylate's –OH
moiety, i.e., rotation about the aspartyl's Cβ—OH bond, such that it no longer hydrogen
bonds indirectly with Cys154S–. This step proceeds via TS6 with a barrier of 39.4 kJ mol1

with respect to IC4. This is only slightly higher by 28.0 kJ mol-1 than that obtained for

the analogous rotation in isolated propanoic acid at the B3LYP/6-31G(d) level of theory.
This likely reflects in part general effects of the active site and the cleaving of the
negatively charged Asp87COOH…OH2…–SCys154 hydrogen bonding interaction. The
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resulting alternate conformer formed, complex IC4', lies 29.8 kJ mol-1 lower in energy
than IC4. The Cys154S…SCys13 distance is only marginally affected by this rotation
being 4.43 Å in IC4', while the sulfenic acids S—OH bond has lengthened marginally to
1.74 Å (Figure 3.7).

Figure 3.6. Free energy surface (kJ mol-1) obtained (see Computational Methods) for the
reduction of sulfenic acid-containing complex to give an intramolecular disulfide bond
with formation of H2O.

The final step of the overall mechanism is nucleophilic attack of the anionic sulfur of
Cys154 at the sulfur center of the Cys13SOH sulfenic acid to give a Cys154S—SCys13
disulfide bond, and proceeds via TS7. As illustrated in Figure 3.7, formation of the
disulfide bond occurs with concomitant transfer of the proton from Asp87COOH via a
bridging water onto the leaving –OH group of the sulfenic acid to give a H2O molecule. It
is noted that this reaction has been computationally investigated previously using density
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functional theory in combination with small chemical models.56 Similar to the present
results it was also found that disulfide bond formation involved an SN2 mechanism in
which S—S bond formation occurred with concomitant proton transfer onto the leaving –
OH group.56 Within the present extensive QM/MM approach, however, the relative
energy of TS7 is lower than that of IC4' (Figure. 3.6). This suggests that upon
rearrangement of the Asp87COOH…OH2…HOSCys13 hydrogen bond network within
the active site environment of MsrA, the reduction of the sulfenic acid to give a disulfide
bond can effectively occur without a barrier. The resulting final product complex (PC)
formed lies considerably lower in energy than IC3' by 133.1 kJ mol-1. The overall highly
exothermic mechanism for sulfenic acid formation and its subsequent reduction supports
the common experimental observation of the high reactivity of sulfenic acid and
challenges in detecting its occurrence in the presence of the recycling cysteine.
It is noted that within the present computational model the rate-limiting step of the
overall mechanism appears to occur after formation of the sulfenic acid and corresponds
to rotation within the Asp87COOH moiety.57 However, this approach is necessarily
'static' and does not include free energy corrections. In contrast, the hydrogen bond
network within the active site is likely quite dynamic. Thus, the presently calculated
results for this stage of the overall mechanism likely represent an upper thermodynamic
value. Indeed, the approximate rate-limiting barrier obtained from experimental kinetic
studies on the wild-type enzyme in the absence of Trx is 56.6 kJ mol-1.30 This is in good
agreement with the rate-limiting barriers presently calculated for the two possible
pathways for sulfenic acid (IC3) formation from PRC: 61.1 and 85.6 kJ mol-1 in the case
of Tyr92 and Tyr44 acting as the second mechanistic acid, respectively.
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Figure 3.7. Schematic illustration of the optimized structures for sulfenic acid reduction
and formation of disulfide bond

In the mechanism described above for sulfenic acid reduction after methionine
formation, the active site model used began with an initially anionic Asp87 (i.e.,
Asp87COO–) and protonated His155 (i.e., His155-H+). That is, these residues were in
their usual charge states at pH 7. Experimentally, Gand et al.58 have examined the kinetic
effects of mutating either Asp87 or His155 and concluded that a main role of Asp87 is in
substrate binding. Our above MD simulations on the pre-reactive complex are in
agreement as suggested by the observation of a consistent direct interaction between
Asp87 and the substrate. However, the results of Gand et al. also found that mutating
either Asp87 or His155 had similar kinetic effects. 58 We examined the effect of mutating
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Asp87 to Alanine. More specifically, we replaced Asp87 by Ala in the pre-reactive
complex (PRCAsp87Ala), then resolvated the complex using the same procedure as detailed
in the Computational Methods. This was followed by a 1 ns MD simulation and the
results obtained analyzed via cluster analysis. Notably, it was observed that in the
PRCAsp87Ala the thiol of Cys154 consistently hydrogen bonds to the imidazole of His155
either directly or via a water molecule (See Appendix Figure A6) This suggests the
possibility of a Cys154-activation pathway involving His155 that is analogous to that we
have previously described involving Asp87. Hence, for completeness and given that the
pKa of the R-group of His lies near 7 and can be modified by the environment, we also
considered an alternate mechanism in which the imidazole of His155 is neutral and thus
able to act as a base. For this mechanism the R-group of Asp87 was modeled as neutral as
it could still have participated in sulfenic acid formation by accepting a proton from
Cys154SH. It should be noted that in the case of His155 facilitating Cys154 activation, no
rotation of the hydroxyl in Asp87COOH would be necessary (i.e., IC4 → IC4').
Importantly, His155 was indeed able to act as a base and accept a proton from the thiol of
Cys154 in the activation of the latter residue (i.e., IC3' → IC4) with a calculated reaction
barrier of 65.1 kJ mol-1 (See Appendix Table B1). While this is enzymatically feasible, it
is higher than obtained for the above mechanism via TS5. This suggests that mutation of
Asp87 may not significantly affect sulfenic acid reduction as either basic residue near the
thiol of the recycling cysteine could potentially facilitate its activation.

Figure 3.8. Schematic illustration of our computationally suggested mechanism.
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3.4 Conclusion
The overall mechanism(s) by which methionine sulfoxide reductase A (MsrA) from
Mycobacterium tuberculosis catalyzes the reduction of S-methionine sulfoxide (Met-O)
to methionine (Met), i.e., the reductase stage, have been investigated via the
complementary application of docking, molecular dynamics (MD) simulations and
ONIOM (QM/MM) calculations. More specifically, docking and MD simulation were
used to obtain solvated structures for the initial active site-bound substrate complex in
which the catalytic cysteine (Cys13SH) is not yet activated (PRC), i.e., neutral. An
ONIOM QM/MM approach in combination with a large active site model has been used
to examine the mechanism of Cys13 activation and subsequent pathway(s) leading to
formation of a sulfenic acid intermediate. In particular, Cys13SH is able to transfer its
proton via a bridging water molecule onto the R-group carboxylate of the active site
glutamate (Glu52) with a modest energy cost of 49.3 kJ mol-1, to give the activated active
site-bound substrate complex, RC. The now anionic Cys13S– sulfur then nucleophilically
attacks the sulfur of the Met-O substrate. This occurs with concomitant proton transfer
from the now neutral Glu52COOH group onto the substrate sulfoxide oxygen. The
resulting sulfurane intermediate is "polarized" by the active site environment.
Consequently, the sulfurane's oxygen can readily accept a proton from the phenol
hydroxyl of either of the active site tyrosyl residues, Tyr44 and Tyr92, with a negligible
barrier or without a barrier, to give a sulfonium cation and water. The water formed is
hydrogen bonded to the R-groups of both active site Tyr44 and Tyr92, and Glu52.
It was found that a water moiety was then able to directly and readily attack the
sulfonium cation at its Cys13S center, i.e., the sulfur of the catalytic cysteine, to give a
sulfenic acid Cys13SOH and methionine in one step. In the active site chemical model
used, the recycling cysteine (Cys154) was neutral, i.e., Cys154SH. It is found that a
neutral Cys154SH group is able to facilitate sulfenic acid formation by accepting a proton
from the attacking H2O while simultaneously transferring its proton via a water to the
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nearby R-group carboxylate of Asp87. For the case in which Tyr92 acted as the second
mechanistic acid this step occurs with a barrier of 32.6 while for the alternate case in
which Tyr44 acted as an acid the barrier is higher but still enzymatically feasible at 85.6
kJ mol-1. The resulting sulfenic acid intermediate complexes formed, IC3a and IC3b
respectively, are calculated to lie significantly lower in energy than RC by -222.4 and 208.3 kJ mol-1.
Reduction of the sulfenic acid to give an intramolecular Cys154S—SCys13 disulfide
bond, with formation of H2O, was found to occur via series of low barrier steps.
Primarily, these steps involve the rearrangement of the active site hydrogen bond network
and suitable positioning of the sulfur centers of Cys154 and Cys13 for reaction. It is
found that nucleophilic attack by the sulfur of the neutral thiol of Cys154SH is facilitated
by the R-group carboxylate of Asp87. In particular, the latter is able to accept the thiol
proton and then transfer it via a H2O onto the leaving –OH group of sulfenic acid
(Cys13SOH) concomitant with formation of the disulfide bond. Further, our results
suggest an SN2 mechanism for disulfide bond formation, and that it would happen
spontaneously after activation of Cys154 and suitable positioning of the Cys13SOH
sulfur for nucleophilic attack by the thiolate sulfur of Cys154.
Thus, the present results also suggest that both active site cysteines can at least
initially be neutral. During the course of the reaction they can be activated for formation
of the sulfurane or reduction of the sulfenic acid via direct or indirect proton transfers to,
for instance, the R-groups of some active site residues including Glu52 and Asp87.
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Chapter 4
Computational Approach Choice in Modeling
Flexible Enzyme Active Sites

4.1 Introduction
In the last two decades, the applications of quantum chemistry have been extended
from small molecules to protein and DNA.1-4 More specifically, the introduction of
density functional theory (DFT) methods as well as the vast growing of computational
resources allowed for further applications in biochemistry.2,5 Enzymatic reactions are one
of the main field were quantum chemistry have been applied successfully providing
detailed information for numerous catalytic mechanisms.6-10 In order to model these
proteins, there are two main approaches:1,3 1) quantum cluster approach in which the
active site is basically extracted from the crystal structure of the substrate analogue bound
proteins; the structure is truncated including only models of the catalytic residues; mostly,
the quantum model is less than 200 atoms. 2) Quantum mechanics/molecular mechanics
(QM/MM) approach in which docking and molecular dynamic (MD) simulations are used
to prepare the model; then the MM minimized structure is truncated up to 10-20Å from
the active site and partitioned into two layers where the catalytic residues are only
included in the quantum layer and the rest of the model is calculated using molecular
mechanics force field. Both approaches have been successfully used to investigate several
enzymatic mechanisms,11-14 however they also have some downsides.1,9,15
Earlier, we investigated in details the catalytic mechanism of Methionine sulfoxide
reductase B (MsrB) using a quantum mechanical (QM)-cluster approach.16 The two
previously experimentally proposed mechanisms were considered: (1) release of Met via
sulfenic acid intermediate followed by nucleophilic attack of the recycling cysteine
thiolate at sulfenic acid (–SOH) sulfur forming disulfide, (2) direct attack of the recycling
cysteine thiolate at the sulfonium catalytic sulfur. Both mechanisms were found to be
feasible! However, the direct sulfur attack was found to be energetically more favorable.
More interestingly, it occurs via low barrier transition state of 23.8 kJ mol-1 which is
almost half the barrier for sulfenic acid formation, 54.6 kJ mol-1. However, this energy
difference is still small compared to computational error raising an important question, as
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it is unclear if this difference is an artifact of the employed computational method or
model. It is also important to mention that, there was a debate with experimentalists as
they accept that a sulfenic acid intermediate would occur in the mechanism.17,18
MsrB is subclasses of ubiquitous group of enzymes that play crucial roles in cellular
protection mechanism against oxidative stress, Methionine sulfoxide reductase (Msr's),
via reducing methionine sulfoxide (MetSO) back into methionine.19,20 MsrA, another
subclass of the same group of enzymes, and MsrB are stereospecific to MetSO S- and Repimers, respectively.21 Initially, the same reduction mechanism was proposed for both
subclasses in which sulfenic acid was proposed to occur as a precursor intermediate to
disulfide bond formation.22,23 In contrast, a direct sulfur attack on sulfonium cation
intermediate mechanism was also suggested.24 More importantly, sulfenic acid
intermediate was only detected in wild type of MsrA.25 However for MsrB, it was only
detected upon mutating the second Cys.26
Sulfenic acid is a fundamental key intermediate involved in redox chemistry of
proteins.27,28 Its role in biochemistry diverge from signal transduction, non-enzymatic
protein folding, protection against ROS and modulating gene transcription.29-34 It occurs
either via direct oxidation of Cys by ROS, peroxynitirite and hypochlorous acid or
indirectly during several enzymes catalytic reactions and xenobiotic metabolism.27,29,35-37
Furthermore, it has been also proposed to occur as an essential precursor intermediate for
disulfide bond formation in several enzymes.25,31,38-40 Since sulfenic acid has both
nucleophilic and electrophilic characters, it is highly reactive and unstable species.27,28
Therefore, once formed several fate reactions have been proposed to occur, such as
overoxidation to sulfinic and sulfonic acids.29,41 Both reactions considered to be
irreversible as their reduction require a very low pH.29 Furthermore, sulfiredoxin (Srx) is
the only enzyme that has been shown to reduce sulfinic acid in Prx.42
In contrast, several reversible protection mechanisms have also been also proposed.
For instance, Nakamura et al. suggested the formation of a hypervalent sulfur
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intermediate in archaeal peroxiredoxin via forming S–N covalent bond between –SOH
and neighboring His.43 Likewise, it is protected in PTPs and OhrR via formation of
sulfenyl-amide intermediate by forming a covalent bond with backbone nitrogen of the
adjacent residue.44,45 More importantly, it could be stabilized and recycled via Sthiolation forming a mixed disulfide bond with Trx, Grx and GSH or using an
intramolecular Cys as in Msr's.46,47
Lately, we also investigated the formation and reduction mechanisms of sulfenic acid
during the reduction mechanism of MetSO via MsrA in which sulfenic acid was found to
form through a concerted TS via a low barrier of 30.7 kJ mol-1. Furthermore, the
reduction to disulfide was found to occur via several low barrier steps suggesting
spontaneous reduction via an SN2 mechanism upon the activation of second Cys and
rotation of sulfenic acid to be in a proper position for nucleophilic attack explaining its
high reactivity. In MsrA, no direct sulfur attack mechanism was obtained due to the large
distance between the two sulfurs. More importantly, the C …C distance of the two
∝

∝

cysteine was found to be around 11Å in most MsrA crystal structures.48
In contrast, in the MsrB crystal structure of N.gonorrhoeae pilB (PDB: 1L1D,49 the
one used in our previous DFT study), the distance between the two sulfurs is 3.29 Å.
More importantly, the C …C distance is around 7.41 Å. Similar distances were also occur
∝

∝

in other crystal structures such as in streptococcus pneumonia (PDB: 3E0M) and
Neisseria meningitidis PilB (PDB: 3HCG) with a C …C distance of 8.29 Å and 8.47 Å,
∝

respectively.

50,51

∝

Earlier, Ranaivoson et al. suggested the presence of high degree of

flexibility in the MsrB's second Cys containing loop, β2-β3.51 Since a distance of 13 Å
were found to occur between the two C in X. campestris (PDB: 3HCI).51 This implies the
∝

need for conformational change prior to disulfide bond formation. More importantly,
Trp65 lies in between the two Cys preventing the formation of disulfide bond. However,
kinetically, these expected drastic conformational changes did not change the ratelimiting step. Furthermore, the C …C distance in the NMR structure of Bacillus subtilis
∝

∝
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MsrB (PDB: 2KZN) is found to be 9.25 Å as well the distance between the two sulfurs is
7.46 Å.52 Hence, all solved crystal structures of MsrB suggest the high flexibility in the
free, complex-like and sulfenic acid forms. However, the driving force for these changes
are still unclear.
In this study, we reinvestigate the last step of the reductase step in MsrB via studying
the effect of method selection, functional and basis sets on the catalytic mechanism.
Further, we also investigate the effect of model preparation comparing quantum cluster
approach to QM/MM. Furthermore, several MD studies have been used to understand the
driving force for any of the suggested pathways. More importantly, investigating a series
of conformational changes in the active site along the catalytic mechanism.

4.2 Computational Methods
4.2.1 DFT Calculations
All calculations were performed using Gaussian 09 suite of program.53 The hybrid
density functional theory method B3LYP; a combination of Becke’s three parameter
exchange functional and Lee, Yang and Parr’s correlation,54-56 was used. Two basis sets
including 6-31G(d) 5d, 6-31G(d,p) 5d were chosen for structures optimization. In
addition, the HM-GGA M06-2X functional57 was also used in accordance with the 6-31G
(d) 5d basis set. Relative energies were obtained via single point energy calculations on
the optimized structures using the 6-311G(d,p) 5d and the 6-311+G(2df,p) 5d basis sets.
Frequency calculations were only used to characterize the optimized structures as minima
or transition structures The same active site model as in our previous study,16 extracted
from the MsrB crystal structure of N.gonorrhoeae pilB (PDB: 1L1D)49, was chosen to
test the effect of functional and basis set choice. This model as previously described
includes main active site residues.16
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4.2.2 QM/MM Models
All QM/MM calculations were performed using Gaussian 09 suite of program using
the ONIOM formalism.53,58 Truhlar's HDFT M06-2x was chosen for the QM layer
calculations for better description of the hydrophobic interactions between the substrate
and Trp442.57 Furthermore, the AMBER96 force field was used for the MM layer as
implemented in Gaussian.59 The 6-31G(d) 5d basis set was chosen for structures
optimization. However relative energies were obtained via single point energy
calculations

on

the

optimized

structures

at

the

ONIOM

(M062X/6-

311+G(2df,p):AMBER96) using the electronic embedding formalism to account for the
polarization of the environment. One monomer of the same MsrB crystal structure of
N.gonorrhoeae pilB (PDB: 1L1D)49 was used to generate QM/MM models, in order to
test the effect of model selection. Furthermore, two QM/MM models were used during
calculations.
To mimic our previous DFT model we used the same crystal structure without running
molecular dynamic simulations to keep the same starting distance between the two sulfur
atoms. We isolated one of the monomers that include a cacodylate molecule in the active
site. Then, the cacodylate was manually modified into Met. Likewise, two selenomethionine 509 and 464 were mutated back to Met. A PFROSST force field was used to
parameterize and optimize the overall structure as implemented in MOE suite of program.
Then, the QM/MM model was built using the whole monomer. No atoms were kept fixed
during the calculations. A large QM model around the second Cys was chosen including
Asp437, Ser438, Ala439, Cys440, Ala441, Trp442, Pro443, Ser444, Arg493, Asp412,
Cys495 , 3 water molecules and the substrate Met. In the QM/MM starting structure a
bond was formed between Cys495 sulfur and the substrate forming a sulfonium cation
intermediate as our starting structure.
The second QM/MM model was built using the same monomer but after minimizing
and running an MD simulation for the sulfonium cation for 5 ns, simulation details are
71

explained in details in the following MD section. First, similar to previous model the
cacodylate and MSE were mutated to Met. Then the catalytic Cys sulfur was bonded to
the substrate sulfur forming a sulfonium cation intermediate. Afterwards, the whole
system was solvated via adding 3434 water molecule to the system. Next, the system was
minimized using the PFROSST force field until the root mean square gradient of the total
energy become less than 0.1 Kcal mol-1 Å-1.

Subsequently, we performed a 5 ns

simulation after performing a 100 ps equilibration step. The distance between the two
sulfur of the catalytic and the second Cys, was used to cluster the resultant structures into
5 Clusters. Then an average structure was obtained from the highest populated cluster.
Similar to previous QM/MM model, a large model around the second Cys including the
same residues and 4 water molecules. Likewise, the whole monomer was used with no
fixed atoms.

4.2.3 Molecular Dynamics Simulations
The MOE suite of program was used to prepare, minimize and analyze all structures.
However, the NAMD program was used to run the MD simulations. An all atom force
field PFROSST were used to parameterize all structures. It uses AMBER10 for
macromolecules and for small molecules it uses parm@forsst parameters and AM1-BCC
for charges. Four different stages in the catalytic mechanism were considered for
simulations including the substrate free active site, the Michaelis complex with
methionine sulfoxide, the sulfonium cation intermediate and sulfenic acid intermediate.
All investigated structures were manually generated via modifying the MsrB
N.gonorrhoeae pilB (PDB: 1L1D) crystal structure. Prior to simulations, all residues were
solvated using the whole monomer as solute adding a layer of water up to 6 Å from the
residues. The S–O bond in sulfenic acid were restrained to previous DFT measured value.
Solvated structures were minimized using PFROSST force field until the total
energies become less than 0.1 Kcal mol-1 Å-1. Next, 500 ps simulating annealing
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simulations with time step of 2 fs were performed on the minimized structures allowing
for thermal relaxation. All simulations were done under constant pressure however the
temp varied during the annealing process. Starting by heating the system form 150° to
300° for 25ps followed by an equilibration step for another 25 ps. Then, it was heated
again from 300° to 400° for 25 ps followed by a longer time equilibration step for 350 ps.
Afterwards, it allowed to cool down to 300° for 25ps followed by a final equilibration for
50 ps. Subsequently, a production run for 15.5 ns, with time step of 2 fs were performed
at constant temp (300°), in the case of wild, Michaelis complex, sulfonium cation and
sulfenic acid intermediates.

Figure 4.1. The second QM/MM model for MsrB sulfonium cation intermediate
optimized structure. The QM layer atoms are highlighted in sticks to the right of the
Figure.

Generated trajectories were then analyzed. Three main criteria were used to analyse
the generated structures, the change in the C …C distance of the catalytic and second Cys
∝

∝
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as well the change in the S…S distance. Furthermore, the RMSD of the active site QM
residues were also obtained. Then, generated structures were clustered into five clusters in
which the average structure was further investigated. The first 1.5 ns of the simulations
were excluded from our analysis as it considered as equilibration period.

4.3 Results and Discussions
4.3.1 QM-cluster Approach
In order to determine the effect of the level theory on the energy difference between
the two pathways, sulfenic acid and direct disulfide formation, several combinations of
functionals and basis sets have been used, see Figure 4.2 and 4.3. Relative energies were
compared at optimization level as well as single points calculations in gas phase. It is
important to mention that all following discussed optimized TSs are enzymatically
feasible. In our previous study, optimized structures were obtained at quite small basis set
using the B3LYP/3-21G* 5d level of theory and the direct disulfide bond formation,
before corrections, was slightly favoured by 2.0 kJ mol-1. However this difference was
significantly changed upon using a larger single point calculations at the B3LYP/6311G(d,p) level of theory to 55.0 kJ mol-1. Upon adding solvation and dispersion
corrections, this difference was reduced to 30.2 kJ mol-1. Therefore, we investigated the
effect of using a larger basis set for optimization using polarization functions as well as
adding f and diffuse function in the single points calculations.
Using the same model as in our previous paper, we optimized the two pathways
starting from 3Large, the sulfonium cation intermediate, using B3LYP/6-31G (d) level of
theory. Surprisingly, the energy difference between the two TSs increased to 60.5 kJ mol1

which is in agreement with our previous single point results emphasizing that a direct

sulfur attack on the sulfonium sulfur is more favourable than forming sulfenic acid
intermediate. This difference was slightly decreased upon adding p functions to the
hydrogen atoms, 56.8 kJ mol-1.
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Figure 4.2. Potential energy surface (PES) for direct disulfide bond formation pathway
from optimization and single point calculations at several level of theory. Relative
energies in kJ mol-1

Single points on previous optimized structure using the same level of theory as in
previous paper B3LYP/6-311G(d,p) have not changed the difference between the barriers,
60.5 and 55.2 kJ mol-1 for the B3lYP/6-31G(d) and B3lYP/6-31G(d,p), respectively.
However, using a larger level of theory B3LYP/6-311+G (2df,p) adding f and diffuse
functions slightly decreased the difference to 53.0 and 48.7 kJ mol-1. These differences is
still in agreement with our previous results at the B3LYP/6-311G(d,p)//B3LYP/3-21G*.
Therefore, our new results with larger basis sets emphasized our previous conclusion in
which the direct formation of disulfide bond is favoured over sulfenic acid formation.

75

Figure 4.3. Potential energy surface (PES) for sulfenic acid formation pathway from
optimization and single point calculations at several level of theory. Relative energies in
kJ mol-1

Since all previous results were obtained using the hybrid DFT B3LYP functional, we
also considered using different functional to test if this difference is an artefact of the
chosen method. Therefore, we also investigated the two pathways using meta hybrid DFT
functional M062X. From previous calculations, the 6-31G(d) seems to be a reasonable
basis set, so it has been employed. The energy difference between the two pathways at
optimization level (M062X/6-31G(d)) gave a similar difference of -46.6 kJ mol-1, in
favour of direct disulfide bond formation. More importantly, the sulfenic acid and
disulfide TSs increased to 95.4 and 48.8 kJ mol-1, respectively. Furthermore, the same
results were obtained at the M062X/6-311G(2df,p) single point calculations showing an
energy difference between the two pathways of 66.5 kJ mol-1. Therefore, using different
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basis sets and functionals does not change our previous conclusion; the direct disulfide
bond formation is approximately 55 kJ mol-1 more favoured than the sulfenic acid
intermediate formation, However both pathways are enzymatically feasible.

4.3.2 QM/MM Results
Since basis sets and functional change confirmed previous conclusions, we also
considered investigating the effect of model choice. Therefore, we used a QM/MM model
as described in the method section to explore both pathways starting from the sulfonium
intermediate structure. A large QM layer around the recycling Cys440 has been chosen.
In all our previous models we considered anionic recycling cysteine, however a neutral
cysteine might affect the proposed mechanism. It is worth mentioning that, the pKa of the
recycling cysteine has been experimentally suggested to be higher than 9.60 Therefore, we
attempted to calculate the proton affinity of Cys440. However, such calculations could
not be obtained as in all our anionic models the optimization leads to the formation of the
disulfide bond emphasizing that a direct nucleophilic attack on Cys495 sulfur forming a
disulfide bond upon activation of Cys440 without an energy barrier.

Figure 4.4. Optimized structures for the direct disulfide bond formation from the
QM/MM calculations in which the sulfonium intermediate were obtained from MsrB
crystal structure.
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The optimized reactive complex of the neutral model shows that, the hydrogen of
Cys440 is hydrogen bonded to Asp412 and Asp437 via several water molecules
suggesting a new role for either of the aspartate residues to activate Cys440. It also shows
that W1 (Figure 4.4) could act as a base as it has very strong hydrogen bonds with
Ser438, NH backbone of Asp437 and W2 with distances of 1.68 Å, 1.99 Å and 1.51 Å,
respectively. In addition it has a weaker hydrogen bonds to Ser444 and the backbone
carbonyl of Pro443 with distances of 2.13 Å and 2.60 Å, respectively. Interestingly, we
found that the activation of catalytic Cys495 occurs via a low barrier, 19.2 kJ mol-1,
concerted TS in which proton shuttle from Cys440 to Asp412 via two water molecules.
The TS structure (Figure 4.4) show that, a proton is shared between W1 and W2 with
distances of 1.26 Å and 1.17 Å, respectively, In turn, the O-H distances in W2 is
elongated to 1.07 Å in which the proton is strongly interacting with Asp412 oxygen, 1.44
Å. Similarly, the S-H bond in Cys440 is elongated to 1.36 Å and is hydrogen bonded to
W1 oxygen at a distance of 2.14 Å. IRC calculations shows that this TS leads to the
activation of Cys440, however no stable intermediate was obtained as Cys440
concomitantly attack the sulfur centre of the sulfonium cation forming disulfide bond.
The formed disulfide intermediate is 246.6 kJ mol-1 lower than RC.
The sulfenic acid pathway is also investigated, however to activate a water molecule
to attack the sulfonium sulfur the Cys440 needs to be activated first and as noted before
once Cys440 is activated it forms the disulfide bond. Therefore, we investigated a
concomitant activation of Cys440 and the sulfenic acid water, however no such TS was
found to occur. Furthermore, the closest water is not in a proper location to attack; as
including the whole monomers limited the ability of having that water in a proper
position. These results actually question the validity of the QM cluster approach in which
the surrounding of the active site are not included allowing for water addition in several
position, which might not be realistic as in this case. In addition the nature of the TS
differs based on chosen computational approach, QM-cluster or QM/MM, as in the
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former one the TS represent the S…S…S bonds formation and dissociation however, the
QM/MM study show that this TS would occur spontaneously upon Cys440 activation.
All previous results emphasize our original proposed mechanism were the direct
disulfide bond formation is more favoured. As previously described we tested the choice
of basis set, the functional and the computational approach, however all these result are
based on the original crystal structure of MsrB in which the distance is 3.29 Å. Therefore,
the obtained PES might be an artifact of the short distance between the two sulfurs in the
crystal structure. Specially as discussed in the introduction that the recycling Cys440 is
located in a flexible loop and the S…S distance in the only solved NMR structure is over
7Å. Furthermore, in several species this distance has been found to be longer. Therefore,
we ran an MD simulation on the sulfonium cation intermediate for 5ns and the generated
structures were clustered and an average structure was obtained from the highest
populated cluster. Interestingly, the S…S distance was elongated during the simulation to
approximately 5Å. Similar to previous QM/MM the whole monomer was used and no
atoms were kept fixed allowing for full relaxation of the system.
The optimized structure of the average structure of the sulfonium cation shows that
(Figure 4.5), the S…S distance is 4.88 Å. More importantly, a water molecule is now
located below the Cys495 sulfur and the SCys495…OW1 distance is 2.44 Å. In turn, the W1
proton is hydrogen bonded to the SCys495 sulfur with a distance of 2.29 Å. Furthermore, It
also has several hydrogen bonds with carbonyl of Pro443 and W3 (to Arg493) with
distances of 1.78 Å and 1.72 Å, respectively. The Cys440-H is strongly hydrogen bonded
to W2 with a distance of 1.43Å, which in turn strongly polarized by two hydrogen bonds
with Asp412 and Asp437 via a distance of 1.48Å and 1.66Å, respectively. This hydrogen
bonding network emphasis our previous proposed mechanism in our previous MsrB and
MsrA studies in which the recycling cysteine activates a water molecule forming sulfenic
acid (Cys440 activates W1, in MsrB). Interestingly, this step was found to occur via a low
barrier of 16.7 kJ mol-1. In this TS (Figure 4.5), Cys440 hydrogen is shared with W2 with
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distances of 1.50 Å and 1.43 Å, respectively. In turn the W2 O-H bond is elongated to
1.05 Å strongly interacting with Asp412, 1.78 Å. As previous no stable intermediate of
the anionic sulfur was optimized, however the activation of Cys440 occur with
concomitant proton transfer from W1 to Cys440 activating W1 and forming sulfenic acid.
The generated sulfenic acid intermediate is 120.6 kJ mol-1 lower in energy than the
sulfonium intermediate, 3Large.
These results raise many questions about the quantum cluster approach especially in
dealing with proteins containing flexible loops showing that misleading results might be
obtained upon using models based on crystal structures without proper preparation. It also
emphasizes the importance of the starting structure in determining enzymatic
mechanisms. Such proper preparation is missing in the Quantum cluster approach as the
models are commonly based on the crystal structure with the substrate analogue. Our
QM/MM MD based calculations showed that a sulfenic acid intermediate is formed in the
MsrB catalytic mechanism which is contradicting our DFT cluster approach as well as
QM/MM crystal structure based calculations.

Figure 4.5. Optimized structures for the sulfenic acid formation pathway from the
QM/MM calculations in which 3large were obtained from sulfonium intermediate MD
simulation.
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4.3.3 Molecular Dynamics Simulations Results
In order to confirm previous results and to understand why the S…S distance is
different from crystal structure, we ran a series of MD simulations for several complexes
starting from Apoenzyme to Michaelis complex, sulfonium and sulfenic acid, as
described in the method section. We first examined the distance between the two Cys
before substrate binding in wild type apoenzyme. A 16 ns MD simulation was enough to
reach equilibrium as can be seen from the RMSD of the QM layer (Figure 4.6). The rmsd
of the apoenzyme-generated structures fluctuate between approximately 0.75 Å and 1.5 Å
indicating the stability of the system. This higher fluctuation range was investigated and
found to be because that the recycling cysteine is located in a high flexible turn as
previously suggested.

Figure 4.6. RMSD's of the QM layer vs time for the four models used to represent the
catalytic cycle (A) Apoenzyme before substrate binding, (B) substrate bound active site,
(C) sulfonium cation intermediate, and (D) sulfenic acid intermediate.

The main criterion in analyzing these simulations is the distance between the Cα's of
Cys440 and Cys495. As can be seen in Figure 4.7, this distance fluctuate approximately
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between 7.0 Å and 9.5 Å with few exceptions where the distance increased near to 11.0
Å, as will be seen in the following discussion. Further, the mean distance is 8.36 Å with a
maximum distance of 11.27 Å and minimum distance of 6.76 Å. Furthermore, all
generated structures were clustered into five clusters and the average structure for each
were determined. The highest populated cluster represents approximately 60% of the
simulation in which the distance in the average structure is 8.36 Å, which is agreement
with the crystal structure, ≈7.40 Å. Furthermore, the highest and lowest distance in this
cluster are 8.88 Å and 7.83 Å, respectively. The second populated cluster represents
approximately 20% of the simulation. The Cα distance significantly decreased in the
average structure to 7.31 Å. In contrast, the distance in the 3rd populated cluster average
structure has increased to 9.4 Å. All three clusters represent more than 95 % of the
simulation. Structures with a distance between 9.93 Å and 11.27 Å in the 4th cluster
represented less than 2.5 %. It is also worth to mention that the average S…S distance is
5.79 Å with a maximum distance of 11.08 and minimum distance of 3.08 Å. All these
results show that the formation of disulfide bond is feasible with no need for
conformational changes in the active site and the average distance is in agreement with
crystal structure.
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Figure 4.7. Distance change between Cα of Cys495 and Cys440 vs time the four models
used to represent the catalytic cycle (A) Apoenzyme before substrate binding, (B)
substrate bound active site, (C) sulfonium cation intermediate, and (D) sulfenic acid
intermediate. Distances are in Angstrom.

Since the Apoenzyme simulation shows a similar close distance, we also investigated
the effect of the substrate binding. As shown in Figure 4.6, the rmsd of the QM layer are
equilibrated with a fluctuation after the first 3 ns between approximately 1.0 Å and 1.4 Å.
Similarly, the distance between the two Cys Cα fluctuate between 10-12 Å with a mean
distance 11.12 which is significantly higher than in the apoenzyme with a huge minimum
distance of 9.39 Å and a maximum distance of 12.83 Å. As before, the generated
structures were clustered into five clusters, which have been further analyzed. The most
populated cluster represents approximately 59% of the simulation with a maximum and
minimum distances of 11.45 Å and 10.79 Å, respectively. It is important to mention a
distance more than 11 Å does not allow for disulfide bond formation. More importantly,
the average structure of this cluster has 11.12 Å distance between the Cα of the two
cysteine. Furthermore, the second and third most populated clusters have a similar
population of 19.5% with an average distance of 11.77 Å and 10.46 Å, respectively. All
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three clusters constitute more than 97% of the simulation. Furthermore, the mean distance
between the two sulfurs has significantly increased to 6.93 Å with a minimum of 4.72 Å
and a maximum of 9.31 Å. Therefore, it’s obvious that substrate binding leads to active
site conformational changes. In fact Cys440 is located on the same loop as Trp442, which
also changes its position upon substrate binding. The strong hydrophobic interaction
between the substrate and Trp442 is very important for substrate binding and catalysis as
have been examined experimentally. This suggest that, as can be seen in Figure 4.8, the
substrate binding enforce Trp442 conformational change which in turn affects the
conformation of the whole turn including Cys440 extending the distance between the two
sulfurs.
In order to confirm prior conclusion, we also considered long MD simulation for the
sulfonium intermediate in which bigger range of fluctuation in the QM rmsd between
approximately 0.6 Å-1.3 Å; this actually an artifact of the turn flexibility and the
sulfonium cation. It's important to mention that the positive sulfur of the sulfonium cation
was not properly parameterized was the current force field, however its partial charges
was correct, which might be a reason for this fluctuation. However, the current results are
in agreement with the former one, as the distance of the Cα is equilibrated and fluctuate
between 9.5 Å and 11.5 Å with a mean of 10.14 Å with a minimum of 8.24 Å and a
maximum of 11.15 Å. This range is still significantly large compared to the apoenzyme
simulation. Furthermore, the distance in the average structures of the three highest
populated, 96%of the simulation, clusters are 10.14 Å, 9.48 Å and 10.80 Å, respectively.
Furthermore, the mean distance between the two sulfurs is 5.80 Å with a minimum of
3.88 Å and a maximum of 8.49 Å. These results of the longer simulation confirm our
QM/MM MD based results were the S…S distance are larger than the crystal structure
allowing for formation of sulfenic acid intermediate in the mechanism as experimentally
suggested.
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Figure 4.8. Superposition of the 4 MD's active site average structures in apoenzyme,
Michaelis complex, sulfonium and sulfenic acid intermediates.

Although earlier results explain the effect of substrate binding on the mechanism and
its effect on the proceeding pathway, however there is still a question to be answered,
which is how the disulfide bond is formed. Therefore we ran another 16ns MD simulation
on the sulfenic acid structure investigating the effect of substrate removal; starting with a
large S…S distance using the average structure of the 5ns sulfonium simulation. As shown
in Figure 4.6, the RMSD of the QM layer is equilibrated fluctuating between 0.4 Å and
1.0 Å. This emphasized from the distance between the two Cα of the two cysteine which
fluctuate approximately between 8.5 Å and 10.5 Å with a mean distance of 9.48 Å with a
minimum of 7.63 Å and maximum of 11.19 Å. Furthermore, the highest populated cluster
represents 59% of the simulation with an average structure distance of 9.48Å which
would allow for a direct disulfide formation with no need to any conformational changes.

85

Similarly, the distance in the average structure of the second and third most populated
cluster is 8.89 Å and 10.08 Å, respectively. All three clusters represent more than 97.5%
of the simulation showing that upon substrate removal the Trp442 and Cys440 turn would
move back toward its original conformation as in the wild type simulation and crystal
structure.
Comparing all previous simulation results show that, before substrate binding the
distance between the Cα of Cys440 and Cys495 in the average structure is 8.36 Å which
then is elongated upon substrate binding to 11.12 Å showing that substrate induce
conformational changes in the active site specially via its hydrophobic interaction with
Trp442 which is located on the same turn as Cys440. These results were confirmed by the
10.14 Å distance in the average structure of the sulfonium cation allowing for sulfenic
acid formation as have been shown in the previous QM/MM section. Finally, upon
formation of sulfenic the substrate leaves the active site allowing for a shorter interaction
distance, 9.48 Å, between the two Cys allowing for disulfide bond formation with no
need for any conformational changes.
Our results emphasize the importance of starting structure preparation as well as
question the applicability of QM cluster approach to system with flexible turns showing
that misleading results might be obtained. Our previous QM-cluster study on MsrB
showed that both mechanisms are energetically feasible however the direct disulfide bond
formation is favorable. In contrast, in this study, running several MD simulations as well
as investigating the effect of substrate binding in the active site showed that a sulfenic
acid intermediate would occur in the mechanism.

4.4 Conclusions
In this study several computational approaches, QM cluster, QM/MM and MD
simulations, have been employed comprehensively to reinvestigate that last step in the
reductase step of the catalytic mechanism of MsrB. First, we investigated the effect of
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level of theory by utilizing several basis sets for optimization and single point
calculations. Increasing the basis set size confirmed our previous conclusion in which the
direct disulfide bond formation is favorable over sulfenic intermediate formation.
Furthermore, the HMGGA M062x was also used to examine the effect of functional on
previous conclusion, however M062x emphasized previous conclusion. In addition, we
also investigated the effect of model choice using QM/MM (ONIOM) approach including
a large QM layer around Cys440. The QM/MM model was directly extracted from the
crystal structure. Interestingly, deprotonating the second Cys440 leads to direct
nucleophilic attack on Cys495 sulfur forming disulfide. Therefore we considered using a
neutral cysteine in our model. Using neutral cysteine changed the nature of the optimized
TS as it is now represent the activation of Cys440 leads to direct formation of disulfide
emphasizing previous results.
In order to eliminate the possibility that all previous results are an artifact of the used
same crystal structure in which the S…S distance is 3.29 Å, we investigated the effect of
the starting distance by running a 5 ns MD simulation on the sulfonium cation
intermediate. Surprisingly, the MD simulation results shows that the distance between the
two sulfur is significantly increased to 4.88 Å. More importantly a water molecule is
located in a proper position for attack forming sulfenic acid intermediate. To investigate
the mechanism from the average structure of the MD simulation, we run QM/MM using a
similar QM layer as in previous calculations. Surprisingly, the an anionic Cys440 leads to
direct formation of sulfenic acid intermediate. We also found the activation of Cys440
occurs via a low barrier of 16.7 kJ mol-1 proposing a catalytic role for Asp412.
Since Our MD results shows different distance from the crystal structure, we
considered running long MD simulations for 16ns using several models representing
active site changes during the catalytic mechanism. MD results show that, before
substrate binding the distance between the Cα of Cys440 and Cys495 in the average
structure is 8.36 Å which then is elongated upon substrate binding to 11.12 Å showing
87

that substrate induce conformational changes in the active site, especially via its
hydrophobic interaction with Trp442 which is located on the same turn as Cys440. These
results were confirmed by the 10.14 Å distance in the average structure of the sulfonium
cation allowing for sulfenic acid formation as have been shown in the previous QM/MM
section. Finally, upon formation of sulfenic the substrate leaves the active site allowing
for a shorter interaction distance, 9.48 Å, between the two Cys allowing for disulfide
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Chapter 5

Small Molecules Activating an Antioxidant
Enzyme

5.2 Introduction
In drug design, enzymes are one of the primary therapeutic targets.1 Indeed, enzyme
inhibitors are widely used as drugs for numerous diseases, today.1 Moreover, in the recent
years, a new role of enzymes in drug development has become apparent, in which small
molecules have been tested to enhance the activity of specific enzymes instead of
inhibiting them as a new therapeutic strategy.2-4 Many enzymes have been shown to be
activated via small molecules including glucokinase, sirtuin, AMPK and RNase.3,5-7
Furthermore, these activation mechanisms have been classified into two main groups,2 in
which small-molecules activators binds either directly to an allosteric site of the enzyme
or to a regulatory subunit, leading to a conformational change and the stabilization of an
open active sites enabling catalysis. Notably, the discovery and validation of possible
target enzymes for activation is a very complicated process and there is no systematic
approach to achieve this goal. In general, the activation of enzymes via small-molecules
is actually favored over their inhibition due to: 1) allosteric sites are not conserved as
active sites, so activators binding is considered more specific in general, 2) unlike
inhibitors, much smaller concentration of the activators is needed to amplify the enzyme
efficiency significantly.2
Methionine sulfoxide reductase (Msr) is a group of ubiquitous antioxidant enzymes
that catalyze the repair of oxidized proteins, reduction of methionine sulfoxide (Met-O) to
methionine (Met),8 with multiple health implications, from aging to several age related
diseases such as Alzheimer's and cancer.9,10 It is mainly consisted of two stereospecific
classes, MsrA and MsrB. Remarkably, the overexpression of MsrA in several species has
been shown to increase their life span as well as knocking it out leads to oxidative
stress.11-13 Indeed, the defensive role of this enzyme against reactive oxygen species has
been the subject of numerous studies.
The catalytic mechanism of MsrA can be divided into two step:14,15 1) the reductase
step, in which Met-O is reduced forming MsrA-sulfenic acid intermediate that
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subsequently reduced forming an intramolecular disulfide bond (MsrAOx), 2) the
regeneration step, in which the protein disulfide is reduced by thioredoxin (Trx)
regenerating the active site (MsrARed). Recently, we have elucidated the mechanism for
the reductase step in detail, showing that it happens via low barriers multistep.14
Experimentally, the rate-limiting step of the overall mechanism has been shown to be
associated with the regeneration step.15 Outstandingly, the two steps of the mechanism
require two different conformations, switching from a closed form active site in the
reductase step to a more open fold for the regeneration step, allowing for Trx binding.16,17
The overall fold of MsrAOx and MsrARed does not change much and the core structure
of the enzyme is maintained. The main difference between the two conformations is the
unfolding of the two-stranded antiparallel β–sheet (Gln122 to Thr132). Coudevylle et al.16
using NMR studies have shown that in the oxidized form the Gln122-Thr132 segment is
unfolded and has no secondary structure. Indeed, the unfolding of this segment is
essential for Trx binding and subsequent reaction to regenerate the active site. In general,
in either conformation, the core enzyme structure is lined with N and C-terminal ends
with no secondary structure. The C-terminal end in Escherichia coli contains the
resolving cysteinyl residue. It is important to mention that the Gln122-Thr132 segment in
the reduced form surrounds the MsrA active site. Similar confirmations of the reduced
form have been found in several species using X-ray crystallography.
Recently, Moskovitz et al.18 have shown that the activity of MsrA in rat neurons can
be induced using a substrate mimic molecule, N-Acetyl Methionine Sulfoxide (Ac-MetO). In vitro and in vivo studies have shown that Ac-Met-O protects the neuron from Aβ42
toxicity suggesting a protective role in Alzheimer's. Based on their results, the authors
suggested that the activity of MsrA might be provoked by small molecules containing a
sulfoxide functional group, providing a novel way to develop antioxidant drugs in
Alzheimer's and other oxidative stress related diseases.18 Consequently, more recently,
Frankiln et al.19 have shown that Pergolide sulfoxide (PergSO) and Pergolide (Perg) as
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well as S-adenosyl methionine (SAM) increases the activity of MsrA in neuronal cells
suggesting similar role to Ac-Met-O. Perg is a dopamine receptor agonist that used to
treat Parkinson's disease until 2007. Furthermore, the authors chose PergSO as it contains
a methyl sulfoxide moiety suggesting that Perg will be first enzymatically converted to
PergSO before activating MsrA.19 However, their results show that Perg is more potent
than PergSO. At 10 µM concentration, Perg and PergSO increased the activity of MsrA
by 158% and ∼130%, respectively. Interestingly, the upregulation of MsrA activity was
partially correlated to its overexpression, suggesting that the activation occurs via an
uncertain mechanism. In addition, SAM was found to have a less activation effect
compared to Perg and PergSO.
Here we investigated the mechanism of MsrA activation by Perg, PergSO and SAM,
considering the possibility of their direct interaction with the enzyme. The binding
pockets were identified using docking techniques. The effects of small-molecules binding
were elucidated using a 9.5 ns MD simulations. Furthermore, virtual-screening was used
to identify other possible activator small-molecules.

5.2 Computational methods
In order to investigate the possibility of direct interaction, the Escherichia coli NMR
structure (PDB: 2GT3) of the reduced form of MsrA was used as a starting structure.16 In
addition, another starting structure was also considered in which the MsrARed was
modified manually to form MsrAOx, by forming the Cys51-Cys198 disulfide bond. In
both cases, the enzyme structure was first solvated, up to 15 Å away from any residue,
and minimized using AMBER12:EHT forcefield. Subsequently, both MsrARed and
MsrAOx were docked using the three ligands Perg, PergSO and SAM. The whole enzyme
structure was used as a receptor for docking. The MOE suite of programs was used for
docking.20 First, the top 100 conformations for each ligand were generated using the
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London dG scoring function. Second, using forcefield refinement method, only the top 50
conformations were retained and analyzed.

5.3 Results and Discussions
Docking the MsrARed form has shown that the three ligands mainly bind to a
hydrophobic pocket at the interaction between the C-terminal and the α4 secondary
structure, in which the ligands interact with Leu207, Pro206, Ala159 and Phe156.
Furthermore, very few conformation were found to occur at the N-terminal end along
with β5.
Notably, upon forming the Cys51-Cys198 bond (MsrAOx) all three ligands were found
to constantly bind to new binding pocket at the interaction of N-terminal and more
importantly the two-stranded antiparallel β–sheet (Gln122-Thr132 segment). These
interactions were found to include several residues such as His130, Arg125 from Gln122Thr132 segment and Phe3, Lys5, Lys5 from the N-terminal. Furthermore, the binding
score of all three ligands in MsrAOx is higher than the previously obtained for MsrARed.
SAM was found to bind less regularly to this new pocket. Moreover, our docking
structures show that the methyl sulfoxide moiety is not involved in these interactions;
instead cation-π and hydrophobic interactions are the main reason for binding.
These results raised a main question if the binding of these ligands to the Gln122Thr132 segment in the oxidized form might facilitate its unfolding and the subsequent
regeneration reaction with Trx leading to MsrA direct activation, as observed
experimentally. Therefore, using 9.5 ns molecular dynamic simulations, we investigated
the dynamics of the Gln122-Thr132 segment upon ligand binding. Prior to MD's, we
docked the three ligands using induced fit approach, in which the previously identified
pocket residues were allowed to move and adjust during the simulation. The highest 10
conformations for each ligands were retained and top three poses were used as a starting
point for MD simulations. Furthermore, a control MD simulation of MsrAOx was also
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performed in order to compare the obtained results. As previous MOE suite of programs
was used to generate and analyze MD's as well as NAMD was used to run the MD
simulations.21

Figure 5.1. Top) docking predicted binding mode of Pergolide, bottom) schematic
representation of Pergolide interactions in the MsrA allosteric site.

Experimentally, based on previous X-ray structures of MsrARed, a main hydrogen
bond between Asp129 (from the Gln122-Thr132 segment) and Tyr197 was though to play
an important role in keeping the folded reduced form of the active site.17 However, in the
used NMR structure, this hydrogen bond is broken, therefore in our analysis we also
considered both scenarios as starting structures. Furthermore, in our analysis we
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considered two main criteria, 1) the molecular surface of the Cys51-Cys198 disulfide
bond and its surroundings residues as well as the disulfide exposure to the solvent, which
reflects its subsequent reaction with Trx, 2) the root-mean-square deviation (RMSD) of
the Gln122-Thr132 residues as well as the facing interacting residues, Gly196, Tyr197,
Cys198 and Gly199 in the C-terminal. Although, all three ligands were investigated, in
the following section we will mainly discuss the results obtained for Perg as it has the
highest effect on MsrA activity.

Figure 5.2. Molecular surface representation of the disulfide surrounding residues
extracted from MD simulations. The surface exposure of the disulfide bond is represented
by yellow colour.

As shown in Figure 5.2, from the control MD, the disulfide bond is buried in the
active site with a very minimal solvent exposure. Furthermore, either upon forming the
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Tyr197…Asp129 hydrogen bond or in its absence the Gln122-Thr132 segment is still
folded completely, covering the active site. The rmsd of the involved residues shows that
after significant change due to annealing the rmsd were kept constant between 2-3 Å
reflecting a small increase upon time, see Figure 5.3. It is also important to mention that
in our previous study on MsrA mechanism we ran a 25 ns simulation of the oxidized
structure and no significant change in the Gln122-Thr132 segment was observed.14
Unlike the control MD, the introduction of Perg was found to increase the disulfide
bond exposure to the solvent, dramatically, see Figure 5.2. More importantly, the Gln122Thr132 segment residues are no longer interacting with the Gly196-Gly199 C-terminal
residues. The superposition of the control versus Perg structure clearly emphasize this
finding. Indeed, this is reflected in the obtained rmsd, in which after almost 7 ns of the
simulation a huge jump was observed to occur breaking the original interactions between
the Gln122-Thr132 residues and the Gly196-Gly199 C-terminal, see Figure 5.3. Similar
dynamics were also observed for PergSO and SAM. Based on the MD generated
structures, a cation-π between Arg125 and Perg arene might be the cause of this
dynamics, see Figure 5.1. Furthermore, using different starting structure, another
interaction was also found to occur with His130. All these results suggest that Perg
binding disrupt the interactions between the Gln122-Thr132 and C-terminal residues,
which might affect the segment folding. However, the generated structures still maintain
the two-stranded antiparallel β–sheet.
In order to speed up the unfolding dynamics within a moderate simulation time, we
ran a second MD (15 ns) starting with the last structure of the Perg MD upon removing
Perg from the allosteric site. Indeed, the rmsd of the Gln122-Thr132 segment shows
significant increase upon time. Notably, snapshots of the MD's conformation show the
total uncovering of the active site and the fluctuation of the Gln122-Thr132 segment from
two-stranded antiparallel β–sheet and no secondary structure. A superposition of the MD
generated structure and the NMR unfolded form of the enzyme (PDB:2IEM)16
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highlighting the exposure of the active site to subsequent reaction with Trx, see Figure
5.4. It is also important to mention that based on docking results that the binding of these
small-molecules activators to the reduced form of the enzyme does not affect its folding
and subsequently will not disturb the first step ( the reductase step) of the mechanism
which require a folded active site.

Figure 5.3. Time evaluation of root-mean-square deviation (Rmsd's) of Gln122-Thr132
segment and Gly196-Gly199 residues with and without Pergolide binding.

Previous results suggest that the activation mechanism of MsrA by Perg, PergSO and
SAM occurs due to direct interaction with an allosteric site of the enzyme facilitating the
unfolding of the Gln122-Thr132 segment. However, Perg cannot be longer used as a drug
as it was withdrawn from the market due to undesirable side effects. Therefore, we also
considered the search for other ligands, which can bind to MsrA producing similar effect.
Using virtual-screening, we searched the subset ZIM from the ZINC drug database for
binding in the previously identified allosteric site.22 ZIM includes all compounds have
been in human including worldwide drugs. Using the triangle matcher placement and
London dG scoring, we docked 11421 molecules, retaining the highest 10 poses for each
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molecule. Based on the scoring function, the highest 292 molecules were selected for
further analysis. In which an induced fit docking approach as well as a second refinement
step, as described earlier, was used retaining the top highest 5 poses for each ligand. A full
list of the 292 molecules with their docking score are included (See Appendix Table B2).

Figure 5.4. Superimposition of the MsrAOx NMR solution structure with that of
MsrAOx MD generated structure upon Pergolide binding and removal.

In general, most of the identified systems were found to include an arene function
group and some of them include the cation-π interaction as in Perg suggesting the
possibility of discovering new small-molecules MsrA activators. Surprisingly, many
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antibiotics such as Cefoperazone, Natamycin and Lymecycline were found to have high
binding affinity to MsrA. Furthermore, many natural occurring molecules including
NAD+, NADH and ATP were also identified as possible ligand. These results raise
another main question, if MsrA is naturally regulated by biomolecules! Finally, part of the
identified molecules has been found or suggested previously to have an antioxidant
effects such as Nicardipine, folinic acid and Sildenafil.23-25 In addition, we run a short MD
simulation (2 ns) on selected ligands including NADH, Natamycin and Cefoperazone.
Although the short simulation time compared to control, our MD's show that the
molecular surface of the disulfide was found to increase significantly in comparison to the
longer 10 ns control simulation.

5.4 Conclusions
In summary, this report suggests the direct activation of MsrA via binding of smallmolecules providing an explanation of the previously recognized experimental results.
Furthermore, our results also suggest other possible activator ligands. Further
experimental studies to test this direct interaction as well as high-throughout screening
will provide tools to confirm our proposed mechanism of activation and develop new
activators with an antioxidant activity.
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Chapter 6

Formation of Stable Iminol Intermediate in the
Redox Regulation Mechanism of PTP1B

6.1 Introduction
Protein tyrosine phosphatases (PTP's) are a large family of enzymes responsible for
dephosphorylating phosphorylated tyrosyl residues in proteins,1,2 a physiologically
important post-translational modification (PTM). In particular, the sub-class PTP1B, first
characterized in 1988,1,3,4 plays a key role in inhibiting insulin and leptin signaling.5-7
Conversely, it has been shown to have a crucial positive role in signaling of, for instance,
cSrc tyrosine kinases in breast cancer3,8,9 and the ubiquitous Ras proteins.10 Consequently,
PTP1B is considered to be an outstanding drug target for the treatment of several diseases
including diabetes, obesity and cancer.3,11-13
PTP1B catalyzes the dephosphorylation of phosphotyrosine via a two step ping-pong
mechanism (Scheme 1).14 In the first step, the sulfur of an active site cysteinyl (Cys215)
nucleophilically attacks the phosphotyrosine ester to form a phosphoenzyme intermediate.
This is accompanied by the concomitant release of the tyrosine. In the second step,
hydrolysis of the phosphoenzyme intermediate occurs via nucleophilic attack of H2O
upon activation by Asp181. Tiago et al.14 have previously investigated both steps using XRay crystallography to characterize transition state analogs.
To date, four different mechanisms have been identified by which the function of
PTP1B can be regulated: phosphorylation, sumoylation, proteolysis and oxidation.3 In
particular, in the latter, Cys215 has been experimentally observed to be reversibly
oxidized to a sulfenic acid (Cys251SOH) by reactive oxygen species' (ROS).15 This
modification is in part facilitated by the unusually low pKa (4.5-5.5) for the thiol of
Cys215.1 This oxidative PTM mediates several signaling pathways. For instance, with
regards to insulin the stimulation of trans-membrane receptor kinase (RTK) leads to the
activation of NADPH oxidase, producing ROS that oxidize Cys215 in PTP1B, thus
transiently inhibiting its function.1 The activity of PTP1B is restored upon reduction by an
external thiol such as thioredoxin (Trx), dithiothreitol (DTT) or Glutathione (GSH).16
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In general, sulfenic acid is susceptible to further and irreversible oxidation to sulfinic
or sulfonic acid. X-ray crystallographic analysis, and pulse-chase labeling and mass
spectrometry experiments suggested that the sulfenic acid can undergo an intramolecular
reaction to give a seemingly unique cyclic sulfenyl-amide species; thus protecting it from
further oxidation.15,17-19 To-date this mechanism has only been observed for PTP1B. But it
should be noted that it has been suggested that such an intermediate may occur in other
proteins including PTP1α, and other protein families such as organic hydroperoxide
resistance regulator (OhrR) in Bacillus subtilis.20,21 In other enzymes sulfenic acid is
protected via, for example, formation of a disulfide (e.g., methionine sulfoxide reductase)
or hypervalent sulfurane species (e.g., archaeal peroxiredoxin).22,23
Initially it was proposed that the sulfenyl-amide forms via a direct SN2 mechanism.
Specifically, the backbone nitrogen of the neighboring serinyl (Ser216) nucleophilically
attacks the sulfenic acid's Sγ atom with concomitant release of H2O (scheme 1).17
Furthermore, the hydrogen bonding interaction between the Nδ1 atom of the invariant
histidyl (His214) and the carbonyl oxygen of Cys215 was suggested to play a key role in
enhancing the nucleophilicity of the Ser216 backbone nitrogen.17 Indeed, it has been
shown that mutation of His214 to Asn or Ala increases the pKa of Cys215.24 Generation
of the sulfenyl-amide intermediate induces an active site conformational change. In
particular, formation of the S–N bond disrupts a hydrogen bond between the R-groups of
Ser216 and Tyr46, rendering the enzyme inactive.25 Thus, there is interest in inducing or
stabilizing this inactive oxidized form as a potential therapeutic approach for several
diseases.25 It is noted that experimentally, several external thiols have been shown to be
able to reduce the sulfenyl-amide, regenerating the activity of the catalytic Cys215.16 This
restoration mechanism has been confirmed via re-soaking crystals of sulfenyl-amide with
dithiothreitol (DTT).17
Sarma et al.26 have previously studied, both experimentally and computationally, the
mechanism of sulfenyl-amide formation in PTP1B using model non-protein molecules. In
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particular, formation of sulfenyl-amide via the above proposed direct mechanism was
calculated at the B3LYP/6-31G(d) level of theory to have a barrier of 206.2 kJ mol-1. In
addition, they considered an alternate mechanism involving heterocyclic substitution of
an oxazoline ortho to the sulfenic acid moiety. This modification significantly reduced the
calculated barrier to 119.8 kJ mol-1. However, they noted that the sulfenic acid model
used did "not effectively mimic the cyclization of protein sulfenic acids".26 Similarly,
Sarma et al.27 examined ortho substitution effects on a small amido thiophenol molecule
and concluded that S…N/O interactions could influence the properties of the sulfenic
acid. Furthermore, nearby residues may have a role in the sulfenyl-amide formation.
More recently, as part of a review, Defelipe et al.28 discussed results they had obtained for
the mechanism of PTP1B using QM/MM. The reactive (QM) region of their chemical
model consisted of Cys215 and Ser216. Similar to the results of Sarma et al.26 they
concluded that the direct formation of sulfenyl amide occurs with a high barrier of 205.0
kJ mol-1. Experimentally, however, several studies have suggested that the rate-limiting
step in sulfenyl-amide formation is generation of the sulfenic acid, not the sulfenylamide.15,20 Hence, many questions remain about the enzymatic mechanism.
In this present study, formation of the putative sulfenyl-amide intermediate from a
Cys215 derived sulfenic acid, within the enzyme environment, is investigated via
complementary application of molecular dynamics simulations and extensive quantum
mechanical/molecular mechanical (QM/MM) modeling.

6.2 Computational Methods
6.2.1 Protein Model Preparation and Molecular Dynamics Simulations
The X-ray crystal structure preparation and the MD analysis were performed using the
Molecular Operating Environment (MOE) software package.29 Molecular dynamics
simulations were conducted using the NAMD Molecular Dynamics software.30 The X-ray

109

crystal structure of the Homo sapiens PTP1B in its sulfenic acid oxidation state was used
as starting structure and obtained from the PDB structure 1OET.17
First, problems encountered in the crystal structure were automatically corrected using
the structural preparation applications in MOE. Second, the missing protons in the crystal
structure were added using the protonate 3D application in MOE that assigns each residue
ionization state by minimizing the total free energy of the system.31 Then, the enzyme
was spherically solvated up to 15 Å beyond every protein atom. Later, the newly
generated structure was minimized using AMBER12:EHT force field, which uses
AMBER12 parameters for protein and Extended Hückel Theory for parameterizing small
molecules.32-34 Finally, in order to allow for thermal relaxation and multiple conformers
generation, the minimized structure was used as starting point for a 3 ns MD simulation.

Scheme 6.1. The proposed dephosphorylation mechanism of phosphotyrosine in PTP as
well as the oxidative regulation mechanism in PTP1B via formation of sulfenyl-amide
and the subsequent reactivation.14,17
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In the MD simulation, all atoms were set free to move and a time step of 2 fs was
used. The Columbic interactions were calculated with the PME method and the short
range van der Waals interactions were truncated at 8-10 Å. The simulation started with an
annealing dynamics from 150 K to 300 K then to 400 K to finally 300 K at a constant
volume for 550 ps, followed by a production run in the NPT ensemble at 300K and 1 bar
for 2500 ps.

Figure 6.1. Illustration of the QM/MM model used (Model I) in this study obtained from
the average structure. The QM layer atoms are highlighted and shown in sticks
representation to the right.

All generated structures were analyzed using MOE software. Furthermore, based on
the root mean square deviation (rmsd) of the active site residues, the generated structures
were clustered into 5 main groups. The average structure of the highest populated group
was selected and further minimized using AMBER12:EHT force field and the resulting
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structure was used for further calculations using quantum mechanical/ molecular
mechanical (QM/MM) approach. Finally, the rmsd for several active site interactions
were also calculated to confirm the consistency of these interactions during the
simulation.

6.2.2 QM/MM Models and Calculations
All calculations were performed within the ONIOM scheme using the Gaussian 09
suite of programs.35 The QM/MM starting structures were acquired from the previous
preparation steps using the whole protein. The QM high layer was described using the
hybrid-meta-exchange-correlation functional M06-2X.36 While the MM low layer was
described by AMBER96 force field as implemented in Gaussian.30 Optimized geometries
were obtained using the 6-31G(d,p) basis set for the high layer. All atoms in the systems
were kept free to move including solvent atoms. Relative energies were then obtained
using single point energy calculations on the optimized structures at the ONIOM(M062X/6-311+G(2df,p):AMBER96) level of theory. The choice of functional and basis sets
was based on our previous benchmarking study of several biological sulfur species in
which M06-2X was found to be one of the best functionals in describing SN bonds with
respect to QCISD and MP2 (manuscript in preparation). Due to the models size and
computational cost, frequency calculations were conducted only on the high layer to
confirm the nature of the optimized structures as previously performed.37,38 In addition,
topological analysis of the electron densities as well as natural bond orbital (NBO)
analysis for certain intermediates were performed at the M062-X/6-311+G(2df,p) level of
theory using AIM2000 program.39
In model I, as shown in Figure 6.1, the QM layer is formed of the catalytic Cys215 in
its sulfenic acid form, Ser216, His214 in protonated form, Ala217, Gly218, Ile219,
Gly220, Arg221, Ser222 and Asn111. In addition the R group of Glu115 as well as the
backbone of Met109 and Leu110 were included. Furthermore, 4 active site water
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molecules were included in the high layer. Besides the previous model, we also
considered modifying model I in which we used a neutral His214 (Model II) to confirm
the role of the histidyl residue in sulfenyl-amide formation.

6.3 Results and Discussion
6.3.1 Insights into Reactive Complex Structures
The MD average structure was first optimized using ONIOM approach as previously
discussed. In model 1, the optimized structure shows that (see RC in Figure 6.4) Ser216
amide hydrogen is strongly hydrogen-bonded to a water molecule with a distance of 2.00
Å; the former is also found to be strongly hydrogen-bonded to Glu115, 1.67 Å.
Furthermore, Arg221 is also found to be doubly hydrogen bonded to Glu115. The
distance between the sulfenic acid sulfur and the amide nitrogen is quite large, 3.83 Å,
which explains the unfeasibility of the direct mechanism.
Since previous proposed mechanism has highlighted the role of His214 hydrogenbonding to Cys215 carbonyl oxygen, we investigated this hydrogen-bond in the optimized
RC. As can be seen in Figure 6.4, His214 is weakly hydrogen bonded to Cys215; instead
it is strongly hydrogen bonded to Asn111. Therefore, we considered optimizing new RC'
structure upon decreasing the distance between the two residues. It is important to
mention that mutating His214 was found to increase the pKa of Cys216.24 In model I, see
Figure 6.4, the RC' structure was found to lie just 1.8 kJ mol-1 lower in energy than RC.
More importantly, the His214H…O_Cys216 distance is now 2.09 Å showing strong
interaction. Furthermore, His214 is also still hydrogen bonded to Asn111 with a distance
of 2.10 Å. More importantly, other active site interaction remain similar to RC with
minute differences such as the hydrogen-bond between Ser216 amide and the water
molecule as well as the water…Glu115 have become slightly stronger with a distance of
1.94 Å and 1.54 Å, respectively.
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Figure 6.2. Plot of the hydrogen-bond distance between His214 and Cys215 with respect
to time in the MD simulation.

In order to rationalize our choice of RC', we analyzed the consistency of this hydrogen
bond interaction during the MD simulation. As can be seen in figure 6.2, the distance
between the His214 hydrogen and the carbonyl oxygen is mainly fluctuating between 2 Å
to 3 Å with less fluctuation around 3 Å to 4 Å. This clearly shows the strength of this
hydrogen bond, fluctuating between strong to weak but it always exists.

6.3.2 Formation of Sulfenyl-Amide via Direct Mechanism
Although as indicated in the introduction that Sarma et al.26 as well as Defelipe et al.28
have studied the formation of sulfenyl-amide via direct mechanism showing an unfeasible
high barrier of over 200 kJ mol-1, we first considered reexamining this possibility in
protein environment using both models. Especially, our MD simulations and QM/MM
optimized structure suggest the presence of a water molecule that might mediate this
reaction via a 6 member ring TS. However, such direct reaction was not found to occur, as
we could not optimize a transition state that correspond to this mechanism. More
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importantly, all attempted calculations have shown that the direct proton transfer to the
sulfenic acid oxygen did not lead to sulfenyl-amide formation instead all calculations
collapse back to form the reactive complex. It is important to mention that the obtained
TS in Defelipe et al. QM/MM study shows a quite large distance of 3.30 Å and 2.36 Å for
S…N and S…O, respectively.28
All previous results suggest the need for investigating other possible mechanisms.
Furthermore, for the nitrogen atom of the S216 to act as nucleophile it has to be first
deprotonated, otherwise it is considered as a poor nucleophile as the π conjugation with
the carbonyl group lead to resonance structure with positive charged nitrogen atom.
By investigating the MD generated structures, we found that a water molecule always
bridge a hydrogen-bond interaction between the Ser216 amide hydrogen and Glu115
oxygen suggesting alternative mechanism. Indeed, this interaction was found to be
consistent during the simulation.

6.3.3 Formation of Sulfenyl-Amide via Stepwise Mechanism
As mentioned earlier, RC and RC' active site interactions as well as MD results
suggest the possibility of activating Ser216 amide nitrogen via Glu115. This step was
found to be enzymatically feasible in with a barrier of 46.8 kJ mol-1. Surprisingly, the TS1
structure shows triple proton transfers in which Ser216 amide hydrogen is shared with the
water molecule oxygen with a distance of 1.27 Å and 1.23 Å, respectively. Furthermore,
the water molecule proton is already transferred to Glu115 that has broken one of its
hydrogen bonds to Arg221. The third proton transfer is between His214 and the carbonyl
oxygen. Indeed, the resulting structure, I1, shows a complete proton transfer from His214
to Cys215 carbonyl oxygen, shifting the double bond to be between the amide nitrogen
and carbonyl carbon forming a novel iminol intermediate. Definitely the nucleophilicity
of the iminol nitrogen is much higher compared to the amide form. Notably, this would
facilitate the nucleophilic attack on the sulfenic acid sulfur and the subsequent formation
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of sulfenyl-amide intermediate. A similar mechanism of amide-iminol tutomerization has
been recently proposed to occur in the case of succinimide formation in the C-terminal
peptide group of aspartic acid residue.40,41
These results suggest a new role for both His214 and Glu115 in sulfenyl-amide
formation. The optimized structure of I1 was found to be slightly less stable than RC' with
an energy difference of 21.3 kJ mol-1.
The same step was reexamined starting from RC in which a weak hydrogen-bond
interaction exists between His216 and Cys215. However, no stable I1 intermediate was
found to exist where in the optimization the proton is transferred back to the amide
nitrogen.
Although the iminol N is nucleophilic in I1, the distance between the

Cys215S

and

Ser216 backbone N is quite large, 3.56 Å. This implies the need for structural
rearrangements in the active site prior to subsequent reactions. Therefore, we considered
optimizing another intermediate (I1') which was found to be more stable than I1, 22.7 kJ
mol-1 lower in energy with respect to I1. More importantly, the S…N distance has largely
decreased to 2.78 Å allowing for following reaction. This rearrangement occurs upon
changing the CCCS dihedral angle from 99.62° to 130.20°. Furthermore, the Glu115 is
still hydrogen-bonded to the water molecule, which is now quite closer to the sulfenic
acid oxygen allowing for proton transfer.
Recently the non-bonded interactions in protein sulfur species are gaining more
attention and they are implicated to play a crucial role in sulfenic acid chemistry.42
Therefore we considered investigating the S…N interaction in I1', using Quantum Theory
Atoms-in-Molecules (QTAIM) to gain further insights. In Bader's QTAIM theory the
presence of critical point between two atoms reflect the existence of chemical bonding
between them.43 Therefore, we performed AIM analysis on I1 and I1'. Indeed, the
generated molecular graphs for I1' indicated the presence of critical bond between S…N
with electron density ρ of 0.016. Furthermore, we also considered the Laplacian ∇ρ2 of
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this critical point to indicate the strength of the interaction, which was found to be 0.017,
indicating the presence of a weak interaction between the two atoms. In general, the nonbonded electrostatic interaction between S and N atoms have been previously
reported.44,45 The nature of this interaction has been suggested to occur due to the shift of
electron density from the N lone pair to the S antibonding orbital (σ*). This shows the
importance of iminol intermediate formation to allow for such interaction to occur.

Figure 6.3. Potential energy surface obtained for the formation of sulfenyl-amide from
sulfenic acid via iminol intermediate, see computational methods.

In order to investigate this shift in electron density between the S…N, we used NBO
analysis on I1 and I1'. The negative charge on the sulfur atom has increased upon I1'
formation from +0.52 to +0.48 in I1 and I1', respectively. Furthermore the electron
density on the sulfenic acid oxygen has also been increased from -0.91 to -0.94.
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Consequently, the electron density on the N atom has decreased from -0.67 to -0.64 in I1
and I1', respectively. This clearly indicates the charge transfer and the interaction between
the N lone pair and the sulfur σ*.

Figure 6.4. Stationary points obtained for model I for the sulfenyl-amide formation
mechanism from sulfenic acid. All atoms in the high QM layer are included in the
representation. However, only the highlighted residues are the ones involved in the
reaction.

The last step of the mechanism was found to occur in a concerted fashion as shown in
TS2, in which the S…N bond is formed concomitantly with S…O dissociation upon a
proton transfer from Glu115 via water molecule. In TS2, the S…N distance is reduced to
1.97 Å while the S…O bond is elongated to 2.00 Å. Furthermore, the water molecule
proton is partially transferred to the sulfenic acid oxygen with a distance of 1.29 Å and
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1.14 Å with respect to molecular oxygen and sulfenic acid oxygen, respectively. The
barrier for this step was found to be 73.3 kJ mol-1 from RC.
Finally, the sulfenyl-amide species was found to lie –27.6 kJ mol-1 lower in energy
with respect to RC forming a stable product as experimentally proposed. In PC, the S…N
distance is 1.76 Å in agreement with the X-ray crystal structure, 1.7 Å.17 Furthermore,
His214 has restored its proton form the carbonyl carbon.

6.3.4 Formation of Sulfenyl-Amide using Neutral His214
In order to confirm previous results and especially the proposed role of His214 as an
acid/base, we also considered modifying model I in which we included a neutral His.
However, no stable I1' intermediate was found to occur emphasizing the newly proposed
role. It is important to mention as indicated in the introduction that the mutation of the
invariant His increased the pKa of the catalytic Cys which suggest the presence of a
protonated His in the active site.
For completeness, we also considered the proton transfer from a neutral His214 with a
concomitant abstraction of another proton from the surrounding residues. Investigating
the surroundings of His214 suggested the possibility of hydrogen-bond network including
the tetrad His214, Tyr124, His173 and Arg156. Therefore, we considered expanding the
modified model I by including previous residues in the QM. However, based on our
current model, there is no stable I1 intermediate.
Although PTP1B has been examined extensively especially regarding to the
dephosphorylation mechanism, less studies have been performed to understand the
regulatory oxidation mechanism. Therefore, based on our obtained results several
experimental results can be performed to confirm our suggested mechanism, for instance
the effect of His214 mutation on sulfenyl-amide, sulfinic and sulfonic acid formation.
Furthermore, the role of His214 as an acid could be confirmed by mutating His to Asn to
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preserve hydrogen-bonding interaction with the carbonyl oxygen. In addition, pH and
kinetic studies during the oxidation mechanism would provide useful insights.
Our results show that the amide-iminol tutomerization is a more energetically
favorable pathway over the unfeasible direct cyclization, which could be transferable to
other amide nitrogen cyclization mechanisms in other PTP's as well as in proteins in
general. Furthermore, the importance of the non-bonded interaction of cysteine sulfur in
proteins is highlighted as a precursor to sulfenyl-amide formation. The rate-limiting step
for this reaction is the formation of sulfenyl-amide from a stable iminol intermediate.

6.4 Conclusions
In this study the atomistic description of sulfenyl-amide formation from sulfenic acid
in PTP1B has been elucidated. Several computational modeling techniques including
molecular dynamics (MD), quantum mechanical/molecular mechanical (ONIOM)
calculations and quantum theory atoms-in molecules (QTAIM) have been employed in
cooperative fashion. More specifically, MD simulation on the solvated PTP1B sulfenic
acid crystal structure was performed to generate potential Michaelis complexes. The MD
generated structures were grouped into 5 main groups based on the root mean square
deviation (rmsd) of the active site residue. The average structures of the highest populated
clusters was selected for subsequent ONIOM calculations. Furthermore, several active
site interactions including the indirect hydrogen bonding between Ser216 amide nitrogen
and Glu115 via water molecule as well as the Cys215 carbonyl oxygen His214 hydrogenbonding were investigated during the course of the simulation to confirm the stability of
these interactions.
Three different models were generated from the MD average structure including
model I which has protonated His214. For completeness, modified QM/MM structures of
model I was also considered including a neutral His214 as well as upon increasing the
size of QM layer.
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The optimized structure of RC indicates the presence of a weak hydrogen bond
between Cys215 carbonyl oxygen and His214. Therefore, another reactive complexes
(RC') was optimized in which this hydrogen-bond become stronger. This has been
justified by investigating the consistency of this interaction during the MD simulation.
Furthermore, RC' was found to be slightly more stable than RC. Using both RC' and RC
as starting structures, our calculation indicated the unfeasibility of the sulfenyl-amide
direct formation. Instead ONIOM calculations as well as the MD results suggested the
stepwise mechanism. In which the Ser216 amide N is first deprotonated by Glu115 with
an energy barrier of 46.8 kJ mol-1. The formed iminol intermediates were found to lay
slightly higher in energy with respect to RC', 21.3 kJ mol-1. The nucleophilicity of the
generated iminol nitrogen is much higher compared to the amide form facilitating the
nucleophilic attack on the sulfenic acid sulfur and subsequent formation of sulfenylamide intermediate. The same step was also examined starting from RC. However, no
stable I1 intermediate was found to occur proposing a new role for His214 as an acid.
A second iminol intermediate (I1') was also considered where the S…N distance has
largely decreased to 2.78 Å. The nature of the S…N interaction in I1' was analyzed using
QTAIM and NBO indicating the presence of a weak interaction between the two atoms.
Furthermore, NBO analysis confirmed the nature of this interaction in which there is a
charge transfer between the N lone pair and the sulfur σ*.
Finally, the S…N bond is formed concomitantly with S…O dissociation forming a
stable sulfenyl-amide intermediate. Notably, the two modified forms of model I including
a neutral His214 showed that no stable iminol intermediate is formed.
Our results suggest the formation a cyclic sulfenyl-amide from sulfenic acid in
stepwise fashion using an amide-iminol tutomerization reaction in which His214 and
Glu115 act as an acid and base catalysts, respectively. Finally, we think this work is
important to the field of PTP1B drug discovery, as one of the main ways to inhibit PTP1B
is to stabilize the sulfenyl-amide inactive oxidized form. Therefore, knowing the exact
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mechanism and the role of the active site residues would be crucial for future drug
development.
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Chapter 7

Pseudo-hypervalent Sulfur Intermediate as a
Protective Mechanism in Peroxiredoxin Enzymes

7.1 Introduction
Peroxiredoxins (Prxs), also known as thiol peroxidases, are a class of ubiquitous
enzymes with central roles in both the regulation of signaling pathways as well as being a
potent antioxidant.1-3 Their main function, foremost, is to catalyze the reduction of
peroxide substrates such as hydrogen peroxide (H2O2) and alkyl-hydro-peroxide
(ROOH).4 Notably, along with their ubiquity, these enzymes are vastly abundant in cells,
up to 1% of the total soluble protein and reach catalytic rates in the order of ~107 M-1 S-1.1
In fact, these remarkable catalytic efficiencies have credited Prxs to reduce ~90% of the
mitochondrial and approaching 100% of the cytoplasmic H2O2.3,5
Prxs are classified into 6 main groups based on sequence similarity: Prx1, Prx6, Prx5,
Tpx, BCP and AhpE (in Mycobacterium tuberculosis).1,4 All groups contain a reducing
thioredoxin (Trx) fold with differences in their oligomeric states, from monomer to
dodecamer.1,6,7 In addition, they also possess high similarities in their active site
structures including the catalytic cysteine (Cp), proline (Pro), threonine (Thr)/serine (Ser)
and arginine (Arg).1,8,9 Furthermore, based on mechanistic differences, Prxs are further
divided into three main groups: 1-Cys, typical 2-Cys and atypical 2-Cys.6 This
classification is dependent mainly on the existence and location of a second mechanistic
cysteinyl residue, known as the resolving cysteine (CR).1 For instance, 1-Cys Prxs does
not contain CR.1,6 In typical 2-Cys Prxs (the largest class of Prxs), however, the enzyme
function is dependent on the presence of an intact homodimer where CP and CR are
located on different monomers.4,10 In contrast, in atypical 2-Cys Prxs, the two mechanistic
cysteinyl residues are located on the same monomer.4,11
All classes of Prxs have a common catalytic cycle involving three main steps:1,4 1) the
peroxidation step, in which CP nucleophilically attacks the peroxide substrate forming
reactive Prx-sulfenic acid (SP-OH) intermediate, 2) the resolution step, where either the
resolving CR or external thiol in 2-Cys Prx or the 1-Cys Prx, respectively, reduce (–SPOH) to form an intramolecular or intermolecular disulfide bond, 3) the recycling step that
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leads to the regeneration of the active site via the reduction of the disulfide by external
thiol such as Trx.12
Several X-ray structures of the Prx family reveal similarities of H2O2 (HOA–OBH
where OA is in close proximity to CP) binding in their active sites, preserving several key
interactions.9,13-15 More specifically, the conserved Arg always is hydrogen bonding to
CP.6,9 This allows for the stabilization of the nucleophilic thiolate as well as it is hydrogen
bonded to the H2O2 oxygen (OA).6,9 The conserved Pro is thought to protect CP from
interacting with solvent. In addition, the Thr residue acts as a hydrogen bond acceptor
with respect to OA.6,9 Furthermore, the H2O2 molecule has been shown to be well
positioned for attack via the previously described hydrogen bonds and two other H-bonds
with the backbone amide of CP and its neighboring residue.6,9 Although existing X-ray
structures highlights the roles of the active site residues, their specific roles in catalysis
remains vague.9 More importantly, the nature of the proton donor needed to neutralize the
hydroxide-leaving group is unknown.9
In general, sulfenic acids are fundamental intermediates for numerous redox processes
in proteins.16 It is highly reactive and can undergo several reactions as a nucleophile or
electrophile.16,17 Thus it can be readily overoxidized to sulfinic and subsequently sulfonic
acids in the presence of H2O2 or other oxidizing agents.16,17 This modification, in general,
is considered irreversible and leads to protein deactivation.18 Notably, the second step of
the mechanism that is characterized by the reduction of –SP-OH by CR, is competing with
its overoxidation especially under oxidative stress.4,19 In Prx, the overoxidation of the
typical 2-Cys occurs at a higher rate than the atypical 2-Cys or 1-Cys subclasses.20
Notably, this occurs as a result of the location of the CR on the adjacent monomer which
requires large structural rearrangement before sulfenic reduction allowing for –SP-OH
interaction with a second peroxide.4 Fortunately, a unique enzyme (sulfiredoxin) was
found to reduce typical 2-Cys Prx sulfinic acid back to sulfenic.20-22 This enzyme was
only found in eukaryotic organisms and was found to be highly specific to the typical 2128

Cys Prx implying the presence of alternative mechanisms to protect the typical 2-Cys in
bacteria and archaea as well as in 1-Cys Prx from overoxidation and subsequently their
inactivation.20
In Archaea, the typical 2-Cys Prx (ApTPx) was recently proposed, based on X-ray
crystallography, to been protected from overoxidation via a unique hypervalent sulfurane
intermediate.23 Nakamura et al.23 characterized an X-ray structure at high resolution of
1.77 Å for a unique intermediate with an electron density representing a covalent
interaction between S of CP50 and the Nδ1 of His42 of approximately 2.2 Å. Small
models calculations were performed at the B3LYP/6-31G* level in the absence of the
active site residues in order to describe the chemical nature of this interaction.23 In result,
two possible sulfurane intermediates were suggested to occur where the CP50 sulfur was
covalently bound to His42, a hydrogen ligand and a hydroxyl group.23 The two proposed
structures differ only by the ionization state of His42. Their calculations show that the
removal of hydrogen ligand from the CP sulfur leads to the disappearance of S…N
interaction.23 However, recently we assessed the performance of several density
functional theory methods in dealing with hypervalent sulfur species in biological
systems using different size basis set; our calculations show that the removal of hydrogen
ligand does not break the interaction using other DFT functionals (manuscript in
preparation). Furthermore, after characterizing the chemical structure of the intermediate
the authors also investigated the mechanism of its formation. They suggested that
sulfurane could not be formed from the direct interaction of sulfenic acid with an
imidazole as the obtained barrier was found to be 215.9 kJ mol-1.23 Thus, an alternative
mechanism where a thiol, a poor nucleophile, reduces the peroxide directly was proposed
forming the sulfurane intermediate in concomitant step.23 It is important to mention that a
similar interaction with a histidinyl residue was previously reported in the human 1-Cys
Prx (hORF6) however the S…N distance was suggested to reflect hydrogen-bonding
interaction.24 In addition, this histidyl residue is not conserved in all Prxs.23
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Recently, there has been several hypervalent sulfur species reported in biological
systems. For instance, in methionine sulfoxide reductase (Msr), a different sulfurane
intermediate has been suggested computationally to occur.25 In addition, in Srx
mechanism, two-hypervalent sulfur-based intermediate have been also suggested
experimentally.26 More recently, a pseudo-hypervalent divalent sulfur species has been
shown to play a critical role in protein architecture and functions.27 This type of weak
interaction (S…X) between divalent sulfur and oxygen, nitrogen or sulfur atoms is quite
similar to halogen-bonds.28 This σ hole bonding originates from a positive electrostatic
potential on the sulfur center allowing for orbital interaction between the X lone pair and
the anti-bonding orbital of the sulfur atom, nX→σ*S.29 Iwaoka et al. have characterized
this weak interactions in four proteins: phospholipase, ribonuclease A, insulin and
lysozyme, suggesting their importance in proteins in general.27
In this study we first used the hybrid quantum mechanical/molecular mechanical
calculations (QM/MM) calculations to elucidate the first step of the mechanism. This
revealed thermodynamics and the roles of active site residues during the reduction of
peroxide and sulfenic acid formation. Second, we investigated the pathway of formation
of the currently proposed hypervalent sulfurane in ApTPx. Third, using QTAIM and
NBO analysis we identified the degree of covalency of the S…N interaction in the
enzyme's active site. Fourth, we also considered the formation of this intermediate in
hORF6 to determine if this is feasible to occur in similar enzymes as a general intrinsic
precaution to over oxidation. Finally, details into the overoxidation mechanism of Prxsulfenic acid to sulfinic acid have been determined.

7.2 Computational Methods
7.2.1 Structural Preparation and Molecular Dynamic Simulations.
The Molecular Operating Environment (MOE) software package was used to prepare
the starting X-ray structures for MD simulations as well as to analyze the simulations
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results.30 The NAMD molecular dynamic software was used to run the MD simulations.31
For ApTPx, the H2O2 bound X-ray of the C207S mutated crystal structure was obtained
form the protein data bank (PDB: 3A2V)13 and used as starting configuration for
simulation using one monomer of the decameric form. In addition, one monomer of the
human 1-Cys Prx (hORF6) Prx-sulfenic acid X-ray structure (PDB:1PRX)24 was used as
starting structure.
Prior to MD simulations, errors in both crystal structures were automatically corrected
using the structural preparation application in MOE. In ApTPX, the position of His42 was
modified manually allowing for His42…Cys50 interaction. The protonated 3D application
in MOE was used to add the missing protons in the crystal structures. For the active site
residues especially Cys50 and His42 the protonation states were determined based on
their pKa values obtained via PROPKA program.32,33 The generated structures were
solvated up to 10 Å beyond every protein atom. Then, were minimized using
AMBER12:EHT force field.34,35 Later, the minimized structures were used as starting
points for 500 ps equilibration MD simulations to generate thermally relaxed structures in
similar protocol as previously used.36,37 In the MD, 2 fs time step was used. The PME
method was used to calculate columbic interactions and the van der Waals interactions
were truncated at 8-10 Å.
In hORF6, the S…O bond in the sulfenic acid intermediate was broken to generate the
reduced form of the enzyme. The peroxide substrate was manually docked in the active
site prior to simulation. In addition, a third MD simulation was performed to simulate the
overoxidation mechanism. First, the QM/MM optimized structure of ApTPx sulfenic
intermediate was used as starting structure. Second, peroxide substrate was also manually
docked in the active site. The Cys50…H2O2 distance was restrained during the
minimization to 3 Å allowing for substrate binding adjustment in the active site. Later,
similar solvation, minimization and MD simulation protocols were used as described
above.
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Figure 7.1. Illustration of the ApTPx QM/MM model used obtained from MD average
structure. The QM layer atoms are highlighted and shown in sticks representation.

7.2.2 QM/MM Models and Calculations.
All calculations were performed within the ONIOM formalism using the Gaussian 09
suite of programs.38 The last structures of the previous MD simulations were used as
starting structures for QM/MM calculations.39 The QM atoms were optimized at the M062X/6-31G(d,p) which was selected based on previous assessment of several level of
theories to optimize the proposed intermediates in ApTPx (manuscript in preparation).40
The rest of the monomer was calculated using the AMBER96 forcefield as implemented
in Gaussian09.35 Frequency calculations were used to confirm the nature of the optimized
stationary points using the QM layer only, due to model size as previously used.36,37
Relative energies were obtained using the ONIOM electronic embedding formalism using
single points calculations at the ONIOM(M06/6-311+G(2d,p):AMBER96) In addition,
other basis sets were also tested such as 6-311G(2d,p), 6-311+G(2df,p) and 6132

311++G(3df,3pd)

using

the

M06

functional

as

well

as

ONIOM(MP2/6-

31G(d,p):AMBER), (See Appendix Figure A7).
Three QM/MM models structures were generated from the last conformer of the
equilibrated MD simulations. All MM atoms 15 Å away from Cys50 sulfur were kept
fixed in the optimization. For ApTPx, the QM layer included H2O2, Cys50, Pro48, Thr47,
the backbone of Val40 and the R groups of His42, Asp45, Asp45, Arg126 and Arg149,
see Figure 7.1. For ApTPx overoxidation state of sulfenic acid, the previously described
residues were included in the QM layer as well as H2O2, Pro43, Ala44 and a water
molecule (See Appendix Figure A8). Finally for hORF6, the QM was formed of H2O2,
Cys47, backbone of Val46, Pro45, Thr44, His39, Pro40, part of Ser38 backbone and the
R groups of Arg132, Arg155, Glu50 and 3 water molecules (See Appendix Figure A8).
In order to investigate the nature of the S…N interaction, the Quantum Theory Atomsin-Molecules (QTAIM) was employed using AIM2000 program.41 Furthermore, natural
bond analysis (NBO) was also used to determine the atomic partial charge of the
optimized structures.

7.3 Results and discussion
7.3.1 Sulfurane intermediate formation in ApTPx.
In ApTPx, the QM/MM optimized reactive complex (RC) structure revealed similar
interactions to X-ray structure9 as discussed in the introduction. Based on estimated pKa's,
our MD starting structure contained a neutral His42 and Cys50. However, in the QM/MM
optimization Cys50 was found to be deprotonated, by transferring a proton to His42 that
in turn transferred its proton to Asp45. Thus, the RC is formed of anionic Cys50, neutral
His42 and Asp45, see Figure 7.2.
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Figure 7.2. Illustration of the QM/MM optimized reactive complex of ApTPx. Only the
QM layer is shown.

The nucleophilic Cys50 anionic sulfur is stabilized via four hydrogen bonds with
Arg126, His42 and Thr49. Furthermore, the H2O2 binding in the active site was found to
involve several strong hydrogen bonds including OB...HNVal49, OA...HNCys50, OA...Arg126
and OAH...Thr49. Notably, these hydrogen bonds destabilize the H2O2 in the active site
promoting catalysis as experimentally suggested. NBO analysis was used to compare the
substrate's charges in the active site and in the absence of the active site using both in gas
phase and protein environment (dielectric= 4). In absence of active site, the negative
charge on H2O2 two oxygen’s were found to be symmetric with values of -0.47 and -0.48
in gas phase and protein environment, respectively. In the active site the O–O bond is
polarized with charges of -0.49 and -0.52 for OB and OA, respectively. The ∠H-OB-OAH dihedral angle is reduced from 179.9° to 112.0°. In addition, Cys50 anionic sulfur has a
charge of -0.63 and the Cys50S...OA distance is 3.2 Å.
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The first step in the proposed mechanism is the reduction of the peroxide. By
investigating this step, our calculations show that this can readily occur via a barrier of
82.1 kJ mol-1, see Figure 7.3. In TS1, the H2O2 OA...OB bond is elongated to 1.80 Å.
Notably, the Cys50S...OA is reduced to 2.21 Å. Two intermediate were optimized from TS1,
sulfenic acid (I1) and sulfenate intermediates (I2). However, I2 was found to be lower in
energy than I1 by 15.0 kJ mol-1. In I1, see Figure 7.4, a proton is being transferred from
Arg126 to OA. In addition, Thr47 is now hydrogen bonded to sulfenic acid oxygen with a
distance of 1.71 Å. I1 is 88.9 kJ mol-1 more stable than RC. In I2, a sulfenate, the S...O
bond is slightly reduced with respect to I1 from 1.66 Å to 1.64 Å. Additionally, the
charge on the oxygen has increased from -0.93 in I1 to -1.09 in I2. Notably, the oxyanion
is stabilized with three strong hydrogen bonds with Thr47, Arg126 and the formed water
molecule with distances of 1.56 Å, 1.43 Å and 1.93 Å, respectively. I2 is 103.9 kJ mol-1
more stable than RC. Since TS1 leads to the formation of either sulfenic or sulfenate, we
considered optimizing TS2 to represent the interchange between the two possible
intermediates. From I1, I2 can be readily formed via a low barrier of 4.8 kJ mol-1. In TS2,
a proton is being shared between Arg126 and sulfenic acid with distances of 1.27 Å and
1.20 Å, respectively.
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Figure 7.3. Potential energy surface obtained for the formation of pseudo-sulfurane
intermediate in ApTPx.

In order to form the proposed sulfurane intermediate and allow for

Cys50S

...

NHis42

interaction, His42 needs to lose its proton. Thus, based on His42 interactions in I2, this
can only be achieved by transferring a proton to sulfenate sulfur to form sulfenic acid
tautomer. In I2, the His42H...SCys50 distance is 2.70 Å which allows for direct transfer. This
step was found to occur via TS3 with a low barrier of 16.5 kJ mol-1. In TS3, a two proton
transfer was found to occur in which the

His42H

is transferred to SCys50 and Asp45 to

His42. The optimized structure shows that the latter proton is 1.14 Å and 1.47 Å from
His42 and Asp45, respectively. From TS3, a sulfenic acid tautomer (I3) was found to
occur and be more stable than I2 by 11.5 kJ mol-1 and lower than RC by -115.4 kJ mol-1.
In I3 optimized structure, the S...O bond is reduced to 1.58 Å. As in I2, the sulfenic acid
tautomer oxygen is stabilized by three hydrogen bonds. Notably, there is a weak
interaction between

His42N

...

SCys50 with a distance of 2.76 Å. This weak interaction

(nN→σ*S) was analyzed using QTAIM in which a critical point was found to connect
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His42 and Cys50 with electron density ρ of 0.020 and Laplacian ∇ρ2 of 0.017. NBO
analysis of I3 shows that there is a positive charge on the Cys50 sulfur of 1.05 as well as a
negative charge on the His42 nitrogen with a value of -0.63. The ∠ N–S–O angle is
164.1°, which is close to X-ray structure.13
Although I3 represents a pseudo hypervalent structure similar to the X-ray obtained,13
the

His42N

...

SCys50 distance is still large. Therefore, we considered a subsequent reaction

that may strengthen this interaction. This was found to occur via TS4 with a barrier of
25.2 kJ mol-1. In TS3, a proton is transferred form His42 to Asp45 in which the H...His42
and H...Asp45 distances are 1.20 Å and 1.36 Å, respectively. For this TS, the His42N...SCys50
was found to be slightly reduced to 2.75 Å. The following intermediate (I4) was found to
contain anionic His42 and neutral Asp45. Indeed, in I4,

His42N

...

SCys50 distance is reduced

to 2.58 Å which is in agreement with crystal structure. In addition, the sulfenic S...O
distance was slightly increased to 1.58 Å. The ∠N–S–O angle is increased to 166.1°. As
previous, the nature of His42...Cys50 interaction was investigated further using QTAIM.
Our analysis was found to still reflect His42...Cys50 weak interaction. However, the
calculated density at critical point was found to be strengthened with respect to I3,

ρ=0.030, as well as the Laplacian ∇ρ2=0.023. NBO analysis shows the increase of the
negative charge on the sulfurane oxygen from -1.09 in I3 to -1.10. The charge on the
sulfurane N was also found to increase to -0.68. In general I4 was found to be less stable
than I3 by 43.7 kJ mol-1. However, I4 is still more stable than RC by -71.7 kJ mol-1.
We also considered investigating a final intermediate (I5) upon transferring a proton
from Arg126 to sulfurane oxygen via TS5, however this intermediate was found to be
high in energy compared to I3 with a value of 15.2 kJ mol-1. The energy difference
between I3 and I5 was found to be 130.6 kJ mol-1, which is unfeasible in enzymatic
systems. More importantly, our QTAIM analysis shows that the His42...Cys50 interaction
is still noncovalent (ρ=0.086 and ∇ρ2=0.083) indicating that the X-ray obtained
hypervalent sulfurane in ApTPx is formed due to noncovalent interactions.
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Figure 7.4. Stationary points obtained for the pseudo-sulfurane formation mechanism.
Shown atoms represent the QM layer. However, only the highlighted are directly
involved in the reaction.

The previous described mechanism provides a detailed mechanism to the formation of
hypervalent sulfurane (I4) from sulfenic acid via low barriers multistep. Furthermore, in
order for the last step in ApTPx to occur, which is the formation of disulfide bond, the
formation of sulfurane has to be reversible allowing for sulfenic acid reduction. Our
obtained potential energy surface shows that the sulfurane (I4) can be readily reduced
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back to sulfenate (I2) or sulfenic acid (I1) via maximum barriers of 28.0 kJ mol-1and 31.3
kJ mol-1, respectively.

7.3.2 Sulfenic acid oxidation mechanism in ApTPx.
Since the formation of sulfurane intermediate is proposed to protect sulfenic acid from
oxidation, we also considered investigating the overoxidation mechanism in the active
site. As indicated in the methods section, the sulfenic acid QM/MM optimized structure
(I1) was used as starting point for equilibrated MD simulation. Two models were used in
which His42 was neutral/protonated. However in our discussion, only the neutral His42
based model will be discussed in details as the obtained barrier for the protonated form
shows unfeasible barrier of 183.3 kJ mol-1.
In the MD simulation, the binding of H2O2 was found to only occur upon the rotation
of the ∠Cα–Cβ–S–O dihedral angle, as experimentally suggested.42 In fact this might
explains the role of sulfurane formation as the presence of His42...Cys50 noncovalent
interaction would prevent such rotation and subsequently overoxidation. In the optimized
QM/MM structure (RCOx), similar H2O2 interactions were found to occur including
OB...HNVal49, OA...HNCys50, OA...Arg126 and OAH...Thr49 with the following distances 1.99
Å, 2.06 Å, 2.57 Å and 1.68 Å, respectively. More importantly, the sulfenic acid S...OA
distance is 3.09 Å. Furthermore, the sulfenic acid is hydrogen bonded to His42, see
Figure 7.5.
The overoxidation mechanism was found to occur via TSOx in which similar
interactions to TS1 were observed. In TSOx the OB...OA distance is increased to 1.87 Å as
well as the Cys50S...OA distance is reduced to 2.05 Å. The obtained barrier for this step was
found to be 121.6 kJ mol-1. The optimized sulfinic acid product (PCOx) was found to be
much more stable than sulfenic acid with energy difference of -179.4 kJ mol-1. This is in
agreement with experiment and explains the irreversibility of the overoxidation.16,17
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Indeed, comparing the energetics of the overoxidation mechanism with the sulfurane
formation shows that sulfurane formation is extremely favorable over sulfinic acid.

Figure 7.5. Illustration of the optimized stationary points for sulfenic acid overoxidation
to sulfinic acid including their relative energies. Shown atoms represent the QM layer.
However, only the highlighted are the ones involved in the reaction.

7.3.3 Sulfurane formation in human hORF6.
Finally, we investigated the possibility of pseudo-sulfurane formation in other
enzymes in the Prx family. As discussed in the introduction, 1-Cys Prxs lack the presence
of a second cysteine,1 which suggests a sulfenic acid protective mechanism. In human 1Cys hORF6, an X-ray structure shows that His39 nitrogen is 3.0 Å away from Cys47
sulfur indicating hydrogen bonding. Thus we elucidated the possibility of sulfurane
formation in hORF6. In order to form this intermediate, as in ApTPx, a base is needed to
deprotonate His39. From MD simulation, a water molecule was always found to connect
His39 to Glu50 implying the possibility of sulfurane formation. Thus we optimized
several intermediates along the reaction pathway.
In hORF6, the QM/MM optimized reactive complex (RChORF6) was found to show
similar H2O2 binding interactions including OB...HNVal46, OA...HNCys47, OA...Arg132 and
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OAH...Thr44 with distances of 2.08 Å, 2.02 Å, 2.29 Å and 1.59 Å, respectively. The
Cys47S

...

OA is 3.42 Å as well as the anionic Cys47 sulfur is stabilized by four hydrogen

bonds with His39, a water molecule and two hydrogen bonds with Arg132 with distances
of 2.02 Å, 2.02 Å, 2.39 Å and 2.27 Å. Based on approximated pKa's, our model contained
a neutral His39 and Cys47, however during the optimization an anionic Cys47 and
protonated His39 was formed. The protonated His39 was found to be strongly hydrogen
bonded to a water molecule, 1.52 Å. In turn this water is strongly hydrogen bonded to
Glu50 with a distance of 1.48 Å.

Figure 7.6. Illustration of the optimized stationary points for pseudo-sulfurane formation
mechanism in hORF6, including their relative energies. Shown atoms represent the QM
layer. However, the only highlighted are the ones involved in the reaction.

Subsequently, we optimized the sulfenic acid intermediate (I1hORF6) which was found
to be more stable than RChORF6 by -111.3 kJ mol-1. Upon sulfenic acid formation His39
was found to donate its proton to Glu50 via the water molecule. Furthermore, as in
ApTPx, sulfenic acid is formed with proton transfer from the neighboring arginine
residue Arg132. The His42...Cys50 distance has increased to 2.36 Å. In addition, His39 is
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still strongly hydrogen bonded to a water molecule, 1.79 Å, which subsequently is
hydrogen bonded to the now neutral Glu50, 1.50 Å.
As previous, in order for His39 to noncovalently bound to Cys47, His39 has to lose its
proton. Based on X-ray and optimized QM/MM structure, this can be only achieved via
sulfenic acid tautomer formation similar to ApTPx. Thus, we optimized the tautomer
structure in which it was found to be lower in energy than RChORF6 and I1hORF6 by -166.4
kJ mol-1 and -55.1 kJ mol-1, respectively. Notably, His39N...SCys47 is now reduced to 2.87 Å
and the QTAIM calculation indicate the presence of noncovalent interaction with a

ρ=0.017 and ∇ρ2=0.015. Furthermore, the optimized structure shows that His39 is now
neutral upon proton transfer from Glu50. Similarly, sulfenic acid donates its proton to
Arg132.
Finally, we also considered forming an anionic His39 to strengthen the S...N
interaction as in ApTPx. Indeed in I3hORF6, the

...
His39N SCys47 is

reduced to 2.78 Å and the

electron density and the Laplacian at the critical point was increased to ρ=0.022 and

∇ρ2=0.017, respectively. Notably, our calculations show that a pseudo-sulfurane
intermediate could form in 1-Cys Prx protecting sulfenic acid from overoxidation. The
presence these noncovalent interaction between His nitrogen lone pair and Cys sulfur σ*
orbital prevent the ∠Cα–Cβ–S–O dihedral angle rotation and subsequently H2O2 binding.
Previous results might suggest the generality of this protective mechanism in Prxs.
Therefore, we also considered investigating the current X-ray structures in the protein
data bank. As in hORF6, another 1-Cys Prx in Arenicola Marina shows that a histidynyl
residue is 3.96 Å away from the Cp in the C45S mutated X-ray structure (PDB:2V32).43
Surprisingly, several structures of human PrxV were found to include histadinyl residues
in close proximity to the catalytic Cys with an approximate distance of 5 Å.44-46 Although
PrxV is an atypical 2-Cys Prx, the distance between the two cysteinyl residues are over 13
Å and require large conformational change before disulfide bond formation which might
imply the need for sulfenic acid protective mechanism.47
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In human PrxIV, typical 2-Cys Prx similar to AtPTx, a threonyl residue was found to
be located beneath the catalytic cysteine (PDB: 3TKS) similar to previous discussed
histidinyl with a distance of approximately 3 Å.48 This suggests the occurrence of
noncovalent interaction between Thr...Cys to form a novel sulfurane intermediate. Indeed,
similar to nitrogen atom in His, the oxygen lone pair of Thr could form a noncovalent
interaction with cysteinyl sulfur atom. As indicated in the introduction similar O...S
interactions have been characterized in several proteins.27
Finally, we also investigated the possibility of S...X noncovalent interaction formation
in other enzymes. By investigating several X-ray structures including sulfenic acid, we
found similar electrostatic interactions to occur. For instance, SUMO protease crystal
structure indicate the presence of His residue 3.61 Å from sulfenic acid sulfur
(PDB:2HKP).49 Earlier, it was suggested that SUMO proteases is regulated by H2O2.49
Similar interaction was also found in E coli Gsp amidase with His...Cys distance of 3.7
Å.50 These structures as well as our results might suggest the generality of noncovalent
interactions to stabilize sulfenic acid in proteins and their protection from overoxidation.

7.4 Conclusion
In this study the mechanistic details of pseudo-hypervalent sulfurane species in
ApTPx and hORF6 have been investigated using molecular dynamics simulations (MD)
and quantum mechanical/ molecular mechanical (ONIOM) calculations. The chemical
nature of the obtained intermediates was also revealed using quantum theory atoms in
molecules (QTAIM) and natural bond orbital analysis (NBO). Furthermore, the atomistic
details of hydrogen-peroxide reduction mechanism in ApTPx have been elucidated.
First, MD and ONIOM calculations have shown that the binding of the substrate in the
active site is similar to previous X-ray structures. Structural and NBO analysis of the
reactive complex suggest the polarization of the OA...OB bond allowing for catalysis. The
catalytic CP was also found to exist as anionic sulfur upon substrate binding and stabilized
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with four hydrogen bonds. The substrate was found to be reduced forming
sulfenic/sulfenate and water molecule via a barrier of 82.1 kJ mol-1. This step was found
to be the rate-limiting step of the mechanism. Arg126 was found to act as an acid in case
of sulfenic acid formation. However, the sulfenate intermediate was found to be more
stable in the active site in which the oxyanion is stabilized by three strong hydrogen
bonds.
The experimentally proposed hypervalent species was found to occur via a low barrier
multistep reaction in which Asp45 was found to play a crucial role in alternating the
ionization state of His42.The first step in this reaction was found to occur via the
formation of sulfenic acid tautomer from sulfenate upon proton transfer from His42.
Indeed, the neutral His42 nitrogen is now 2.76 Å from Cys50 sulfur. QTAIM analysis
confirmed the presence of weak interaction between the two residues. This interaction
was found to be strengthening upon the formation of anionic His42 upon proton transfer
to Asp45. The S...N distance in the formed intermediate is in agreement with the X-ray
structure. Another step was also considered in which the sulfenic acid tautomer oxygen
abstract a proton from Arg126. However, this was found to be energetically unfeasible.
Second, we also considered investigating the overoxidation mechanism of sulfenic to
sulfinic acid. This was found to occur upon another peroxide binding in the active site
upon sulfenic acid dihedral rotation as suggested by previous experiment. The mechanism
was found to occur via a high barrier, still enzymatically feasible, of 121.6 kJ mol-1.
Indeed the formation of pseudo hypervalent sulfurane is much more favorable over
sulfinic acid formation emphasizing the role of sulfurane formation in protecting ApTPx
sulfenic acid.
Third, we also considered investigating the possibility of similar hypervalent species
in huamn 1-Cys hORF6. MD and ONIOM results suggested that Glu50 could act as an
acid/base catalyst as in ApTPx. In order to investigate the mechanism, we optimized
several intermediate along the reaction pathway. Notably, a similar reaction was found to
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occur as in ApTPx. Although the S...N distance in hORF6 pseudo hypervalent species is
larger than ApTPx, QTAIM suggest there is a presence of a weak interaction between the
two residues.
Finally, we also considered investigating the protein data bank X-ray structures for
similar possible interactions. Similarly to hORF6, the 1-Cys Prx in Arenicola Marina
have a histidinyl residue. Remarkably, several structures of human PrxV were found to
include histidinyl residues in close proximity to the catalytic Cys with an approximate
distance of 5 Å. Furthermore, in the typical 2-Cys human PrxIV, a threonyl residue was
found to 3 Å away from CP suggesting the possibility of a novel sulfurane formation. We
also considered investigating sulfenic acid X-ray structures in other proteins. In SUMO
protease a His residue was found to be located 3.61 Å from sulfenic acid sulfur. Similarly,
in E coli Gsp amidase a His residue was found to be in close proximity.
Our MD, ONIOM, QTAIM, NBO and X-ray structure analysis suggest the generality
of sulfenic acid sulfur noncovalent interactions forming pseudo hypervalent as protective
mechanism against overoxidation in Prxs and other proteins. It also emphasizes the role
of weak interaction in restricting dihedral rotation and subsequently in catalysis. Several
studies can be conducted in order to confirm the generality of these mechanisms in
protein sulfenic acid chemistry.
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Chapter 8
QM/MM Investigation of the Reduction
Mechanism of Cysteine Sulfinic Acid in
Peroxiredoxin via Sulfiredoxin

8.1 Introduction
Elevated levels of reactive oxygen species (ROS), such as hydrogen peroxide (H2O2),
have been known for their abilities of modifying several cellular components including
proteins, DNA and lipids leading to cell damage.1,2 Such oxidative stress in cells has been
highly related to aging and age related diseases including cancer and Alzheimer's.2-5
Dissimilarly, low levels of H2O2, under subtoxic concentration, are essential for a variety
of cellular functions including proliferation, differentiation, adhesion and migration by
stimulating signal transduction.6-8 Indeed, H2O2 fulfills the requirement to act as a second
messenger as it is rapidly produced and controlled via antioxidant enzymes.9 However,
for H2O2 to act as a signaling molecule its concentration has to reach and to maintain a
certain threshold level. 10
In cells, H2O2 is reduced via two main mechanisms;9 1) It is being reduced by one
electron reduction mechanism using transition metal such as in catalases or,11 2) it is
reduced by the two electron nucleophilic substitution reaction by protein cysteinyl or
seleno-cysteinyl residues, forming sulfenic/selenenic acid and water molecule such as in
thiol and glutathione-peroxidases.12-14
Peroxiredoxin (Prxs), also known as thiol peroxidases, are ubiquitous thiol-dependent
enzymes that reduce H2O2 as well as other ROS species.12,15 It is highly abundant within
cells and it represents the main enzyme for reducing H2O2 with a catalytic rate constant of
107 M-1 s-1.15 Previous studies have shown that Prxs can readily reduce all cytoplasmic
and nearly 90% of the mitochondrial H2O2 emphasizing its role in regulating low levels of
H2O2 and its subsequent signaling.10
In general, Prxs are categorized into three main classes, 1-Cys, typical 2-Cys and
atypical 2-Cys, based on the number and location of the catalytic cysteinyl residues as
well as the formation of inter or intra disulfide bond in the mechanism.16 For example, in
1-Cys there is only one catalytic cysteinyl residue. In both 2-Cys classes two catalytic
cysteinyl residues are involved in the mechanism.12 The first step of the H2O2 reduction
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via Prxs is similar in which a conserved catalytic cysteinyl residue, known as peroxidatic
cysteine, (Cys-SPH) attacks the H2O2 molecule forming a highly reactive sulfenic acid
intermediate (Cys-SPOH).12 Subsequently, the later molecule is reduced using a resolving
cysteinyl residue (Cys-SRH) forming a disulfide bond. In the atypical 2-Cys, the resolving
Cys is located on the same monomer.17 Dissimilarly, in the typical 2-Cys, Cys-SRH is
located on the adjacent monomer of the Prxs dimer. Ultimately, an external thiol reduces
the sulfenic acid intermediate in 1-Cys or the disulfide bond in 2-Cys restoring the
catalytic activity of the enzyme as the formation of sulfenic acid or disulfide transiently
stops the peroxidatic activity.12
In eukaryotic cells, the reduction of sulfenic acid, in the typical 2-Cys, by the adjacent
monomer Cys-SRH requires large structural rearrangements decreasing the rate of
disulfide formation.18,19 Notably, this can lead to the overoxidation of the highly reactive
sulfenic acid by a second H2O2 molecule forming a sulfinic acid (–SO2H) intermediate.19
Subsequently, under oxidative stress sulfinic acid is overoxidized to sulfonic acid (–
SO3H).20 The formation of sulfinic acid in Prxs was found to not only inactivate the
peroxidatic activity allowing for the increase in the peroxide level and signal stimulation
but also it leads to the formation of high molecular mass Prxs aggregates with a
chaperone activity.21,22 In addition to typical 2-Cys, the oxidation of sulfenic acid has
been found to occur in 1-Cys and in the atypical 2-Cys but at slower rates.23 It is
important to mention that this overoxidation mechanism has been found to occur in other
proteins such as protein tyrosine phosphatases 1B (PTP1B) and carbonic anhydrases.24,25
In general, theses overoxidation states of sulfenic acid are considered irreversible, leading
to the inactivation of the enzyme.26,27 Furthermore, the formation of sulfinic and sulfonic
acid has been found to be associated with multiple disorders including cancer and age
related diseases.22,28-30 Fortunately, the overoxidation of the typical 2-Cys Prxs to sulfinic
acid is reversible by sulfiredoxin (Srx) via a unique mechanism.22
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Srx was first identified in 2003 in Saccharomyces cerevisiae in which a disulfide bond
was formed between Srx and 2-Cys Prx.31 The reduction mechanism was found to be
dependent on the presence of ATP and magnesium.31 Later several studies have indicated
the conservation of Srx in eukaryotic organisms.22 In human, Srx is mainly localized in
the cytosol allowing for the restoration of the peroxidatic activity of PrxI and PrxII as
well as the mitochondrial PrxIII and the ER PrxIV.22 Therefore, Srx can bind to all human
typical 2-Cys Prxs and reverse the oxidation to sulfinic acid. However, previous studies
have also shown that the Srx-Prx reduction mechanism is inefficient, with catalytic rate
constant of 0.1 to 1.8 min-1, emphasizing the role of Srx in regulating 2-Cys Prxs and
subsequently H2O2 signaling.22,32 Wood et al.31 have proposed a floodgate hypothesis in
which transient intracellular peroxide burst increases the level of peroxide leading to the
rapid inactivation of 2-Cys Prx allowing for H2O2 to act as messenger interacting with
other proteins. However, in the presence of high concentration of Prx peroxide signaling
would be stopped. Hence this overoxidation/reduction mechanism is essential for
peroxide signaling as well as Prxs chaperon activity.21,23
The molecular basis of this unique interaction of Srx-Prx has been investigated using
several techniques including structural, mutational and mass spectrometry studies.22
However, the exact mechanism is debatable. Originally, Biteau et al.33 proposed that the
mechanism would occur in two steps in which Srx act as a phophotransferase and
thioltransferase. First, the sulfinic acid is phosphorylated forming a novel sulfinic acid
phosphoryl ester intermediate, see scheme 8.1. This reaction is reminiscent and is known
to occur in several enzymes for the activation of a carboxylic group by phosphorylation
such as in glutamine synthetases.34 However, this reaction is unique for sulfur chemistry.
Then, the activated phosphoryl ester intermediate might reacts with a conserved Srx
cysteinyl residue (Cys99) forming Srx-Prx thiosulfinate intermediate,33 see scheme 8.1.
Finally, an external thiol, such as Trx, reduces the thiosulfinate intermediate restoring the
Prx activity.
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Scheme 8.1. The proposed regulation mechanism of typical 2-Cys Prx via Srx upon the
hyperoxidation of Prx sulfenic acid by hydrogen peroxide.

On the contrary, Jeong et al.19 proposed different mechanism in which the Srx
conserved Cys is first phosphorylated similar to the phosphorylation mechanism of
PTP1B active site cysteinyl residue.35 Followed by the transfer of the phosphate group to
the sulfinic acid oxygen forming the sulfinic acid phosphoryl ester. Later the intermediate
is directly reduced via thiol molecule (RSH). Furthermore, their mutation studies
indicated that Arg50, Asp57 and Asp79 are essential for substrate binding.19 It is
important to mention that the mutation of Cys99 was found to terminate the reductase
activity of Srx.33
Jönsson et al.32,36,37 have performed several crystallographic studies to investigate the
nature of the formed intermediates in the mechanism. Their results support the original
mechanism, see scheme 8.1, in which Srx performs bifunctional roles. Since their
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obtained crystal structure of Srx-Prx complex as well as the quaternary structure of SrxPrx in the presence of ATP and Mg2+ shows that the distance between the γ-phosphate and
Cys99 sulfur is nearly 5 Å.36 Notably, the position of Cys99 does not allow for in line
nucleophilic attack. On the contrary, the Prx Cys52Asp oxygen is in a perfect position for
in line nucleophilic attack with a distance of 4.3 Å from the phosphate group.36 In
addition, in their Srx, ATP and Mg2+ crystal structure the γ-phosphate was found to point
toward the solvent.37 Furthermore, the formation of the thiosulfinate intermediate has
been proven in both human and yeast in previous studies.38,39 The role of the Mg ion was
also investigated in which it was found to ligate to the three phosphate groups of ATP
resulting in directing the γ-phosphate toward the Prx Cys-Sp.22 Finally crystal structure
indicated the unfolding of the Prx to allow for its interaction with Srx.32
Until now, this unique sulfur reaction has not been investigated neither using small
molecules nor within the Srx-Prx active site. Therefore in this study the reduction
mechanism of Prx sulfinic acid via Srx is investigated in details using quantum
mechanical/ molecular mechanical (QM/MM) modeling approach based on the Srx-Prx
ATP and Mg2+ bound protein crystal structure. Computational chemistry is now
established as a main tool for investigating catalytic mechanisms and has been
successfully used to gain atomistic details of the enzymatic mechanisms including
intermediates, transition states and energetics.40-43

8.2 Computational Methods
8.2.1 Protein Model Preparation
The X-ray crystal structure preparation and the MD analysis were accomplished using
the Molecular Operating Environment (MOE) software package.44 Molecular dynamic
simulation was performed using the NAMD Molecular Dynamics software.45 The initial
coordinates were taken form the X-ray crystal structure of human Srx in complex with
typical 2-Cys Prx (PrxI), ATP and Mg2+, PDB: 3HY2. 36
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Figure 8.1. The QM/MM model for the Srx-Prx Michaelis complex used to investigate
the first step of the mechanism. The QM layer atoms are highlighted in sticks to the right
of the Figure.

First, the PrxI Cys52Asp was mutated to sulfinic acid. Second, the missing protons in
the crystal structure were added using the protonate 3D application in MOE that assigns
each residue ionization state by minimizing the total free energy of the system.46 Then,
the two enzymes complex structure was spherically solvated up to 15 Å beyond every
protein atom. The distance between the γ-phosphate and one of the sulfinic oxygen's was
restrained to 3–3.5 Å. Subsequently, the protein complex was minimized using
AMBER12:EHT force field in which AMBER 12 parameters are used for protein and
Extended Hückel Theory for parameterizing small molecules.47,48 Finally, in order to
allow for thermal relaxation especially after introducing sulfinic acid in the structure, the
minimized structure was used as starting point for a short 500 ps MD simulation at 300 K
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similar to previous studies.49 Finally, the final structure of this short simulation was
chosen as the starting structure for further calculations.
In order to investigate the second step of the reaction, a second 500 ps MD simulation
was also performed to model possible arrangements in the active site upon sulfinic acid
phosphoryl ester intermediate formation. The starting structure for this simulation was
obtained from the QM/MM optimized structure of the intermediate. The distance between
sulfinic acid phosphoryl ester sulfur and the Srx Cys99 sulfur was restrained to 2.5–3 Å in
order to allow for subsequent reaction. The same protocol was used as in the first
simulation and the last structure of the simulation was chosen as the starting point for
QM/MM calculations.

8.2.2 QM/MM Models and Calculations
All calculations were performed within the ONIOM scheme using the Gaussian 09
suite of programs.50 The QM/MM starting structures were taken from previous steps
using the whole protein Srx-Prx complex. The QM high layer was described using the
hybrid-meta-exchange-correlation functional M06-2X.51 While the MM low layer was
described by AMBER96 force field as implemented in Gaussian. Optimized geometries
were obtained using the 6-31G(d,p) basis set for the high layer. Due to computational cost
as well as to keep the integrity of the protein-protein interaction all atoms 15 Å away
from the γ and β phosphate linking oxygen were kept frozen in the calculations. Relative
energies were then obtained using a single point energy calculations on the optimized
structures at the ONIOM(M06-2X/6-311+G(2df,p):AMBER96) level of theory within the
electrostatic embedding (EE) formalism.52 The EE formalism accounts for the
polarization of the core layer by the low layer at the QM level of theory. The choice of
functional and basis sets was based on our previous benchmarking study of several
biological sulfur species in which M06-2X was found to be one of the best functionals
with respect to a benchmarking QCISD and MP2 calculations (manuscript in
157

preparation). Frequency calculations were performed on the high layer only to confirm
the nature of the optimized structures as previously conducted.53,54

Figure 8.2. The QM layer residues included in model II to study the second step of the
reduction mechanism converting sulfinic acid phosphoryl ester into thiosulfinate.

As can be seen in Figure 8.1, the Michaelis complex structure included only the
cysteinyl sulfinic acid residue (Csd52) from PrxI. Besides several residues from the Srx
protein as the ATP molecule is mainly bonded to the Srx active site, similar to
experimental results, including the conserved Cys99, His100, Lys61, Arg101, Gly97 and
Gly98. Furthermore, in addition to ATP and Mg2+, several active site water molecules
were also added to the high layer.
For the second step of the reaction, the QM layer of the sulfinic acid phosphoryl
intermediate was slightly increased allowing for better description of the sulfinic acid
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phosphoryl ester surroundings interaction. As can be seen in Figure 8.2, the used model
included Csd52, Pro53 and Thr54 from PrxI. In addition, the same Srx residues as in
model I were included beside Ser55 and Arg51 as well as the R group of His100.

Figure 8.3. Potential energy surface obtained for the formation of sulfinic acid
phosphoryl intermediate and ADP from Prx-sulfinic acid and ATP via a concerted
mechanism.

8.3 Results and Discussion
8.3.1 Formation of sulfinic acid phosphoryl ester
The total active site interactions of the optimized structure of the reactive complex
(RC) are similar to the Srx-Prx X-ray structure. The phosphate groups of the ATP
molecule is stabilized and bound to the Srx proteins by several hydrogen bonding's with
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Srx residues including Lys62, Arg101, Cys99 and the backbone amide of His100, Cys99
and Gly98. Previous mutational studies have confirmed the role of these residues in ATP
binding. In addition, as in the crystal structure the Mg2+ ion is coordinated to the three
phosphate of the ATP molecule. Besides Mg2+ ion coordination to the phosphate groups, it
is also coordinated to three water molecules with an average distance of 2.06 Å. this
octahedral interactions of the Mg2+ ion direct the γ-phosphate toward the Prx sulfinic acid
(Csd52).
The Srx-Cys99 sulfur is 3.85 Å from the γ-phosphate atom. More importantly, the
distance between the Prx-Csd52 oxygen and the γ-phosphate atom is 3.08 Å, see Figure
8.4. Therefore, the position of Prx-Csd52 is in a better position for direct in line
nucleophilic attack as previously proposed. Furthermore, the Prx-Csd52 second oxygen is
sharing a proton with one of the Mg ion bound water molecule in which the proton is 1.39
Å and 1.09 Å from the water oxygen and the sulfinic acid oxygen, respectively. In
addition, the Mulliken population analysis shows that the sulfinic acid oxygen has a
negative charge of -0.54 and the γ-phosphate atom has a positive charge of 1.28.
Based on structural arrangement and charge distribution, we investigated the first step
of the mechanism in which a direct in line nucleophilic attack of Prx-Csd52 oxygen to
form sulfinic acid phosphoryl ester. This step was found to occur via a low barrier of 16.3
kJ mol-1. In TS1, the Prx-csd52 oxygen is 2.13 Å form the γ-phosphate atom. Similarly,
the γ-phosphate…O bond is elongated to 2.14 Å showing that phosphoryl transfer is
happened via a concerted mechanism. Other interactions in the active site remain similar
to the reactive complex.
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Figure 8.4. Schematic representation of the optimized stationary points for the overall
reaction, from sulfinic acid to thiosulfinate product formation. All atoms in the QM layer
are included however, we only highlighted the atoms included in the reaction as balls and
sticks.

The energy of the sulfinic acid phosphoryl intermediate (I1) is quite similar to RC
with a difference of -0.5 kJ mol-1. Indeed in the I1 optimized structure, see Figure 8.3, the
phosphoryl group is already transferred to the sulfinic acid in which the Prx-Csd52
oxygen…phosphorus distance is 1.7 Å. Furthermore, the phosphoryl group is totally
dissociated from the ATP forming an ADP molecule with a P…O distance of 2.88 Å.
Furthermore, the dissociated ADP oxygen is now hydrogen bonded to Srx-Cys99 and the
backbone amide of His100. The Mg2+ ion is still coordinated to the three phosphate
groups. In I1, the distance between the Srx-Cys99 sulfur and the sulfinic acid phosphoryl
intermediate sulfur is quite long for subsequent reaction, 5.70 Å. This indicates the need
for structural rearrangements of the active site upon formation of I1. Therefore, as
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indicated in the computational method section, we performed a second MD on the I1
optimized structure allowing for the following interaction to happen. It is important to
mention that previous study indicated the change of the two sulfur's distance to
approximately 3 Å upon sulfinic acid phosphoryl ester formation.

8.3.2 Formation of thiosulfinate intermediate
The obtained MD structure of I1' was optimized as in the previous step however, a
larger QM layer was included to better describe new interactions in the intermediate, see
computational section. Several new interactions were obtained in the QM/MM optimized
I1' upon allowing for structural rearrangements such as Mg2+ ion is now coordinated to
two oxygen of the sulfinic acid phosphoryl ester as well as three oxygen from the ADP
molecule in addition to a water molecule keeping its octahedral structure. The second
oxygen of the Csd52 is double hydrogen bonded to Prx-Thr54. In addition several water
molecules are hydrogen bonded to the phosphoryl moiety of the sulfinic acid ester.
Furthermore, the Srx-Cys99 is strongly hydrogen bonded to the sulfinic acid phosphoryl
ester, 2.06 Å, see Figure 8.4. More importantly, the distance between the Srx-Cys99
sulfur and the sulfinic acid sulfur is now 3.33 Å allowing for subsequent reaction.
Furthermore, the Mulliken population analysis shows that the sulfinic acid phosphoryl
ester has a positive sulfur center of 0.152. In contrary the Srx-Cys99 sulfur has a negative
charge of -0.312.
The second step of the reaction involving thiosulfinate formation was also found to
occur in a concerted mechanism with an energy barrier of 81.6 kJ mol-1 with respect I1',
see Figure 8.5. The optimized transition state for this reaction (TS2) shows that the SrxCys99 is already activated forming a better nucleophile by the phosphoryl sulfinic acid
ester oxygen. Notably the S…S distance is reduced to 2.64 Å with a concomitant
elongation of the S…OPO3H bond to 2.02 Å. This indicates that the reaction would occur
via an SN2 mechanism as in the first step. Furthermore, in TS2, the Mg2+ ion losses one of
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its coordination with the now protonated oxygen of the phosphoryl moiety, replacing it
with a second water molecule. The now nucleophilic Srx-Cys99 sulfur is currently
stabilized by hydrogen bonding with Srx-Arg51 as well as a water molecule.
The formation of the disulfide bond forming the thiosulfinate product complex and
phosphoryl group (PC) is found to lay 66.2 kJ mol-1 higher in energy than I1'. Indeed, the
PC optimized structure shows the cleavage of the S…OPO3H bond with a distance of 2.71
Å. More importantly, the Srx-Cys99 sulfur is bounded to Prx-Cys52 with a distance of
2.14 Å. Furthermore, the Mg2+ ion has restored its double coordination with the released
phosphoryl group.

Figure 8.5. Potential energy surface obtained for the formation of thiosulfinate product
complex via the interaction of Prx-sulfinic acid phosphoryl ester and Srx-Cys99 via a
concerted mechanism.

In general, our results support the previously suggested reduction of Prx-sulfinic acid
via ATP and Srx. Additionally, our obtained energies suggest that the rate-limiting step of
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this part of the reduction mechanism is the formation of the thiosulfinate intermediate.
Our obtained energies also suggest that the inefficiency and the slow catalytic rate for this
reaction is mainly due to the final step in which an external thiol reduces the thiosulfinate
intermediate. In fact this is in agreement with several enzymatic mechanisms including
external thiol such as Trx. For example in methionine sulfoxide reductase Msr's where the
reduction of the disulfide by Trx is the rate-limiting step.43 Finally, our results provide a
detailed mechanism for sulfinic acid reduction, which could open the door to design new
antioxidants capable of reducing such irreversible modifications of proteins.

8.4 Conclusions
The atomic description of the reduction mechanism of Prx-sulfinic acid via ATP and
Srx has been elucidated in details using the hybrid quantum mechanical/ molecular
mechanical (QM/MM) approach, within the ONIOM formalism. The Srx-Prx proteinprotein starting model was first obtained from the X-ray structure of the Prx-Cys52Asp
mutated structure with Srx, ATP and Mg2+. Prior to QM/MM calculation, first, the PrxAsp52 was modified to sulfinic acid. Subsequently, the whole structure was solvated and
minimized using AMBER12:EHT force field. Then the minimized structure was
thermally relaxed using short molecular dynamics simulation for 500 ps allowing for
equilibration of the active site upon modifications. Finally, the last MD structure was
chosen as a starting structure for the QM/MM calculations.
The previously proposed mechanism for sulfinic acid reduction via direct formation of
sulfinic phosphoryl ester and finally thiosulfinate was examined. The Srx-Prx complex
was divided into two layers in which the high layer included only the active site residues
and their calculations were performed using the M06-2X, DFT functional. The rest of the
complex was optimized using AMBER96 force field.
The first step of the mechanism was found to occur via a direct concerted mechanism
forming sulfinic phosphoryl ester with a small activation energy of 16.3 kJ mol-1. In TS1,
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the Prx-csd52 oxygen perform an in line nucleophilic attack on the γ-phosphate as
previously suggested forming a slightly stable sulfinic acid phosphoryl intermediate with
respect to RC. The I1 optimized structure shows that the phosphoryl group is already
transferred to the sulfinic is dissociated from the ATP forming an ADP molecule. In I1,
the distance between the Srx-Cys99 sulfur and the sulfinic acid phosphoryl intermediate
sulfur indicated the need for structural rearrangements of the active site upon the
intermediate formation allowing for subsequent reaction.
A second MD on the sulfinic acid phosphoryl ester was performed allowing for
structural rearrangements. The last MD structure was chosen for subsequent QM/MM
calculations as in the previous step. A larger QM layer was included in the starting
structure of the second step allowing for better description of the active site. The QM/MM
optimized of I1' shows several structural rearrangements in the active site, such as the
Mg2+ ion double coordination the sulfinic acid phosphoryl moiety. Notably, the distance
between the Srx-Cys99 sulfur and the sulfinic acid sulfur is 3.33 Å allowing for
subsequent reaction.
The second step of the mechanism was also found to occur in a concerted mechanism
with an activation energy of 81.6 kJ mol-1. In TS2, the Srx-Cys99 is first activated
forming a better nucleophile followed by nucleophilic attack on the sulfinic acid sulfur
with a concomitant cleavage of the S…O bond via an SN2 mechanism. The formed
thiosulfinate product complex was found to lay 66.2 kJ mol-1 higher in energy than I1'.
Our results suggest that the rate-limiting step of this part of the reduction mechanism is
the formation of the thiosulfinate intermediate indicating that the rate limiting–step of the
overall reaction is related to the reduction of the thiosulfinate intermediate via an external
thiol as in other proteins.
Finally, this study set up the basis for understanding the chemistry behind this
fascinating sulfur reaction in Srx which could open the door to design Srx ATP mimic
antioxidants as new hope to fight oxidative stress which is hallmark for many diseases.
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Chapter 9

Computational Investigations on the Catalytic
Mechanism of Maleate Isomerase: the Role of
the Active Site Cysteine Residues

9.1 Introduction
For biomolecules, structure and function are often intimately inter-related.
Consequently, their chemical and physical diversity is an essential factor for life as it
enables them to exhibit numerous differentiated and highly specific functionalities.1
This range of functionality arises not only from the use of dissimilar molecules but
also from geometrical isomers of the same molecule.2 For example, L-glutamate is a
building block of proteins and has a role as an essential neurotransmitter in all
complex living organisms.3 Its stereoisomer D-glutamate, however, does not share
these functionalities; for example, it is instead a key component in bacterial cell wall
synthesis.4 Cells can also differentiate between isomers of exogenous molecules such
as therapeutic drugs, e.g., the enantiomers of thalidomide in which one is an effective
treatment for morning sickness while the other causes birth defects.5,6
Cis-trans isomerization (CTI) is an important approach for generating geometrical
isomers,7 and is involved in many biochemical phenomena such as protein folding.8
Such reactions require the breaking of a double bond, which typically has a high
activation barrier. However, they can be chemically-facilitated by, for example, the
use of metal ions, nucleophilic attack or acid/base catalysis.8,9 Alternatively, photoexcitation can lead to isomerization via π-π* singlet and triplet excited states.10-12
A number of enzymes that catalyze CTI have been examined experimentally and
theoretically, revealing a wide range of mechanisms. For example, the glutathione
(GSH)-dependent enzyme maleylacetoacetate isomerase, converts maleylacetoacetate
to fumarylacetoacetate via transient covalent modification.13 The related enzyme
maleylpyruvate isomerase utilizes a similar mechanism.14 In contrast, the mechanism
by which retinal isomerases converts 11-trans-retinal to 11-cis-retinal proceeds via a
radical intermediate.15 The peptidyl-prolyl cis-trans isomerase family catalyzes the
interconversion of cis/trans peptide bonds that involve prolyl. Notably, they have been
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proposed to use a variety of different mechanistic approaches including nucleophilic
and proton addition.16,17
Asp/Glu racemase superfamily members share several structural features including
a pseudosymmetrical active site-containing domain, carboxylate-containing substrate,
dioxyanion hole to help stabilize the carboxylate,18 and in most members, two
catalytic cysteinyls.4 The catalytic role of the latter two residues has been
experimentally confirmed using site directed mutagenesis,9,19,20 and two mechanisms
have been proposed for their activation. In particular, in some members such as
glutamate racemase (GluRs) the catalytic Cys may be activated by a conserved His
and Asp residues.21 In contrast, a previous study on proline racemase (ProRs),
involving molecular dynamics (MD) simulations suggested that activation may occur
via a water or the substrate itself.18 Regardless of such differences, however, the
catalytic mechanism of all members is believed to involve formation of an enediolate
intermediate.18,22
Maleate cis-trans Isomerase (MI) is a member of the Asp/Glu racemase
superfamily found in bacteria that collectively exhibit a diverse range of functions
including catalyzing the conversion of L-amino acids to D-amino acids during cell wall
biosynthesis.19,23,24 MI is a key enzyme in the metabolic degradation pathway of
nicotinic acid.25 Notably, it is utilized by many microorganisms such as Pseudomonas,
Alcaligenes, Serratia and Proteus to catalyze the geometric isomerization of maleate
to fumarate (Scheme 1).6,26 The latter is an essential intermediate in the citric acid
cycle.27 In addition, it is also an important industrial target as it is involved in aspartic
and L-maleic acid production.28,29 Recently, there has also been increasing attention in
using MI for degradation of tobacco waste.30 Hence, there is great interest in gaining a
better understanding of the mechanism and properties of MI and its related
enzymes.23,29,31,32
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Scheme 9.1. Illustration of the overall isomerization reaction catalyzed by Maleate
cis-trans Isomerase (MI).

Maleate cis-trans Isomerase (MI) is a cofactor-independent member of the
Asp/Glu racemase superfamily.26,33 Recently, X-ray crystal structures of both wildtype MI from Nocardia farcinia and the corresponding C194A mutant with a
succinyl-cysteine intermediate trapped within the active site has been determined.34 In
the same study, site directed mutagenesis studies showed that mutation of Cys194 to
Ala results in enzyme inactivation.34 Furthermore, substitution of either active site
cysteinyl Cys194 or Cys76 by serine reduces the rate of reaction of MI by 8000 and
1474-fold, respectively.34 In addition, it was noted that as with other Asp/Glu
racemase members several residues form a dioxyanion hole to help stabilize reaction
intermediates.9,34 However, the more hydrophobic nature of MI's active site likely
results in a less effective stabilization.34
Based in part on these studies, two possible isomerization mechanisms have been
proposed as shown in Scheme 2. Both involve an initial direct nucleophilic attack of
deprotonated Cys76 (i.e., Cys76S–) at the maleate substrate's C2 carbon centre.
Notably, it is as yet still unclear how Cys76 is deprotonated (i.e., activated) so that it
can more readily act as a nucleophile.34 Furthermore, this nucleophilic role is
distinctly different to that observed in other superfamily members such as GluR and
arylmalonate decarboxylase (AMD) in which the active site cysteinyls act as acids
and/or bases and do not form a covalent enzyme-substrate complex.18,35 Importantly,
in one pathway (A) this occurs with concomitant transfer of the Cys194 thiol proton
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onto the substrate's C3 carbon centre to form a succinyl-cysteine-type intermediate
(Scheme 2A). It is important to mention that this intermediate has been observed using
X-ray crystallography in the C194A mutant structure at high resolution and it was also
confirmed using mass spectrometry.34 In the alternate pathway, however, Cys194 acts
simply as a hydrogen bond donor to one of the substrate carboxylates throughout the
mechanism, stabilizing its anionic charge (Scheme 2B). That is, pathway B proceeds
via an enediolate-type intermediate. Despite these differences, the next step in both
proposed mechanisms is rotation around the newly formed C2–C3 single bond to give
a fumarate-like structure. In the succinyl-Cys pathway (Scheme 2A), the Cys76S–C2
bond dissociates concomitantly with deprotonation of -C3H2- by Cys194S–, thus
forming fumarate with regeneration of a neutral Cys194SH. In contrast, in the
enediolate pathway (Scheme 2B), cleavage of the Cys76S–C2 bond leads directly to
formation of fumarate.
Scheme 9.2. Proposed mechanisms for the maleate/fumarate isomerization reaction
catalyzed by MI via an (A) succinyl-Cys or (B) enediolate intermediate.34
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Computational chemistry has been shown to provide detailed insights into
biological systems, and in particular, enzymatic mechanisms.36-39 In this present study,
density functional theory-based QM-cluster and ONIOM QM/MM methods have been
used to investigate the initial substrate-bound active site complex and protonation
states of key residues, as well as the catalytic mechanism of Maleate cis-trans
Isomerase (MI).

9.2 Computational Methods
All docking and molecular dynamics simulations were performed using the
Molecular Operating Environment (MOE) program,40 while all QM-cluster and
ONIOM QM/MM calculations were performed using the Gaussian 0341 and 0942 suite
of programs. The density functional theory method B3LYP, a combination of Becke’s
three parameter exchange functional43 and Lee, Yang and Parr’s correlation
functional44 as implemented in the Gaussian programs, was the QM method used in
the present calculations.
9.2.1 DFT-Small Model Studies
A series of initial studies were done in order to help determine an appropriate basis
set to use in the larger studies (see below), and to examine the effects of the
environment's polarity on the protonation state and properties of the substrate,
mechanistic intermediates and product. More specifically, optimized geometries were
obtained of maleic acid, its mono- and di-anionic deprotonated derivatives, succinate
and succinyl-methylthiol using the B3LYP method in combination with basis sets
ranging from 6-31G(d) to 6-311+G(2df,p). Effects of a polar environment were
included by use of the integral equation formalism polarizable continuum model (IEFPCM) as implemented in Gaussian.41,42 In particular, dielectric constants (ε) of 4 and
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10 were used to model a protein environment as previously suggested,45,46 while
ε=78.39 was used to model an aqueous environment.

9.2.2 QM-Cluster Studies
All structures were optimized at the B3LYP/6-31G(d,p) level of theory. Relative
energies were obtained via single points at the B3LYP/6-311+G(2df,p) level of theory
on the optimized structures with the inclusion of the corresponding solvation
correction obtained at the IEF-PCM (e=4.0)-B3LYP/6-31G(d,p) level of theory.
Frequency calculations were used to characterize transition structures as first-order
saddle-points.
A suitable chemical model was derived using the X-ray crystal structure of
Nocardia farcinia, NfMI (PDB ID: 2XEC).34 Specifically, dianionic maleate was
docked into the active site of NfMI; all residues within 10 Å of the catalytic cysteine
(Cys76) being considered as the active site. In the above crystal structure the R-group
of Cys76 points away from the active site pocket and therefore was manually
reoriented prior to docking and MD simulations. Docking was performed using the
London dG scoring function followed by optimization of the top 100 generated
structures using a force field refinement method using AMBER99. The best 30
scoring structures were then examined visually to choose the most suitable starting
structure for further calculations. The active site of the chosen structure was then
solvated up to 10 Å from the substrate. The solvated enzyme-substrate complex was
then allowed to thermally relax by performing an MD simulation for 1 ns with a time
step of 2 fs as has been previously used.47,48 A cluster analysis was then performed
based on the distance between the sulfur of Cys76 and maleate's -C2H2- carbon in
order to obtain an average structure, which was then optimized using the AMBER99
force field.49 From this optimized structure, the active site-bound substrate model
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shown in Scheme 3 was obtained for use in the QM-cluster studies. In particular, it
included appropriately truncated models of Cys76, Cys194, Val78 and Gln196 as they
are known or have been suggested to be catalytically important.34 In addition, the Rgroups of Tyr133, Asn14, and Asn163 were included as they directly interact with the
substrate, e.g., via hydrogen bonding. Finally, Leu77 and Val195, both modelled as
alanyls, were also included. As is common practice50 when using QM-cluster models,
in order to maintain the integrity of the model, a minimum number of atoms, remote
from the reactive region, were kept fixed at their MM optimized coordinates and are
highlighted in red in Scheme 3.

Scheme 9.3. The active site-bound substrate chemical model of NfMI used for the
QM-cluster studies (atoms fixed at their MM optimized coordinates are highlighted in
red and atom numbering used for Maleate carbons is also shown).
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9.2.3 QM/MM Studies
The hybrid quantum mechanics/molecular mechanics (QM/MM) method as
implemented in the ONIOM formalism in Gaussian 0942 was used for all QM/MM
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calculations.51 The reactive region, high (QM)-layer, was described using the same
level of theory and basis set size as per the above QM-cluster approach, B3LYP/631G(d,p). The rest of the chemical model, the low (MM)-layer, was described using
the AMBER96 MM force field. Relative energies were obtained via single points at
the ONIOM(B3LYP/6-311+G(2df,p):AMBER96) level of theory on the above
optimized structures.

Scheme 9.4. Schematic illustration of the chemical model, derived from the X-ray
crystal structure PDB ID: 2XED, used in the ONIOM QM/MM calculations. The
inner circle represents the high (QM)-layer while the outer represents the low (MM)layer.
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A suitable chemical model for use in the QM/MM calculations was obtained from
the X-Ray crystal structure of the Cys194Ala NfMI mutant enzyme with a covalently
active site-bound succinyl-cysteine intermediate (PDB ID: 2XED).34 A wild-type
178

Michaelis complex was generated by mutating Ala194 to Cys and cleaving the
enzyme-substrate covalent bond. The structure was then minimized using the
AMBER99 force field. The resulting minimized structure was then truncated to
include all residues within 15 Å of the substrate and is shown in Scheme 4. Within
this, the QM-layer was chosen to contain all residues previously used in the QMcluster chemical model as well as the Gln196–Met197 and Val78–Ala79 peptide
bonds. All other residues were placed in the MM-layer. In order to help maintain the
model’s integrity, and since a large QM-layer was selected, most MM-layer atoms
were held fixed at their minimized (see above) positions.52 The QM-cluster and
QM/MM optimized reactive complexes (RCs) were compared to verify consistency in
their structures. Notably, their RMSDs were determined to have only quite negligible
differences. In addition, the QM/MM optimized succinyl-Cys intermediate was
compared to the corresponding chemical region of the crystallized intermediate (i.e.,
PDB ID: 2XED)34 and found to have minor RMSDs of just 0.29 Å.

9.3 Results and Discussion
9.3.1 DFT-small model studies on isomerization
As noted in the Introduction, both proposed mechanisms involve nucleophilic
attack of a cysteinyl thiolate at the C2/C3 position of dianionic maleate.34 However,
one proceeds via a succinyl-Cys and the other an enediolate intermediate. The former
occurs with protonation of the adjacent =CH- while the latter does not (see Scheme 2).
To help obtain additional insights into factors that may influence maleate to fumarate
isomerization, a series of DFT-small model studies were performed. Specifically, we
considered formation of these intermediates for all 3 possible ionization states of the
substrate; di- (the most common form in aqueous solution)53 and monoanionic
maleate, and neutral maleic acid (Scheme 5). The HOMO and LUMO of each species
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was also determined, where those of maleate are shown in Figure 9.1.

Scheme 9.5. Schematic illustration of the gas-phase optimized structures of the 3
possible substrate states (∠C1-C2-C3-C4 = 0.0º in each).
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The gas-phase optimized structure of dianionic maleate has a ∠C1-C2-C3-C4
dihedral angle (φ) of 0.0º with the two carboxylates almost perpendicular to each other
(Supporting Information: Table S1). The C3–C4 bond (1.543 Å) is slightly elongated
with respect to C1–C2 (1.537 Å) as the HOMO lies mainly on the C1 carboxylate
which lies more in the plane of the carbon backbone. Notably, C2 has only a small
contribution to the HOMO orbital while to the LUMO it makes the largest
contribution (Figure 9.1). Thus, it would be expected to be the carbon centre most
susceptible to nucleophilic attack as has been proposed.34 Increasing the polarity of
the environment to 4.0 and 10.0, values commonly used to model the internal
environment of a protein, the HOMO and LUMO of maleate had negligible change. It
is noted that decreasing the charge in maleate via sequential protonation of the
carboxylates has only quite minor effects (-0.003 and -0.002 Å respectively) on the
C2=C3 bond length. Notably, however, the carboxylate/carboxylic groups now lie
more in the plane of the carbon backbone (see Scheme 5).
For maleate and monoanionic maleate, nucleophilic attack of a methylthiolate
(CH3S–) at C2 without concomitant protonation of C3 does not give a stable species
for all environmental polarities (ε values) considered (ε = 1.0, 4.0, 10.0 and 78.39
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(water)). Specifically, formation of an enediolate is unstable with respect to
dissociation of the S–C2 bond. The same occurs for monoanionic maleate when
CH3S– attacks at C3 (C3C4COOH) instead of C2.

Figure 9.1. The (a) HOMO and (b) LUMO of dianionic maleate in the gas-phase (ε =
1).

In contrast, for maleic acid nucleophilic attack of CH3S– at C2 gives a stable
enediolate structure. This occurs with marked lengthening in the C2–C3 bond from
1.343 to 1.471 Å, respectively. Simultaneously, a significant increase in the ∠C1-C2C3-C4 angle (φ) occurs from 0.0º to 57.6º, respectively. Furthermore, such changes
are observed for all values of ε; i.e., regardless of the environments polarity.
A stable succinyl-cysteinyl type intermediate was obtained for all 3 ionization
states of the substrate. However, its nature was sensitive to the environment and the
ionization state of the substrate. For example, for dianionic maleate, gas-phase
formation of such an intermediate occurred with significant increases in both the C2–
C3 bond length from 1.35 to 1.53 Å, and the dihedral φ from 0.0º to 159.7°. However,
as e was increased to 4.0, 10.0 and higher, the magnitude of rotation decreased. In
contrast, for maleic acid φ in the resulting intermediate was reasonably consistent at
approximately 60.0° for all values of e.
Thus, it appears that both the ionization state of the substrate and the polarity of
the environment can have significant effects on the stability and nature of possible
mechanistic intermediates.
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9.3.2 The ionization states of Cys76, Cys194 and the substrate
As described in the Introduction, in both proposed mechanisms, Cys76 acts as the
nucleophile while Cys194 acts as a proton or hydrogen bond donor.34 In order for
Cys76 to act as a more effective nucleophile it must be deprotonated, as assumed in
the mechanisms.34 Knowing the likely initial ionization state of both active site
cysteinyl residues is central for understanding their roles and the preferred reaction
pathway. Consequently, the proton affinities (PAs) of the Cys76S– and Cys194S–
thiolates within the various possible ionization states of the apo-enzyme and substratebound active site were examined using the present QM/MM models. The results
obtained are shown in Figure 9.2.

Figure 9.2. The calculated proton affinities (see Computational Methods) of C76S–
and C194S– before and after substrate binding, and the PA of the substrate in the
active site.

The proton affinity (PA) of methylthiolate (model for deprotonated cysteine) in
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aqueous solution is calculated to be 1514.7 kJ mol-1 at the present level of theory (see
Computational Methods). For the active site cysteinyl thiolates (i.e., C76S– and
C194S–), their PAs were first calculated within the apo-enzyme active site for both
possible scenarios; where the other cysteinyl is (i) anionic or (ii) neutral. For the first
case the PA of C76S– is 1541.4 kJ mol-1 while that of C194S– is 1448.5 kJ mol-1. That
is, the PA of C76S– has increased while that of C194S– has decreased compared to
CH3S– in aqueous solution. In contrast, in the case where the other cysteinyl is kept
neutral the PAs of both C76S– and C194S– decrease significantly to 1418.3 and
1325.2 kJ mol-1, respectively. Interestingly, in both scenarios the PA of C194S– is
lowest. This may reflect the fact that as seen in the X-ray crystal structure (PDB ID:
2XED),34 C194 is surrounded by more possible hydrogen bond donors than C76, thus
any anionic charge on the former is likely to be better stabilized.
From Figure 9.2 it can be seen that upon binding the dianionic substrate (Sub=),
the proton affinity of both C76 and C194 has increased markedly from their
corresponding values in all possible apo-enzyme active sites. In contrast, in all
substrate-bound active sites containing one or more neutral cysteinyls, the PA of Sub=
has decreased from its calculated value in aqueous solution (1877.3 kJ mol-1; not
shown). Importantly, however, despite these decreases, in those cases where only one
of the cysteinyls is neutral, the PA of Sub= remains higher than that of the ionized
cysteinyl. For instance, when C194 is neutral the PA of Sub= is 1811.1 kJ mol–1 while
that of C76S– is 19.0 kJ mol–1 lower at 1792.1 kJ mol–1. Similarly, when C76 is
neutral, the decreased PA of Sub= (1785.0 kJ mol–1) is still 71.7 kJ mol–1 higher than
that of C194S– (1713.3 kJ mol–1). Thus, in either system Sub= will be preferentially
protonated over the ionized active site cysteinyl.
Indeed, the proton affinity of Sub= when both cysteinyls are neutral is 1546.6 kJ
mol–1, while that of the ionized cysteinyl in C76S–/Sub–/C194SH and C76SH/Sub–
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/C194S– is 1527.7 and 1475.0 kJ mol–1, respectively. It is noted that in the latter
system the PA of C194S– is also lower than that of methylthiolate in aqueous solution.
These results thus suggest that the substrate-bound active site prefers to exist as
having a monoanionic maleate and ionized Cys194 (i.e., C194S–), but a neutral Cys76
(i.e., C76SH). This further suggests that the substrate itself may be able to play a role
in activating an active site cysteinyl, specifically Cys194, to be the required
nucleophile, while Cys76 may instead act as the proton or hydrogen bond donor.

Figure 9.3. PES obtained using a QM-cluster approach (see Computational Methods)
of the catalytic mechanism of MI in which Cys76 acts as a nucleophile.

9.3.3 Cys76-pathway: mechanism with Cys76 as the nucleophile
In both of the experimentally proposed mechanisms the thiol of Cys76 is
deprotonated and acts as a nucleophile to attack the C2 position of dianionic maleate,
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while Cys194 is neutral. Such possible catalytic mechanisms were thus considered
using a QM-cluster approach. The potential energy surface (PES) obtained is shown in
Figure 9.3 while the corresponding optimized stationary point structures, with selected
distances, are shown in Scheme 9.6.
In the optimized structure of the reactant complex, RCQM, the substrate’s
carboxylates are each stabilized by multiple hydrogen bonds. More specifically, C1OO– forms hydrogen bonds with the R-groups of Cys194 and Tyr133, and the
backbone –NH– moieties of Leu77 and Val95. The -C4OO– carboxylate, in contrast,
is stabilized by only three hydrogen bonds formed with the R-groups of Asn14 and
Asn163, and the backbone –NH– of Gln196. Meanwhile, the Cys76S– forms just a
single hydrogen bond with the backbone –NH–of Val78.

Scheme 9.6. Schematic illustration of the optimized structures obtained using a QMcluster approach (see Computational Methods) for the mechanism in which Cys76
acts as nucleophile
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Using the QM-cluster approach no mechanism involving an enediolateintermediate could be characterized. However, an alternate possible pathway
involving a succinyl-Cys type intermediate was obtained. The latter begins with
nucleophilic attack of the Cys76S– at the substrate's C2 center with a concomitant
proton transfer from the thiol of Cys194 onto C3. This step occurs via TS1QM with a
markedly high relative energy barrier of 142.0 kJ mol-1. In the optimized structure of
TS1QM (Scheme 6) the Cys76S…C distance has shortened considerably to 2.36 Å
while the C3…H…SCys194 distances are 1.74 and 1.53 Å, respectively. These
distances further illustrate the concomitant formation of the Cys76S—C2 bond and
proton transfer from Cys194. Notably, during formation of the succinyl-Cys
intermediate the ∠C1-C2-C3-C4 (φ) increases from 1.1º to 68.0º while the C2—C3
bond has lengthened to 1.42 Å; it now has significantly reduced double bond
character. That is, IC1QM resembles more a fumarate-like structure.
The resulting intermediate (IC1QM) formed lies 88.5 kJ mol-1 lower in energy than
RCQM. The dihedral angle φ has significantly increased to 210.8 (-149.2)º while the
C2—C3 bond has lengthened to 1.53 Å, i.e., is now essentially a single bond with a
trans-like orientation of the substrate's carbon backbone. The hydrogen bond network
between the substrate and active site residues is generally retained, with only some
minor differences. For example the Gln196 –NH– backbone now hydrogen bonds to
the thiolate of Cys76 instead of the substrates’ –C4OO– group.
In the next and final step the Cys76S–C2 bond is cleaved while concomitantly the
-C3H2- moiety transfers a proton onto the Cys194S– thiolate. This concerted step
proceeds via TS2QM with a barrier of 81.8 kJ mol–1 with respect to RCQM; 160.3 kJ
mol-1 with respect to IC1QM. That is neither step 1 or 2 are likely to be enzymatically
feasible.54,55 In TS2QM, the Cys76S…C2 bond has elongated to 2.60 Å; while the
Cys194S…H…C3 distances are 1.68 and 1.52 Å, respectively. As a result the C2—C3
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bond now has regained some double bond character. Furthermore, the dihedral angle φ
is now 182.9º. The product complex (PCQM) lies 28.5 kJ mol-1 lower in energy than
RCQM. Notably, the C2—C3 bond is now formally a double bond with a distance of
1.34 Å while φ has increased slightly to 191.9º.
It is noted that the corresponding "succinyl-Cys" mechanism in which the proton
transfers involving Cys194 occurred via a H2O moiety was also examined. However,
the relative energies with respect to RCQM of TS1QM and TS2QM increased
significantly to 123.0 and 193.9 kJ mol-1, respectively.
An ONIOM(QM/MM) approach (see Computational Methods) was then used to
further examine possible mechanisms in which Cys76 may act as the nucleophile. In
particular, mechanisms in which Cys76 and Cys194 may initially be neutral, as
suggested by the above PA calculations, were considered. The PES obtained is shown
in Figure 9.4 while the corresponding optimized structures, with selected distances,
are shown in Scheme 9.7.
Again, in the reactant complex the –C1OO– carboxylate is stabilized via multiple
strong hydrogen bonds with the side chain hydroxyl of Tyr133 and the backbone –
NH– functionalities of Ala79, Leu77 and Val195. Similarly, the -C4OO– group is
again stabilized via three strong hydrogen bonds with the side chains of Asn14 and
Asn163, and the backbone–NH– of Gln196. It is noted that the thiol of Cys194 forms
a

weak

hydrogen

bond

with

–C1OO–;

r(SH…O)

=

2.52

Å.
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Figure 9.4. PES obtained using an ONIOM(QM/MM) approach (see
Computational Methods) of the catalytic mechanism of MI in which Cys76 acts as a
nucleophile.
As noted, Cys76SH is proposed to act the nucleophile after it has been activated,
i.e., deprotonated. Unfortunately, Cys76 is situated in a hydrophobic region with no
suitable candidate base residue to cause its activation. However, an alternate
possibility is that the substrate may be able to facilitate such a process due to its
carboxylates. Indeed, the PA calculations described above suggest that the substrate
may have a suitably high-enough PA compared to Cys76SH.
In RC, the Cys76SH proton is 2.85 and 3.70 Å from the nearest oxygen of the –
C1OO– and –C4OO– groups, respectively Table S2). The first step of the overall
mechanism is transfer of the thiol proton of Cys76 via the –C1OO– moiety onto the –
C4OO– group. This occurs via TS1 with a barrier of 80.2 kJ mol–1 with respect to RC
(Figure 9.4). In TS1 (Scheme 7) the proton being transferred is essentially on the –
C1OO– group; r(C1OO–…H+) = 1.05 Å. Simultaneously, however, it lies about
midway between the Cys76 thiolate sulfur and the nearest oxygen of the –C4OO–
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moiety with distances of 2.31 and 2.15 Å, respectively (see Scheme 7). It is noted that
no intermediate was obtained with the Cys76SH proton on the –C1OO– group. This
may reflect that this carboxylate already makes stronger and more hydrogen bonds
with active site residues than the –C4OO– group. Thus, the –C1OO– group's anionic
character is better stabilized than that of the –C4OO– group. The Cys76S– thiolate now
appears suitably positioned to attack C2 (Scheme 7).
In the resulting intermediate formed, IC1, the proton from Cys76SH has been
transferred fully to the –C4OO– group. That is, the substrate is now a monoanionic
maleate with a neutral Cys194. Meanwhile, the anionic Cys76S– forms a single weak
hydrogen bond (2.57 Å) with the backbone –NH- of Val78. More importantly the
Cys76S…C2 distance has shortened to 2.75 Å while the C2–C3 bond has elongated
from 1.35 to 1.37 Å. IC1 lies lower in energy than RC by just 9.1 kJ mol-1.
As suggested by the DFT-small model studies (see above), a stable enediolate
intermediate could not be obtained within the active site using the QM/MM model.
Rather, the next step is nucleophilic attack of the thiolate of Cys76S– at the C2 carbon
centre of the substrate. Concomitantly, the thiol of Cys194 transfers its proton onto the
substrate's adjacent C3 center. This concerted step proceeds via TS2 at a cost of 52.4
kJ mol-1 with respect to IC1. This is illustrated by the fact that in the optimized
structure of TS2 the Cys76S…C2 distance has shortened significantly to 1.96 Å.
Meanwhile, the Cys194SH proton now lies between the Cys194 sulfur and C3 with
distances of 1.51 and 1.80 Å, respectively.
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Scheme 9.7. Schematic illustration of optimized structures obtained using an
ONIOM(QM/MM) approach (see Computational Methods) for the mechanism in
which
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The resulting succinyl-Cys intermediate formed, IC2, lies significantly lower in
energy than RC by 91.5 kJ mol-1. Also, the C2–C3 bond distance is now 1.54 Å.
Notably, it corresponds to the crystallographically obtained "intermediate" in a
Cys194Ala mutant MI enzyme.34
The next step is likely rotation about the C2–C3 bond (1.52 Å) to give an enzymebound fumarate-like intermediate IC3. Such a species similarly lies considerably
lower in energy than RC by 75.6 kJ mol–1. Unfortunately, no TS (TS3) for such a
rotation could be optimized at the present level of theory. However, the barrier is
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expected to be feasible as observed in the Cys194-pathway discussed below (see
Figure 9.5).
The subsequent and final step is then formation of the product complex PC; an
active site-bound fumarate. This concerted step, involving both cleavage of the C2—
SCys76 bond and a proton transfer from the substrate's -C3H2- group to Cys194,
occurs via TS4 at a cost of 119.2 kJ mol-1 with respect to IC3. Notably, the energy
difference between IC2 and TS4 is 135.1 kJ mol-1; which has been suggested to be
thermodynamically greater than that which is enzymatically feasible.54,55 This also
represents the largest difference between any minimum and TS along this possible
mechanism, and is likely the rate limiting step for such a mechanism. The apparent
considerable energy required for IC2 to either proceed to product or back to reactant
(requires 171.7 kJ mol–1) may provide insights into the ability of experimentalists to
obtain an X-ray crystal structure of such an intermediate in a Cys194Ala mutant
enzyme. Notably, the detection of the succinyl-Cys in C194A suggests the presence of
an alternate proton-transferring agent that helps stabilize the intermediate. However,
the absence of a suitable mechanistic base (i.e., loss of Cys194S–) does not allow for
product formation.
The final product complex, PC, lies slightly higher in energy than RC by 10.9 kJ
mol-1, indicating that the overall mechanism is endothermic. The C2–C3 double bond
is 1.37 Å, further indicating the formation of the fumarate product.
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Figure 9.5. PES obtained using an ONIOM(QM/MM) approach (see
Computational Methods) of the catalytic mechanism of MI in which Cys194 acts as a
nucleophile.

9.3.4 Cys194-pathway: mechanism with Cys194 as the nucleophile
As noted above, the PA calculations suggested that rather than Cys76, Cys194
may in fact be preferably ionized within the substrate-bound active site. Hence,
possible catalytic mechanisms in which Cys194 may act as the nucleophile were
investigated. The resulting PES obtained is shown in Figure 9.5 while the
corresponding optimized stationary point structures are illustrated in Scheme 8.
Beginning from the same RC as for the above mechanism in which Cys76 acts as
the nucleophile, the first step is the analogous substrate facilitated activation of
Cys194. This step, however, proceeds via TS1' at a cost relative to RC of only 40.1 kJ
mol-1 (Figure 9.5). This is half that required to activate Cys76 via an analogous
pathway (cf. Figure 9.4). Furthermore, unlike that observed for activation of Cys76,
the Cys194 thiol proton is transferred directly onto an oxygen of the -C4OO– group
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with r(Cys194S…H) and r(H…OOC4) distances in TS1' of 1.63 and 1.24 Å,
respectively (Scheme 7). The resulting intermediate formed IC1', lies lower in energy
than RC by 62.4 kJ mol-1. Notably, this is 53.3 kJ mol-1 lower in energy than IC1 on
the Cys76-pathway (cf. Figure 9.4). This is likely due in part to the fact that in
contrast to the single weak stabilizing hydrogen bond observed in IC1, in IC1' the
Cys194S– thiolate forms three hydrogen bonds. Specifically, it forms two with the
backbone –NH–'s of Gln196 and Met197, and one with the amide side chain of
Asn163 via a water molecule. Meanwhile, as in IC1, the proton from Cys194 is
wholly transferred onto the substrate's –C4OO– group and now forms an
intermolecular hydrogen bond with the –C1OO– moiety. Also, the C2–C3 bond in
IC1' (1.35 Å) remains little changed from that obtained for RC, in contrast to that
observed for IC1 in the alternate Cys76-pathway.
As for the Cys76-pathway the subsequent step is formation of a succinyl-Cys type
intermediate (IC2'). Again this involves nucleophilic attack of the thiolate, though
now it is Cys194S–, at the substrates C2 center, with concomitant transfer of the thiol
proton from the second active site cysteine (now Cys76) onto the adjacent C3 center.
No stable enediolate intermediate could be found. This step occurs via TS2' with a
barrier of 19.0 kJ mol–1 with respect to RC, or 81.4 kJ mol-1 relative to IC1'. The
resulting succinyl-Cys intermediate IC2' lies lower in energy than RC by -39.4 kJ
mol-1. However, notably, this is in fact 52.1 kJ mol–1 higher in relative energy than the
same corresponding intermediate IC2 of the Cys76-pathway (cf. Figure 9.4). The C2–
C3 bond has now elongated to 1.55 Å; that is, it is now a single bond.
At the heart of the isomerization mechanism is rotation about the C2—C3
bond, i.e., the cis-trans isomerization. In contrast to the seemingly one-step
isomerization upon formation of a succinyl-Cys intermediate for the Cys76-pathway,
a multi-step process was obtained on the Cys194-pathway (Figure 9.5). This process
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itself can be thought to occur in 3-stages. In the first, the intramolecular -C4OOH…–
OOC1- hydrogen bond is broken. Instead, the -C4OOH group now forms a strong
hydrogen bond with the thiolate of Cys76S–; r(C4OOH…–SCys76) = 1.84 Å. This
step occurs via TS3' with a low barrier of just 12.7 kJ mol-1 to give the alternate
succinyl-Cys type intermediate IC3'. The latter in fact lies slightly lower in energy
than IC2' by 8.6 kJ mol–1. More importantly, the ∠C2-C3-C4-O increases from 44.8°
to 71.8°. Notably, the twist about the C2—C3 bond, i.e., ∠C1-C2-C3-C4 (f), has
slightly changed from that observed in IC2', -294.3º to 306.0º in IC3'.
The next step is essentially the twist from a cis conformation to trans. This occurs
via TS4' with a barrier of 41.9 kJ mol–1 relative to RC or 89.9 kJ mol–1 with respect to
IC3'. In the resulting alternate succinyl-Cys type intermediate IC4', lying just slightly
higher in energy than IC3' by 5.3 kJ mol–1, ∠C1-C2-C3-C4 (f), has increased
significantly to 137.2º. All active site-substrate interactions observed for IC3' are
maintained (and the C2–C3 bond length stays the same as in IC3'). Importantly, this
represents the rate-limiting step along the Cys194-pathway having both the highest
barrier for a single reaction step and relative to RC. Furthermore, it is in good
agreement with the barrier of ~70 kJ mol-1 calculated using experimental kinetics
measurements.34 In addition, it is significantly lower than the 135.1 kJ mol–1 required
for the rate-limiting step of the alternate Cys76-pathway: going from IC2 to PC.
The third stage is cleavage of the Cys76S–…HOOC4 hydrogen bond. This step
occurs via TS5' at a cost of 52.0 kJ mol-1 with respect to IC4', or 9.3 kJ mol–1 relative
to RC. In the resulting alternate succinyl-Cys type intermediate formed, IC5', the C2–
C3 bond has shortened by 0.02 Å to 1.53 Å, while the dihedral angle ∠C1-C2-C3-C4
is now 160.4°. More importantly, the C4OH group now forms a quite strong hydrogen
bond of length 1.80 Å with an active site water molecule (Scheme 8). It should be
noted that this latter water simultaneously forms a weak hydrogen bond (2.45 Å) with
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the sulfur of Cys194 (Scheme 8). In addition, the distance between the thiolate sulfur
of Cys76 and the nearest -C3H2- proton has now decreased from 3.05 Å in IC4' to
2.45 Å in IC5'. Thus, the Cys76 now seems well-positioned relative to the substrate to
abstract a proton. Thermodynamically, IC5' has an energy relative to RC of 9.4 kJ
mol-1, 0.1 kJ mol–1 above that of TS5'. This is a common artefact of single-point
energy calculations on a flat PES and indicates that the reverse reaction, IC5' to IC4',
essentially occurs without a barrier.
The final step is proton abstraction by the thiolate of Cys76 from the substrates C3H2- moiety, with concomitant cleavage of the Cys194S—C2 bond. However,
unlike the Cys76-pathway where the analogous step occurred with a high barrier, on
the Cys194-pathway this step proceeds via TS6' at a very low cost of only 29.9 kJ
mol-1 relative to IC5'. The concerted nature of this step is highlighted by the fact that
in TS6' the Cys194S…C2 bond has elongated to 1.97 Å, while the C3H…SCys76 and
C3—HSCys76 distances are now 1.65 and 1.50 Å, respectively. The final product
complex PC, in which fumarate is now non-covalently bound within the active site, is
25.5 kJ mol-1 lower in energy than RC with a C2–C3 bond of 1.35 Å. Thus, unlike that
calculated above for the Cys76-pathway, this alternate mechanism in which Cys194
acts as the nucleophile is thermodynamically favoured.

9.4 Conclusions
In this study the mechanism by which the enzyme maleate isomerase catalyzes the
cis-trans interconversion of maleate and fumarate has been computationally
investigated. Specifically, DFT methods in combination with small chemical models
were used to gain fundamental insights into the nature of possible mechanistic
intermediates, while QM-cluster and ONIOM(QM/MM) methods have been used to
examine the nature of the substrate-bound active site and the catalytic mechanism.
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The feasibility of the formation of proposed enediolate and succinyl-Cys type
intermediates from a neutral, monoanionic or dianionic maleate substrate was initially
examined using DFT-small chemical model studies For both neutral and monoanionic
maleate an enediolate intermediate, formed by nucleophilic attack of methyl thiolate
(CH3S–) at their C2 center, was unstable, i.e., dissociated back to the original
substrates. In contrast, the succinyl-Cys type intermediate, formed by concomitant
thiolate addition to C2 and protonation of C3, was stable for all 3 ionization states of
the initial maleate. Furthermore, for dianionic maleate the formation of succinyl-Cys
leads to a barrierless rotation about the substrates central C2—C3 bond. Increasing the
polarization of the environment was observed to decrease the angle of rotation. In
order to understand the driving force for rotation, the LUMO and HOMO were also
examined.
The ionization state of the active site cysteinyl's (Cys76 and Cys194) and the
substrate were examined using an ONIOM(QM/MM) based approach for both the
apoenzyme and the substrate-bound active site. The results suggest that the proton
affinity (PA) of Cys76S– is higher than that of Cys194S– in both the apo-enzyme and
when the dianionic maleate substrate is bound within the active. Furthermore, the
combined results suggest that upon substrate binding the preferred initial state of the
substrate-bound active site contains a monoanionic maleate substrate, an ionized
Cys194 (i.e., Cys194S–) and a neutral Cys76 (i.e., Cys76SH).
Two possible mechanistic pathways were investigated using QM-cluster and/or an
ONIOM(QM/MM) approach. The first pathway corresponds to that previously
experimentally proposed in which the active site residue Cys76 acts as the mechanistic
nucleophile that attacks the substrates sp2 C2 centre; the Cys76-pathway. In the
alternate pathway Cys194 acts as the required nucleophile; the Cys194-pathway.
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Scheme 9.8. Schematic illustration of optimized structures obtained using an
ONIOM(QM/MM) approach (see Computational Methods) for the mechanism in
which Cys194 acts as nucleophile.
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In both pathways the Cys76 or Cys194 thiol, can be deprotonated via proton
transfer onto the maleate substrate's carboxylate positioned nearest Asn14 and
Asn163. However, the barrier for this step on the Cys194-pathway (40.1 kJ mol–1) is
only half that of the analagous step on the Cys76-pathway (80.2 kJ mol–1). This is due
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in part to greater stabilization of Cys194S– than Cys76S– by hydrogen bonding within
the active site.
The subsequent step in these pathways is the nucleophilic attack of the thiolate at
the maleate substrate's C2 centre. Additionally, this occurs with concomitant proton
transfer from the R-group thiol of the second active site cysteinyl to give a succinylCys intermediate (IC2 and IC2', respectively). Importantly, in the case of the Cys76pathway such an intermediate (IC2) lies significantly lower in energy than the initial
reactant complex (RC) by 91.5 kJ mol–1. Furthermore, subsequent rearrangement and
reaction of IC2 to give the final product complex (PC) requires a considerable amount
of energy; 135.1 kJ mol–1. This is in fact the rate-limiting process of the Cys76pathway. In contrast, for the Cys194-pathway the resulting succinyl-Cys intermediate
(IC2'), while lower in energy than the RC, is not as significantly stabilized, lying just
39.4 kJ mol–1 lower in energy than RC. It is able to undergo a series of relatively lowenergy rearrangements and reactions to give the final product complex (PC'). The
rate-limiting step along the Cys194-pathway is the step in which a twist from a cis
conformation to trans occurs. The calculated barrier for this step if 89.9 kJ mol–1 is in
good agreement with the barrier calculated using experimentally determined kinetics;
~70 kJ mol-1.34
Thus, the present results suggest that the overall catalytic mechanism of Maleate
Isomerase is initiated by a substrate-assisted activation of the active site cysteinyl
Cys194. This is followed by the concerted formation of a succinyl-Cys intermediate in
which Cys76 acts as an acid. Thus, Cys194 is the mechanistic nucleophile while
Cys76 instead acts as an acid/base along the mechanism. The desired rotation about
the C2—C3 bond occur via multiple relatively low-barrier steps with assistance of the
anionic Cys76S–, generated during formation of a succinyl-Cys intermediate. Finally,
cleavage of the Cys194S–C2 bond concomitant with proton abstraction by Cys76S–
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from the intermediates C3H2 group leads to the formation of the fumarate product.
The conserved nature of the active site in the racemase superfamily suggests possible
transferability of the mechanism outlined to other species in the family.
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Chapter 10
Conclusions

In this thesis the redox chemistry of sulfur in several enzymes has been investigated
using various computational approaches. Particularly, previously proposed mechanisms
for sulfenic acids formation and reduction/overoxidation pathways have been examined.
In Chapter 3, the catalytic mechanism of MsrA in Mycobacterium tuberculosis, in
which S-methionine sulfoxide (Met-O) is reduced to Methionine (Met), has been
investigated using docking, molecular dynamics (MD) simulations and ONIOM
(QM/MM) methods. In addition, the roles of specific active site residues including an
aspartyl (Asp87) near the recycling cysteine, tyrosyl's (Tyr44 and Tyr92) and glutamyl
(Glu52) have been examined, as well as the general effects of the protein and active site
on the nature and properties of mechanistic intermediates. The mechanism is initiated by
proton transfer from the catalytic cysteine's thiol (Cys13SH) via a bridging water to the
R-group carboxylate of Glu52. The now anionic sulfur of Cys13 nucleophilically attacks
the substrate's sulfur with concomitant proton transfer from Glu52 to the sulfoxide
oxygen, generating a sulfurane. The active site enhances the proton affinity of the
sulfurane oxygen which, can readily accept a proton from the phenolic hydroxyls of
Tyr44 or Tyr92 to give a sulfonium cation. Subsequently, Asp87 and the recycling
cysteine (Cys154) can facilitate nucleophilic attack of a solvent water at the Cys13S
center of the sulfonium to give a sulfenic acid (Cys13SOH) and Met. For the subsequent
reduction of Cys13SOH with intramolecular disulfide bond formation Asp87 can help
facilitate nucleophilic attack of Cys154S at the sulfur of Cys13SOH by deprotonating its
thiol. This reduction is found to likely occur readily upon suitable positioning of the
active site hydrogen bond network and the sulfur centers of both Cys13 and Cys154. The
calculated rate-limiting barrier is in good agreement with experiment.
In Chapter 4, the last step in the reductase step of the catalytic mechanism of MsrB
(MsrA sister enzyme) was re-investigated using several computational approaches. Our
previous DFT cluster paper showed that two possible mechanisms could occur, however
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the direct formation of disulfide from sulfonium cation was favored over sulfenic acid
formation. In contrary, experimental studies suggest sulfenic acid formation. Therefore,
first, we investigated the effect of level of theory, which confirmed previous conclusion.
In addition, the effect of model choice was also investigated using ONIOM including a
large QM layer around Cys440. Interestingly, deprotonating Cys440 leads to direct
nucleophilic attack on Cys495 forming disulfide. Second, to eliminate the possibility that
all previous results are an artifact of the used crystal structure in which the S…S distance
is 3.29 Å, we ran a 5 ns MD simulation on the sulfonium cation intermediate.
Surprisingly, our results show that the distance between the two sulfur is significantly
increased to 4.88 Å. More importantly a water molecule is located in a proper position for
nucleophilic attack. QM/MM calculations shows that sulfenic acid is formed via low
barrier of 16.7 kJ mol-1. Finally, the effect of substrate binding on the two Cys's distance
were investigated via running several MD simulations of possible intermediates, showing
that substrate binding induces conformational changes increasing the sulfur's distance
which is decreased upon substrate removal upon sulfenic acid formation. These results
question the applicability of QM cluster approach in systems including flexible turns. It
also emphasizes the importance of proper preparation of the starting structure.
Both Chapters 3 and 4, show that the same mechanism occurs in MsrA and MsrB
despite their active sites structural differences. As future direction, it would be interested
to investigate the mechanism in the 1-Cys Msr, which contains only one Cys residue in
the active site, particularly the stabilization mechanism of sulfenic acid in the active site
against overoxidation. Furthermore, in human, MsrB reduction mechanism uses an active
site selenocysteine (Sec) residue. Therefore, mechanistic difference between Cys and Sec
in MsrB could be revealed.
In Chapter 5, Docking and Molecular dynamic simulations were synergistically used
to elucidate the mechanism of MsrA activation via small molecules. Experimentally,
Pergolide (Perg) and Pergolide-sulfoxide (PergSO) have been shown to increase the
!
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activity of MsrA via an unknown mechanism. In this study we investigated the possibility
of MsrA induction via direct molecular interaction. Our docking calculations show that
Perg and PergSO as well as S-adenosyl methionine (SAM) bind to a novel allosteric site
of the oxidized form of the enzyme. MD simulations have also shown that the binding of
these molecules disrupts the interaction between the Gln122-Thr132 segment and Cterminal residues facilitating the binding of thioredoxin and the regeneration step in the
mechanism. These finding represent for the first time a direct mechanism to activate
MsrA providing a novel therapeutic pathway. Furthermore, virtual screening was used to
screen the subset ZIM from the drug database ZINC against our identified allosteric site.
Several ligands were identified to bind with high affinity to MsrA. Several following
studies are needed to verify the proposed activation mechanism. For instance, the direct
interaction hypothesis could be tested experimentally. Furthermore, identified possible
ligands can also be tested to select lead compounds. Subsequently, quantitative structural
relationship studies could be used to optimize the lead ligands.
In Chapter 6, the formation mechanism of sulfenyl-amide intermediate from sulfenic
acid in protein tyrosine phosphatase 1B (PTP1B) has been investigated. Using a wide
array of computational modeling techniques including MD simulations and high-level
ONIOM calculations possible catalytic pathways has been investigated. Several potential
reactive complexes were considered in the calculations. The only feasible mechanism was
found to occur in a stepwise fashion, in which a stable iminol intermediate is formed.
This step has an activation energy of 48.6 kJ mol-1. Later, a much more stable iminol
intermediate is formed in which a noncovalent electrostatic interaction of the sulfenic acid
sulfur anti-bonding orbital with the iminol nitrogen lone pair was found to occur.
Subsequently, a cyclic sulfenyl-amide is formed with a concomitant proton transfer from
Glu115 to the sulfenic acid oxygen. Our results suggest that Glu115 and His214 play a
crucial role in the mechanism. These results could contribute to the discovery of PTP1B
inhibitors and the stabilization of the enzyme oxidized form.
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In Chapter 7, mechanistic details for the reduction of hydrogen peroxide and the
formation of a proposed hypervalent sulfurane species in ApTPx have been elucidated via
the synergistic use of MD simulations and ONIOM. Our results show that the reduction
mechanism is driven by the destabilization of the peroxide substrate in the active site,
facilitating the nucleophilic attack from the peroxidative cysteine. Following the reduction
of hydrogen peroxide, a pseudo hypervalent sulfurane intermediate is suggested to form
with a weak interaction between His42 and the oxidized Cys50. This interaction was
confirmed using QTAIM and NBO analysis. Indeed, the formation of the sulfurane was
found to be energetically favorable over the overoxidized sulfinic acid species and thus
would provide a mechanism protecting sulfenic acid from overoxidation. A similar
intermediate was discovered for the first time in the human 1-Cys hORF6. Moreover, by
comparing X-ray structures with several different Prxs and other proteins we suggest this
intermediate may be generally formed when sulfenic acid is involved in protein
chemistry. This can be tested via synergistic use of computational and experimental
techniques to elucidate sulfenic acid interactions in PrxV and PrxIV as well as other
proteins such as SUMO proteases and Gsp amidase.
In Chapter 8, the reduction of typical 2-Cys perxoiredoxins (Prxs) sulfinic acid to
sulfenic acid via a repair enzyme known as sulfiredoxin (Srx) has been investigated.
Molecular modeling techniques including MD simulations (MD) and ONIOM approach
were used to elucidate the atomistic details of this unique reaction in sulfur chemistry.
Our results support the previous experimentally proposed mechanism in which the
sulfinic acid oxygen perform an in line direct nucleophilic attack on the γ-phosphate of
ATP forming sulfinic acid phosphoryl ester intermediate and ADP, via a low barrier of
16.3 kJ mol-1. Subsequently, the formed intermediate is directly reduced via an SN2
mechanism by the Srx-Cys99 forming thiosulfinate. Our results suggest that the ratelimiting step of the reduction mechanism is associated with the reduction step of the
thiosulfinate intermediate. Notably, this work improves the current knowledge of this
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unique reaction, which could contribute to the discovery of new groups of antioxidants
capable of reducing this irreversible overoxidized state in other proteins.
In Chapter 9, the maleate isomerase (MI) catalyzed isomerization of maleate to
fumarate has been investigated using a wide range of computational modeling techniques,
including small model DFT calculations, QM-cluster approach, ONIOM and MD
simulations. Several fundamental questions regarding the mechanism were answered in
detail, such as the activation and stabilization of the catalytic Cys in a rather hydrophobic
active site. The two previously proposed mechanisms were considered, where either
enediolate or succinyl-Cys intermediate forms. Small model calculations as well as an
ONIOM-based approach suggest that an enediolate intermediate is too unstable.
Furthermore, the formation of succinyl-Cys intermediate via the nucleophilic attack of
Cys76– on the substrate C2 (as proposed experimentally) was found to be energetically
unfeasible in both QM-cluster and ONIOM approaches. Instead, our results show that
Cys194, upon activation via the substrate, acts as a nucleophile and Cys76 acts as an
acid/base catalyst, forming a succinyl-Cys intermediate in a concerted fashion. Indeed,
the calculated PA of Cys76 is always higher than that of Cys194 before or upon substrate
binding in the active site. Furthermore, the mechanism proceeds via multiple steps by
substrate rotation around C2–C3 with the assistance of the now negatively charged
Cys76, leading to the formation of fumarate. Finally, our calculated barrier is in good
agreement with experiment. These findings represent a novel mechanism in the racemase
superfamily.
With!the!fast!growing!number!of!X:ray!identified!sulfenic!acids!in!proteins,!more!
computational! studies! are! needed! to! further! elucidate! sulfenic! acid! chemistry!
specially! their! protective! mechanism! and! interactions.! In! addition,! the! role! of! non:
covalent! interactions! in! stabilizing! sulfur! species'! needs! further! investigation.! ! In!
addition!the!transferability!of!any!of!our!studied!mechanism!to!other!proteins!would!
improve!our!understanding!of!these!reactions.!Although!our!studies!do!not!discuss!
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all! aspect! of! sulfur/sulfenic! chemistry,! it! gave! some! important! insights! that! enrich!
our!knowledge!about!sulfur!chemistry.!!
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